This is a Validated Antibody Database (VAD) review about human CD45, based on 1387 published articles (read how Labome selects the articles), using CD45 antibody in all methods. It is aimed to help Labome visitors find the most suited CD45 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD45 synonym: B220; CD45; CD45R; GP180; L-CA; LCA; LY5; T200

others
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 4f
 CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 4f). J Clin Invest (2020) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Nature (2020) ncbi
  • flow cytometry; mouse; loading ...; fig 4d
 CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). J Biol Chem (2020) ncbi
 CD45 antibody (Biolegend, RA3-6B2) was used . BMC Immunol (2020) ncbi
  • flow cytometry; mouse; loading ...; fig 4a
 CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4a). Front Pharmacol (2019) ncbi
  • flow cytometry; mouse; loading ...; fig 1a
 CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2019) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Nat Med (2019) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Immunol (2019) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Clin Invest (2019) ncbi
 CD45 antibody (Biolegend, RA3-6B2) was used . Science (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Front Immunol (2018) ncbi
 CD45 antibody (Biolegend, RA3-6B2) was used . PLoS ONE (2018) ncbi
 CD45 antibody (BioLegend, RA3-6 B2) was used . EMBO J (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Nature (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Exp Med (2018) ncbi
 CD45 antibody (BioLegend, Ra3-6B2) was used . Nat Med (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Clin Invest (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Cell Metab (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Cell Biol (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Nature (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Nat Commun (2018) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Cell (2018) ncbi
 CD45 antibody (Biolegend, RA3-6B2) was used . Nat Commun (2017) ncbi
 CD45 antibody (Biolegend, RA3-6B2) was used . Cancer Res (2017) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Eur J Immunol (2017) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . J Exp Med (2017) ncbi
 CD45 antibody (eBioscience, UCHL1) was used . J Allergy Clin Immunol (2018) ncbi
In order to show that TLR4 signals through the BCR leading to activation of SYK, ERK, and AKT as well as through MYD88 leading to activation of NFkappaB, CD45 antibody (BioLegend, RA3-6B2) was used . J Exp Med (2017) ncbi
 CD45 antibody (BioLegend, RA3-6B2) was used . Immunology (2017) ncbi
In order to examine the impact of emergency granulopoiesis on T and B cell function, CD45 antibody (Biolegend, RA3-6B2) was used . J Exp Med (2016) ncbi
BioLegend
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...
BioLegend CD45 antibody (BioLegend, 304048) was used in flow cytometry on human samples at 1:50. Life Sci Alliance (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (Biolegend, 304042) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Front Immunol (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1a
BioLegend CD45 antibody (BioLegend, 368510) was used in flow cytometry on human samples (fig 1a). World J Stem Cells (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD45 antibody (Biolegend, 304008) was used in flow cytometry on human samples (fig s1b). Stem Cell Res Ther (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend CD45 antibody (Biolegend, 103243) was used in flow cytometry on mouse samples (fig 5f). Adv Sci (Weinh) (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Leukemia (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:150; loading ...
BioLegend CD45 antibody (Biolegend, 103245) was used in flow cytometry on mouse samples at 1:150. PLoS Biol (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend CD45 antibody (BioLegend, 103211) was used in flow cytometry on mouse samples (fig s3). J Clin Invest (2022) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s11
BioLegend CD45 antibody (BioLegend, 304039) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s11). Nat Commun (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
BioLegend CD45 antibody (BioLegend, 103247) was used in flow cytometry on mouse samples (fig 1). Clin Transl Med (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s4a
BioLegend CD45 antibody (BioLegend, 368507) was used in flow cytometry on human samples (fig s4a). J Clin Endocrinol Metab (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2g
BioLegend CD45 antibody (Biolegend, 103201) was used in immunohistochemistry - paraffin section on mouse samples (fig 2g). Cell Rep (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2b, 3c
BioLegend CD45 antibody (BioLegend, 2D1) was used in flow cytometry on human samples (fig 2b, 3c). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (HI30)
BioLegend CD45 antibody (Biolegend, HI30) was used . Mol Cell Proteomics (2022) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig 3a, 3b
BioLegend CD45 antibody (Biolegend, HI100) was used in mass cytometry on human samples (fig 3a, 3b). Mol Cell Proteomics (2022) ncbi
mouse monoclonal (UCHL1)
  • mass cytometry; human; loading ...; fig 3a, 3b
BioLegend CD45 antibody (Biolegend, UCHL1) was used in mass cytometry on human samples (fig 3a, 3b). Mol Cell Proteomics (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2a
BioLegend CD45 antibody (BioLegend, 304012) was used in flow cytometry on human samples (fig 2a). Front Immunol (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s3b, s5e, 5e
BioLegend CD45 antibody (BioLegend, 304014) was used in flow cytometry on human samples (fig s3b, s5e, 5e). Sci Adv (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples (fig s1). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s16
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig s16). Mol Ther Methods Clin Dev (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig s5f
BioLegend CD45 antibody (BioLegend, 103231) was used in flow cytometry on mouse samples at 1:200 (fig s5f). Nat Commun (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples (fig s1a). Oncoimmunology (2022) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1c). Oncoimmunology (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a, s8c
BioLegend CD45 antibody (Biolegend, 103227) was used in flow cytometry on mouse samples at 1:100 (fig 3a, s8c). Nat Commun (2022) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 2e). PLoS ONE (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s12b
BioLegend CD45 antibody (BioLegend, 304021) was used in flow cytometry on human samples (fig s12b). Cell Rep Med (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig e5c, e7c, 2g, 2i
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig e5c, e7c, 2g, 2i). Nature (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c, s3a, s3b
BioLegend CD45 antibody (BioLegend, 103207) was used in flow cytometry on mouse samples at 1:200 (fig 1c, s3a, s3b). Development (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s21a, s25a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig s21a, s25a). Nat Commun (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:50; loading ...; fig s6g
BioLegend CD45 antibody (Biolegend, 103251) was used in flow cytometry on mouse samples at 1:50 (fig s6g). Nat Commun (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig s6c
BioLegend CD45 antibody (Biolegend, 103205) was used in flow cytometry on mouse samples at 1:200 (fig s6c). J Immunother Cancer (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1f, s1b
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 1f, s1b). MBio (2022) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s5f
BioLegend CD45 antibody (Biolegend, 304223) was used in flow cytometry on human samples (fig s5f). Biomark Res (2022) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig s4a
BioLegend CD45 antibody (Biolegend, 304143) was used in mass cytometry on human samples (fig s4a). Biomark Res (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend CD45 antibody (BioLegend, 103246) was used in flow cytometry on mouse samples (fig 6d). J Immunol (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples at 1:100 (fig 1a). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 7f
BioLegend CD45 antibody (Biolegend, 304130) was used in flow cytometry on human samples (fig 7f). J Exp Med (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5f, s5i
BioLegend CD45 antibody (Biolegend, 103240) was used in flow cytometry on mouse samples (fig s5f, s5i). J Exp Med (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD45 antibody (BioLegend, 304036) was used in flow cytometry on human samples (fig 1d). Oncoimmunology (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, 103239) was used in flow cytometry on human samples . J Clin Invest (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5c
BioLegend CD45 antibody (BioLegend, 103212) was used in flow cytometry on mouse samples (fig s5c). J Clin Invest (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; fig s7
BioLegend CD45 antibody (BioLegend, 368506) was used in flow cytometry on human samples at 1:100 (fig s7). Sci Transl Med (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD45 antibody (BioLegend, 368516) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4h, s10
BioLegend CD45 antibody (BioLegend, 103206) was used in flow cytometry on mouse samples (fig 4h, s10). Sci Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:333; loading ...; fig 2d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:333 (fig 2d). Mol Psychiatry (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 0.125 ug/ml; fig s1a
BioLegend CD45 antibody (BioLegend, 2D1) was used in flow cytometry on human samples at 0.125 ug/ml (fig s1a). Ocul Surf (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, 103207) was used in immunohistochemistry on mouse samples (fig 3a). Nat Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, 103244) was used in flow cytometry on mouse samples . Signal Transduct Target Ther (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:1000; fig s6g
BioLegend CD45 antibody (Biolegend, 103227) was used in flow cytometry on mouse samples at 1:1000 (fig s6g). Nat Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:300; loading ...; fig 2f
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:300 (fig 2f). Nat Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
BioLegend CD45 antibody (Biolegend, 103204) was used in flow cytometry on mouse samples at 1:200 (fig s1). Front Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 3b). Cancer Res (2021) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s4a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s4a). Commun Biol (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples . Front Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; loading ...
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:500. Acta Neuropathol Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2a). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; 1:100; fig 2a
BioLegend CD45 antibody (Biolegend, 368538) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Cancer Res (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD45 antibody (Biolegend, 103259) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD45 antibody (Biologend, 304008) was used in flow cytometry on human samples (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, 304112) was used in flow cytometry on human samples (fig 3a). Aging (Albany NY) (2021) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, 304206) was used in flow cytometry on human samples (fig 3a). Aging (Albany NY) (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, 103210) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend CD45 antibody (BioLegend, 368508) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1-1h
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1-1h). elife (2021) ncbi
mouse monoclonal (HI100)
  • immunocytochemistry; human
BioLegend CD45 antibody (BioLegend, HI100) was used in immunocytochemistry on human samples . Aging Cell (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig 1j
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 1j). Front Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (BioLegend, 103223) was used in flow cytometry on mouse samples (fig 1c). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (Biolegend, 304005) was used in flow cytometry on human samples . BMC Biol (2021) ncbi
mouse monoclonal (HI30)
  • mass cytometry; human; loading ...; fig 4e
BioLegend CD45 antibody (Biolegend, HI30) was used in mass cytometry on human samples (fig 4e). Acta Neuropathol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD45 antibody (BioLegend, 103235) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD45 antibody (BioLegend, 304132) was used in flow cytometry on human samples (fig s3a). Immunity (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD45 antibody (BioLegend, 304026) was used in flow cytometry on human samples (fig s1a). Immunity (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 3:100; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples at 3:100 (fig 1a). elife (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, 103207) was used in flow cytometry on mouse samples . Cell Rep (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 11b
BioLegend CD45 antibody (BioLegend, 368532) was used in flow cytometry on human samples (fig 11b). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD45 antibody (Biolegend, 304031) was used in flow cytometry on human samples (fig 5c). Nat Commun (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, 304141) was used in flow cytometry on mouse samples . J Autoimmun (2021) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:100
BioLegend CD45 antibody (Biolegend, 304206) was used in flow cytometry on human samples at 1:100. Science (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig s1j
BioLegend CD45 antibody (BioLegend, 103212) was used in flow cytometry on mouse samples at 1:400 (fig s1j). Nature (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig s5a, s5b
BioLegend CD45 antibody (BioLegend, 103261) was used in flow cytometry on mouse samples at 1:200 (fig s5a, s5b). Cancer Res (2021) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig ev2c
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig ev2c). EMBO Mol Med (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD45 antibody (Biolegend, 304016) was used in flow cytometry on human samples (fig s1c). Sci Rep (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4d
BioLegend CD45 antibody (BioLegend, 304006) was used in flow cytometry on human samples (fig 4d). Nat Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 2h, 5c
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 2h, 5c). EMBO Rep (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD45 antibody (Biolegend, 103223) was used in flow cytometry on mouse samples (fig s2a). J Hematol Oncol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD45 antibody (Biolegend, 103208) was used in flow cytometry on mouse samples (fig 4d). Theranostics (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s2). Aging Cell (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . Aging Cell (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 1:100; loading ...; fig 8d
BioLegend CD45 antibody (Biolegend, 304008) was used in flow cytometry on mouse samples at 1:100 (fig 8d). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5e
BioLegend CD45 antibody (Biolegend, 103212) was used in flow cytometry on mouse samples (fig s5e). Nat Commun (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD45 antibody (Biolegend, 304010) was used in flow cytometry on human samples (fig 4a). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2a, 3b
BioLegend CD45 antibody (Biolegend, 304145) was used in flow cytometry on human samples (fig 2a, 3b). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1-1
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s1-1). elife (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD45 antibody (Biolegend, 103211) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 5d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 5d). elife (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig s2-1c
BioLegend CD45 antibody (Biolegend, 304239) was used in flow cytometry on human samples (fig s2-1c). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD45 antibody (BioLegend, 103224) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2020) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 2b
BioLegend CD45 antibody (Biolegend, HI30) was used in immunocytochemistry on human samples at 10 ug/ml (fig 2b). BMC Cancer (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend CD45 antibody (BioLegend, 103260) was used in flow cytometry on mouse samples (fig 4c). Int J Mol Sci (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1b). J Immunother Cancer (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2020) ncbi
mouse monoclonal (HI100)
  • western blot; human; 1:100; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, 304130) was used in western blot on human samples at 1:100 (fig 3a). Science (2020) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, 368516) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 9a
BioLegend CD45 antibody (BioLegend, HI30) was used in immunohistochemistry - frozen section on mouse samples (fig 9a). J Exp Med (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:400; loading ...; fig 2a
BioLegend CD45 antibody (BioLegend, 304062) was used in flow cytometry on human samples at 1:400 (fig 2a). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3i
BioLegend CD45 antibody (Biolegend, 103211) was used in flow cytometry on mouse samples at 1:100 (fig s3i). Nat Commun (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD45 antibody (Biolegend, 304136) was used in flow cytometry on human samples (fig s1c). Cell (2020) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 4f
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 4f). J Clin Invest (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2s5a
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3a). Adv Sci (Weinh) (2020) ncbi
rat monoclonal (RA3-6B2)
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used . Nature (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s7c
BioLegend CD45 antibody (BioLegend, 304012) was used in flow cytometry on human samples (fig s7c). J Clin Invest (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples . Sci Adv (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples . Sci Adv (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). J Biol Chem (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; loading ...; fig s1b
BioLegend CD45 antibody (Biolegend, RA2-6B2) was used in flow cytometry on mouse samples at 1:500 (fig s1b). Blood (2020) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; 1:500; loading ...; fig s1b
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on mouse samples at 1:500 (fig s1b). Blood (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig 4h
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:400 (fig 4h). elife (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1b). JCI Insight (2020) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:25; loading ...; fig s2
BioLegend CD45 antibody (Biolegend, 368539) was used in flow cytometry on human samples at 1:25 (fig s2). Stem Cell Res Ther (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Oncogenesis (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2b). Sci Adv (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3e
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s3e). BMC Immunol (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD45 antibody (Biolegend, RA3682) was used in flow cytometry on mouse samples (fig 2a). Aging Cell (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3e). Front Immunol (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Virol (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s1a). Sci Adv (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend CD45 antibody (BioLegend, 103225) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig s1c
BioLegend CD45 antibody (BioLegend, 304056) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig s1c). Nat Cell Biol (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, 103222) was used in flow cytometry on mouse samples at 1:200 (fig 3a). Nat Commun (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2d). Science (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s16a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s16a). Nat Commun (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig s19b
BioLegend CD45 antibody (Biolegend, 103208) was used in flow cytometry on mouse samples at 1:100 (fig s19b). Nat Commun (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, 304128) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5d
BioLegend CD45 antibody (Biolegend, 304107) was used in flow cytometry on human samples (fig 5d). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD45 antibody (BioLegend, 304016) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 7b
BioLegend CD45 antibody (Biolegend, 304014) was used in flow cytometry on human samples (fig 7b). Cell Rep (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). Cell (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s20
BioLegend CD45 antibody (Biolegend, 304140) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, 103224) was used in flow cytometry on mouse samples at 1:200 (fig 1a). elife (2019) ncbi
rat monoclonal (RA3-6B2)
  • mass cytometry; mouse; 1.5 ug/ml; loading ...; fig 5d
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in mass cytometry on mouse samples at 1.5 ug/ml (fig 5d). Science (2019) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig 1b, 1d, s2
BioLegend CD45 antibody (Biolegend, HI 100) was used in mass cytometry on human samples (fig 1b, 1d, s2). Cell Rep (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2d, 5d, s3b
BioLegend CD45 antibody (Biolegend, 103241) was used in flow cytometry on mouse samples (fig 2d, 5d, s3b). Cell Rep (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD45 antibody (Biolegend, 304048) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a, 4a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2a, 4a). BMC Immunol (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6
BioLegend CD45 antibody (Biolegend, 103244) was used in flow cytometry on mouse samples at 1:200 (fig 6). JCI Insight (2020) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; 1:250; fig 2a
BioLegend CD45 antibody (BioLegend, HI30) was used in immunocytochemistry on human samples at 1:250 (fig 2a). PLoS ONE (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s1). Aging Cell (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4a). Front Pharmacol (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD45 antibody (Biolegend, 304051) was used in flow cytometry on human samples (fig s6a). Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s14b
  • flow cytometry; mouse; loading ...; fig s19b
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig s14b) and in flow cytometry on mouse samples (fig s19b). Science (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s6c
BioLegend CD45 antibody (Biolegend, 2D1) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig e1b, e1c
BioLegend CD45 antibody (Biolegend, 304011) was used in flow cytometry on human samples at 1:100 (fig e1b, e1c). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig e3s, e3t
BioLegend CD45 antibody (BioLegend, 103255) was used in flow cytometry on mouse samples at 1:200 (fig e3s, e3t). Nature (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD45 antibody (BioLegend, 304143) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig e6a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig e6a). Nature (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, 304238) was used in flow cytometry on human samples (fig 1a). Nat Commun (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1e
BioLegend CD45 antibody (BioLegend, 103201) was used in immunohistochemistry - paraffin section on mouse samples (fig 1e). Genes Dev (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; 1:500; loading ...; fig ex8d
BioLegend CD45 antibody (Biolegend, 368513) was used in flow cytometry on mouse samples at 1:500 (fig ex8d). Nature (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD45 antibody (Biolegend, 304210) was used in flow cytometry on mouse samples (fig 5c). J Immunother Cancer (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend CD45 antibody (BioLegend, 304008) was used in flow cytometry on mouse samples (fig s5b). Nat Immunol (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; fig e7b
BioLegend CD45 antibody (Biolegend, 103209) was used in flow cytometry on mouse samples at 1:100 (fig e7b). Nature (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1d). J Immunol (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1a). Clin Exp Immunol (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s10a
BioLegend CD45 antibody (BioLegend, 304036) was used in flow cytometry on human samples (fig s10a). Haematologica (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD45 antibody (BioLegend, 103211) was used in flow cytometry on mouse samples (fig 2d). Purinergic Signal (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4b
BioLegend CD45 antibody (BioLegend, 103229) was used in immunohistochemistry - frozen section on mouse samples (fig 4b). Immunity (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD45 antibody (BioLegend, UCHL1) was used in flow cytometry on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD45 antibody (BioLegend, 304005) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig s10a
BioLegend CD45 antibody (Biolegend, 304032) was used in flow cytometry on human samples at 1:100 (fig s10a). Nat Commun (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD45 antibody (Biolegend, 304012) was used in flow cytometry on human samples (fig 2e). Cancer Cell (2019) ncbi
mouse monoclonal (HI100)
  • other; human; loading ...; fig 4b
BioLegend CD45 antibody (BioLegend, 304157) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (UCHL1)
  • other; human; loading ...; fig 4b
BioLegend CD45 antibody (BioLegend, 304255) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:40; loading ...; fig 5j, 5k, s22c
BioLegend CD45 antibody (Biolegend, 368540) was used in flow cytometry on human samples at 1:40 (fig 5j, 5k, s22c). Nat Commun (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig e3b
BioLegend CD45 antibody (Biolegend, 103212) was used in flow cytometry on mouse samples at 1:200 (fig e3b). Nature (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 4a). J Exp Med (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, RA3?C6B2) was used in flow cytometry on mouse samples . Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2c
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2c). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1a). Am J Respir Crit Care Med (2019) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig s1d
BioLegend CD45 antibody (Biolegend, 304002) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig s1d). Haematologica (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD45 antibody (BioLegend, 103247) was used in flow cytometry on mouse samples (fig 2a). Cell Rep (2019) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig s1
BioLegend CD45 antibody (BioLegend, HI100) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (HI30)
  • mass cytometry; human; loading ...; fig s1
BioLegend CD45 antibody (BioLegend, HI30) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig s3). Front Immunol (2019) ncbi
mouse monoclonal (HI30)
  • mass cytometry; human; loading ...; fig 1b
BioLegend CD45 antibody (Biolegend, 304002) was used in mass cytometry on human samples (fig 1b). Cell (2019) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD45 antibody (Biolegend, 304102) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig s2d
BioLegend CD45 antibody (Biolegend, 103208) was used in flow cytometry on mouse samples at 1:100 (fig s2d). Nat Commun (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1h
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1h). Nat Med (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a-b
BioLegend CD45 antibody (BioLegend, 304112) was used in flow cytometry on human samples (fig s1a-b). Immunity (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 5). Front Immunol (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig s1c, s2a
BioLegend CD45 antibody (Biolegend, 304024) was used in flow cytometry on human samples at 1:100 (fig s1c, s2a). Cancer Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 2 ug/ml; loading ...; fig s3b
BioLegend CD45 antibody (BioLegend, 304014) was used in flow cytometry on mouse samples at 2 ug/ml (fig s3b). Science (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 5 ug/ml; loading ...; fig s12
BioLegend CD45 antibody (BioLegend, 103236) was used in flow cytometry on mouse samples at 5 ug/ml (fig s12). Science (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3g
BioLegend CD45 antibody (Biolegend, 304019) was used in flow cytometry on human samples (fig 3g). Science (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...; fig 4a
BioLegend CD45 antibody (BioLegend, 304041) was used in flow cytometry on human samples at 1:50 (fig 4a). Arthritis Res Ther (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend CD45 antibody (Biolegend, 103204) was used in flow cytometry on mouse samples (fig 1h). EMBO J (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s6b
BioLegend CD45 antibody (BioLegend, 304128) was used in flow cytometry on human samples (fig s6b). J Clin Invest (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s7a
BioLegend CD45 antibody (BD, 304012) was used in flow cytometry on human samples (fig s7a). J Clin Invest (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, 304024) was used in flow cytometry on human samples . Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a, s2
BioLegend CD45 antibody (BioLegend, 103210) was used in flow cytometry on mouse samples (fig 1a, s2). Antioxid Redox Signal (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig 1e
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:400 (fig 1e). Science (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s6g
BioLegend CD45 antibody (BioLegend, 304110) was used in flow cytometry on human samples (fig s6g). Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1d). Science (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1f
BioLegend CD45 antibody (BioLegend, 304142) was used in flow cytometry on human samples (fig 1f). Cell (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 3c
BioLegend CD45 antibody (BioLegend, 368504) was used in flow cytometry on human samples (fig 3c). J Exp Med (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1c
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 1c). Cell Stem Cell (2019) ncbi
mouse monoclonal (2D1)
  • immunohistochemistry; mouse; loading ...; fig s2b
BioLegend CD45 antibody (Biolegend, 368521) was used in immunohistochemistry on mouse samples (fig s2b). Oncogene (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2019) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; loading ...; fig s1c
BioLegend CD45 antibody (Biolegend, 304042) was used in immunocytochemistry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD45 antibody (Biolegend, 304016) was used in flow cytometry on human samples (fig 3b). Cell Discov (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, 304128) was used in flow cytometry on human samples (fig 1a). Cell Discov (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD45 antibody (Biolegend, 103227) was used in flow cytometry on mouse samples (fig 1d). Immunity (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). Biochem Biophys Res Commun (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 5a). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunocytochemistry; mouse; loading ...; fig s5d
BioLegend CD45 antibody (Biolegend, 103226) was used in immunocytochemistry on mouse samples (fig s5d). Cell Rep (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s3k
BioLegend CD45 antibody (Biolegend, 304006) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). Transl Oncol (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 4d). J Clin Invest (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
BioLegend CD45 antibody (BioLegend, 103202) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Cell (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl s1
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s9a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s9a). Science (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4a
BioLegend CD45 antibody (BioLegend, 304036) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2b). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 9d
  • flow cytometry; mouse; loading ...; fig 10a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 9d) and in flow cytometry on mouse samples (fig 10a). PLoS ONE (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, 304023) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 1c). Nat Commun (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:30; loading ...; fig 2e
BioLegend CD45 antibody (Biolegend, 103232) was used in flow cytometry on mouse samples at 1:30 (fig 2e). Cell Res (2018) ncbi
mouse monoclonal (MEM-55)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, 310202) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4g
BioLegend CD45 antibody (BioLegend, RA3-6 B2) was used in immunohistochemistry - frozen section on mouse samples (fig 4g). EMBO J (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 7b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 7b). Nature (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:600; loading ...; fig 4g
  • flow cytometry; mouse; 1:600; loading ...; fig 5d
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples at 1:600 (fig 4g) and in flow cytometry on mouse samples at 1:600 (fig 5d). Nat Commun (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, 368521) was used in flow cytometry on human samples (fig 1a). Cell Rep (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2c
BioLegend CD45 antibody (Biolegend, 103247) was used in flow cytometry on mouse samples (fig s2c). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s3b
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s16b
BioLegend CD45 antibody (BioLegend, 304012) was used in flow cytometry on human samples (fig s16b). Nat Med (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:100; loading ...; fig 2a
BioLegend CD45 antibody (BioLegend, 304206) was used in flow cytometry on human samples at 1:100 (fig 2a). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 9b
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 9b). J Cell Biol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2j, s3k
BioLegend CD45 antibody (Biolegend, 103223) was used in flow cytometry on mouse samples (fig 2j, s3k). Genes Dev (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1e). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 5a). Mol Ther Nucleic Acids (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). Sci Rep (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend CD45 antibody (BioLegend, Ra3-6B2) was used in flow cytometry on mouse samples (fig 3g). Nat Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2a). J Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1b). Cell Metab (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). J Cell Biol (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, UCHL1) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s4b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig s4b). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry; mouse; 1:200; fig 2f
BioLegend CD45 antibody (BioLegend, 304016) was used in immunohistochemistry on mouse samples at 1:200 (fig 2f). Oncogene (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s3a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry; human; loading ...; fig s2g
BioLegend CD45 antibody (Biolegend, UCHL1) was used in immunohistochemistry on human samples (fig s2g). Curr Biol (2018) ncbi
mouse monoclonal (HI100)
  • immunohistochemistry; human; 5,000 ug/ml; loading ...; fig s2d
BioLegend CD45 antibody (Biolegend, HT100) was used in immunohistochemistry on human samples at 5,000 ug/ml (fig s2d). Curr Biol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1a
BioLegend CD45 antibody (BioLegend, 103206) was used in flow cytometry on mouse samples at 1:200 (fig s1a). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). Nature (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s5). Nat Commun (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend CD45 antibody (BioLegend, RA3) was used in flow cytometry on mouse samples (fig s5b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3b). Exp Hematol (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig s2e
BioLegend CD45 antibody (BioLegend, 304227) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; fig s4a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig s4a). Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD45 antibody (BioLegend, 304042) was used in flow cytometry on human samples (fig 2c). Stem Cells Transl Med (2018) ncbi
mouse monoclonal (2D1)
  • immunohistochemistry - frozen section; human; fig 4g
BioLegend CD45 antibody (BioLegend, 2D1) was used in immunohistochemistry - frozen section on human samples (fig 4g). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5e
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 5e). J Exp Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:100 (fig 1a). Int Immunol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 1c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD45 antibody (Biolegend, 304012) was used in flow cytometry on human samples (fig 1c). Cell Death Dis (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD45 antibody (Biolegend, 304107) was used in flow cytometry on human samples . Cell Death Dis (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, BioLegend CD45 antibody (BioLegend, BLE304011) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1e
In order to characterize the clonal B cell expansion in autoreactive germinal centers, BioLegend CD45 antibody (BioLegend, 103235) was used in flow cytometry on mouse samples (fig 1e). Cell (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1d
BioLegend CD45 antibody (BioLegend, 103227) was used in flow cytometry on mouse samples at 1:200 (fig s1d). Leukemia (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig 7h
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:400 (fig 7h). Nat Commun (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1a). Sci Rep (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s9a
In order to evaluate mouse models of hepacivirus infection, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s9a). Science (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1a). J Virol (2017) ncbi
mouse monoclonal (UCHL1)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD45 antibody (BioLegend, UCHL1) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s6a). Cancer Res (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2a). Eur J Immunol (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD45 antibody (BioLegend, 304204) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD45 antibody (BioLegend, 304112) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1b). Eur J Immunol (2017) ncbi
mouse monoclonal (2D1)
  • immunohistochemistry - paraffin section; human; fig 6b
BioLegend CD45 antibody (Biolegend, 368502) was used in immunohistochemistry - paraffin section on human samples (fig 6b). Oncotarget (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...; fig s2a
In order to define the transcriptional network specifies conferring microglia identity, BioLegend CD45 antibody (BioLegend, 304014) was used in flow cytometry on human samples at 1:50 (fig s2a). Science (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1d). Oncotarget (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to characterize murine monocytes through transcriptome and genome analyses, BioLegend CD45 antibody (BioLegend, 103211) was used in flow cytometry on mouse samples (fig 2a). Immunity (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig st1
In order to investigate the effect of PD-1 expression on phagocytosis and tumour immunity, BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig st1). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2b). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2d). Cell Mol Immunol (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend CD45 antibody (biolegend, HI30) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; loading ...; fig 1j
In order to map the lineage of human dendritic cells, BioLegend CD45 antibody (BioLegend, HI100) was used in mass cytometry on human samples (fig 1j). Science (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to investigate to the involvement of IgD-class B-cell antigen receptor in CXCR4 signaling and function, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1a
In order to study the involvement of endocannabinoid system in intestinal immune homeostasis, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize CD8 T cells isolated patients with stage IV melanoma before and after treatment with pembrolizumab, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1b). Nature (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 6c
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 6c). Nat Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Int J Parasitol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to assess the functionality of aged marginal zone B cells, BioLegend CD45 antibody (biolegend, RA3?\6B2) was used in flow cytometry on mouse samples (fig 2a). Immunology (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s2a
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2a). Nucleic Acids Res (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to show that TLR4 signals through the BCR leading to activation of SYK, ERK, and AKT as well as through MYD88 leading to activation of NFkappaB, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, BioLegend CD45 antibody (BioLegend, 103207) was used in flow cytometry on mouse samples . Oncogene (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3a
In order to examine the relationships among the B cell receptor, TLR9, and cytokine signals that regulate B cell responses to DNA-containing antigens, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD45 antibody (Biolegend, 304014) was used in flow cytometry on human samples (fig 6a). Mol Ther Methods Clin Dev (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 4a). Oncoimmunology (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
mouse monoclonal (HI100)
  • mass cytometry; human; fig s8
BioLegend CD45 antibody (BioLegend, 304102) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 1e
BioLegend CD45 antibody (BioLegend, 103201) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 1e). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to compare human and mouse BCMA expression, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD45 antibody (Biolegend, 304016) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s2b
BioLegend CD45 antibody (BioLegend, 304038) was used in flow cytometry on human samples (fig s2b). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 5d
In order to explore the contribution of epithelial cells to systemic sclerosis pathogenesis, BioLegend CD45 antibody (BioLegend, 103205) was used in flow cytometry on mouse samples (fig 5d). J Exp Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3
In order to examine B cell homeostasis modifications in an experimental model of systemic sclerosis, BioLegend CD45 antibody (BD Bioscience, 103208) was used in flow cytometry on mouse samples at 1:200 (fig 3). Front Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to investigate the effect of CD47 on B cells in antibody dependent cellular phagocytosis., BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Mol Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). Immunology (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:2000; loading ...; fig 2c
In order to report that neurodegenerative disease enhances arthritis development, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:2000 (fig 2c). J Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1d
In order to explore the function of autophagy in B cells, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig s1d). Science (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend CD45 antibody (biolegend, HI100) was used in flow cytometry on human samples . Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5c
In order to propose that type 2 immunity is induced by a unique mechanism in the genital tract, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...; fig 4c
BioLegend CD45 antibody (BioLegend, 304041) was used in flow cytometry on human samples at 1:50 (fig 4c). Arthritis Res Ther (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:33; loading ...; fig 3a
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples at 1:33 (fig 3a). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to utilize a G2-Gata4Cre;R26REYFP mouse line to track the developmental fate of the G2-Gata4 cell lineage, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Haematologica (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 4h
  • flow cytometry; mouse; 1:50; loading ...; fig 3b
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 4h) and in flow cytometry on mouse samples at 1:50 (fig 3b). Nat Commun (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to find the specific gene signature related to iron metabolism consisting of genes regulating iron uptake, mitochondrial FeS cluster biogenesis and hypoxic response, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Oncotarget (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
In order to describe and differentiate human amniotic fluid mesenchymal stem cells into endothelial-like cells, BioLegend CD45 antibody (Biolegend, 304008) was used in flow cytometry on human samples (fig 2). Acta Histochem (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples . Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, 103212) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
mouse monoclonal (HI30)
  • blocking or activating experiments; human; loading ...; fig s6c
BioLegend CD45 antibody (BioLegend, HI30) was used in blocking or activating experiments on human samples (fig s6c). Nat Genet (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:25; loading ...; fig 1c
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples at 1:25 (fig 1c). Cell Transplant (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 5
In order to determine the role of IL-17A in airway fibrosis, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 5). Am J Physiol Lung Cell Mol Physiol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD45 antibody (BioLegend, 368509) was used in flow cytometry on human samples (fig 1b). Oncol Lett (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:50; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1i
In order to indicate that MYSM1 has an essential role in B cell lineage specification but is dispensable at later stages of development, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1i). J Leukoc Biol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3d
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 3d). J Virol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., BioLegend CD45 antibody (Biolegend, 103204) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5a
In order to use MRI to track iron oxide nanoparticles in vivo, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s5a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Virol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s8). Science (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD45 antibody (Biolegend, 103224) was used in flow cytometry on mouse samples (fig 1c). Oncogene (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
BioLegend CD45 antibody (BioLegend, 103205) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1a
In order to clarify the B cell-intrinsic functions of c-REL and RELA, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; loading ...; fig s7
BioLegend CD45 antibody (BioLegend, HI30) was used in immunocytochemistry on human samples (fig s7). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s1
BioLegend CD45 antibody (Biolegend, H1 100) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; 1:100; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on human samples at 1:100. Nat Commun (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:25; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples at 1:25. Nat Commun (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD45 antibody (BioLegend, UCHL1) was used in flow cytometry on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (HI30)
In order to research the role of ORP4L for T-cell acute lymphoblastic leukemia cell survival, BioLegend CD45 antibody (BioLegend, 304056) was used . Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to investigate the hierarchical genomic and regulatory states that lead to neutrophil or macrophage specification, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 1b
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s12b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig s12b). J Clin Invest (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2c
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s2
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the contribution of the PD-1 pathway in allogeneic stem cell transplantation, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 3a). Biol Blood Marrow Transplant (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig 4
BioLegend CD45 antibody (eBioscience, 103236) was used in flow cytometry on mouse samples at 1:200 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
BioLegend CD45 antibody (Biolegend, 103224) was used in flow cytometry on mouse samples (fig 3). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 6a
In order to elucidate how hematopoietic ANGPTL4 deficiency increases atherogenesis, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 6a). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
In order to examine the impact of emergency granulopoiesis on T and B cell function, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used . J Exp Med (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2
In order to study the impact of p21 signaling on monocyte reprogramming, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s2). J Clin Invest (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:300; loading ...; fig s4a
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:300 (fig s4a). Nat Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig s3c). Science (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig st2
In order to identify the origin of vascular smooth muscle cells and macrophages within atherosclerosis lesions, BioLegend CD45 antibody (BioLegend, 103221) was used in flow cytometry on mouse samples (fig st2). Atherosclerosis (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6e
BioLegend CD45 antibody (BioLegend, RA36B2) was used in immunohistochemistry - frozen section on mouse samples (fig 6e). J Immunol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples . Science (2016) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; 1:150; fig s2
BioLegend CD45 antibody (BioLegend, HI30) was used in immunocytochemistry on human samples at 1:150 (fig s2). Sci Rep (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 2). J Clin Invest (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on African green monkey samples (fig 2a). J Med Primatol (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (BioLegend, 368508) was used in flow cytometry on human samples (fig 1). Int J Mol Med (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:20; loading ...; fig 5f
In order to develop and characterize a humanized ossicle xenotransplantation approach, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples at 1:20 (fig 5f). Nat Med (2016) ncbi
mouse monoclonal (HI30)
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BioLegend CD45 antibody (Biolegend, 304050) was used . Nat Cell Biol (2016) ncbi
mouse monoclonal (2D1)
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BioLegend CD45 antibody (Biolegend, 368512) was used . Nat Cell Biol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
  • immunohistochemistry; mouse; fig 1
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1) and in immunohistochemistry on mouse samples (fig 1). Cell Mol Immunol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3g
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 3g). Nat Commun (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
  • immunocytochemistry; human; fig 2
In order to study the differentiation of chondrocyte-like cells from mesenchymal stem cells, BioLegend CD45 antibody (Biolegend, 304008) was used in flow cytometry on human samples (fig 3) and in immunocytochemistry on human samples (fig 2). Acta Histochem (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to test if microRNA-23a, -24-2, and 27a are essential for immune cell development, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). J Leukoc Biol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s6b
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig s6b). Nature (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3c). Mucosal Immunol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 7e
BioLegend CD45 antibody (BioLegend, 304029) was used in flow cytometry on human samples (fig 7e). J Biol Chem (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend CD45 antibody (BioLegend, 103227) was used in flow cytometry on mouse samples (fig 8a). J Biol Chem (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 6c
In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend CD45 antibody (biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 6c). Oncotarget (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
BioLegend CD45 antibody (Biolegend, RA3-61B2) was used in flow cytometry on mouse samples (fig s1). Oncotarget (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:20; loading ...; tbl 2
In order to develop a cell sorting technique for use with a suspended microchannel resonator that measures the biophysical characteristics of a single cell, BioLegend CD45 antibody (BioLegend, 304019) was used in flow cytometry on human samples at 1:20 (tbl 2). Integr Biol (Camb) (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2a
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2a). Diabetes (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; fig 5
BioLegend CD45 antibody (Biolegend, 304006) was used in flow cytometry on mouse samples (fig 5). Oncoimmunology (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1). Int Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s13
In order to study the response of intestinal tuft cells to parasites, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s13). Science (2016) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig 3
BioLegend CD45 antibody (Biolegend, 304002) was used in immunocytochemistry on human samples (fig 3). PLoS ONE (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD45 antibody (biolegend, HI100) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s4c
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD45 antibody (biolegend, UCHL1) was used in flow cytometry on human samples (fig s4c). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD45 antibody (biolegend, HI30) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1
In order to research the role of Tim-1 and Tim-4 blockade in the atherosclerotic pathogenesis, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). Arterioscler Thromb Vasc Biol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . EMBO Mol Med (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to study dendritic cells in Sirt6 knock out mice, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Aging (Albany NY) (2016) ncbi
mouse monoclonal (HI30)
BioLegend CD45 antibody (Biolegend, 304008) was used . Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to elucidate the role of TfR1 in adaptive immunity, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4d). Nat Genet (2016) ncbi
mouse monoclonal (HI30)
BioLegend CD45 antibody (Biolegend, 304015) was used . Sci Rep (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to investigate how Tregs are maintained in adipose tissue, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 4). Analyst (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
BioLegend CD45 antibody (biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to study factors that specify the Treg lineage, BioLegend CD45 antibody (BioLegend, 304112) was used in flow cytometry on human samples . elife (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, BioLegend CD45 antibody (BioLegend, 304230) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
mouse monoclonal (HI30)
  • western blot; human; loading ...; fig 8b
In order to discover that CD147-CD98 is a major carrier of poly-N-acetyl-lactosamine on human pre-B cell line, BioLegend CD45 antibody (Biolegend, 304002) was used in western blot on human samples (fig 8b). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (HI30)
BioLegend CD45 antibody (BioLegend, 304020) was used . J Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study Cxcl12-expressing reticular cells in the germinal centers, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study the life span of individual memory B cells, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunocytochemistry; human; 1:200; fig 1d
In order to elucidate how hepatitis C virus infection alters B cell proliferation, BioLegend CD45 antibody (Biolegend;, 103201) was used in immunocytochemistry on human samples at 1:200 (fig 1d). Oncogene (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; human
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - frozen section on human samples . Science (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s3
In order to determine how induced arthritis can be effectively treated by CTRP6, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c
In order to define a differentiation system to generate definitive hematopoietic multipotent progenitor cells from hemato-endothelial progenitors via the endothelial monolayer, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1c). J Cell Physiol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, BioLegend CD45 antibody (Biolegend, 304004) was used in flow cytometry on human samples (fig 3). Gastroenterology (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, 304128) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples . Kidney Int (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 4
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 4). J Hematol Oncol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:800; fig s2
BioLegend CD45 antibody (BioLegend, 103212) was used in flow cytometry on mouse samples at 1:800 (fig s2). Nat Commun (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; fig 1
BioLegend CD45 antibody (BioLegend, #103202) was used in flow cytometry on mouse samples at 1:100 (fig 1). Exp Ther Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:200; fig 6
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples at 1:200 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:200; fig s4
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples at 1:200 (fig s4). Nat Commun (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4b
In order to discover a new tissue macrophage subset in the thymus that is dependent on transcription factor NR4A1 for development, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4b). Sci Rep (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
BioLegend CD45 antibody (Biolegend, 103204) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:80
In order to develop a system to determine human DC development and differentiation, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples at 1:80. J Immunol Methods (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:200
In order to develop a system to determine human DC development and differentiation, BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples at 1:200. J Immunol Methods (2015) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - frozen section; human; fig 1
  • flow cytometry; human; fig 1
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend CD45 antibody (BioLegend, HI30) was used in immunohistochemistry - frozen section on human samples (fig 1) and in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 5
BioLegend CD45 antibody (Biolegend, # 304008) was used in flow cytometry on human samples (fig 5). Biomaterials (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . Nature (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
BioLegend CD45 antibody (Biolegend, 304035) was used in flow cytometry on human samples (fig 2). Scand J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:40
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:40. PLoS ONE (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (HI100)
  • other; human; fig s2
BioLegend CD45 antibody (Biolegend, HI100) was used in other on human samples (fig s2). PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 4
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4). Stem Cell Res (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s1
BioLegend CD45 antibody (Biolegend, 304022) was used in flow cytometry on human samples (fig s1). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (Bio-Legend, 304012) was used in flow cytometry on human samples (fig 1). J Clin Invest (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:160; fig 4
BioLegend CD45 antibody (BioLegend, 103211) was used in flow cytometry on mouse samples at 1:160 (fig 4). Nagoya J Med Sci (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:160; fig 7
BioLegend CD45 antibody (BioLegend, 103211) was used in flow cytometry on mouse samples at 1:160 (fig 7). Immun Ageing (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; fig 1
BioLegend CD45 antibody (Biolegend, 103208) was used in flow cytometry on mouse samples at 1:100 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 3:100; fig 7
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples at 3:100 (fig 7). Nat Commun (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 4
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BioLegend CD45 antibody (BioLegend, 304003) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study the human breast for transcriptional and epigenetic determinants, BioLegend CD45 antibody (BioLegend, 304003) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 4
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 4). J Exp Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1). J Exp Med (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; tbl s3
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s2
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples (fig s2). J Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; fig 8
BioLegend CD45 antibody (BioLegend, 304022) was used in flow cytometry on mouse samples (fig 8). J Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 2
BioLegend CD45 antibody (BioLegend, H100) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
rat monoclonal (RA3-6B2)
BioLegend CD45 antibody (BioLegend, 103211) was used . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend CD45 antibody (BioLegend, 103224) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples (fig 2). Oncotarget (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, 1103206) was used in flow cytometry on mouse samples . Lab Anim (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; fig 6
  • flow cytometry; mouse; fig 4
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples (fig 6) and in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 4
BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, 103210) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 2,500 ug/ml; fig 3
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples at 2,500 ug/ml (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to discover regulatory networks from epigenomes of surface ectoderm-derived cell types, BioLegend CD45 antibody (BioLegend, 304003) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to isolate and characterize endothelial cells and microparticles obtained directly from the site of cardiac damage, BioLegend CD45 antibody (Biolegend, 304010) was used in flow cytometry on human samples . Thromb Haemost (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in immunohistochemistry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, HI100) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; tbl s1
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (tbl s1). Stem Cells (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples . Oncotarget (2014) ncbi
mouse monoclonal (HI100)
BioLegend CD45 antibody (BioLegend, HI100) was used . J Exp Med (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study IkappaB kinase-induced proteolysis of NF-kappaB1 p105 in B cells using Nfkb1(SSAA/SSAA) mice, BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend CD45 antibody (Biolegend, HI100) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; fig 5
  • flow cytometry; mouse; fig 5
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 5) and in flow cytometry on mouse samples (fig 5). Nat Immunol (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD45 antibody (Biolegend, 304014) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (HI100)
BioLegend CD45 antibody (Biolegend, 304121) was used . J Biol Chem (2014) ncbi
rat monoclonal (RA3-6B2)
In order to show that CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells respond to thymic stromal lymphopoietin, BioLegend CD45 antibody (BioLegend, RA3-6-B2) was used . J Immunol (2014) ncbi
rat monoclonal (RA3-6B2)
BioLegend CD45 antibody (Biolegend, 103223) was used . J Vis Exp (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples . Blood (2014) ncbi
rat monoclonal (RA3-6B2)
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used . J Virol (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BioLegend CD45 antibody (Biolegend, clone HI100) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to assess how invariant natural killer T cells distribute, differentiate, and function in fetal peripheral lymphoid and non-lymphoid organs, BioLegend CD45 antibody (Biolegen, HI30) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2014) ncbi
mouse monoclonal (HI30)
In order to study the expression of the cancer stem cell markers CD24 abd CD44 in urothelial bladder cancer and their utility in prognosis and in predicting radical cystectomy outcome, BioLegend CD45 antibody (BioLegend, 304022) was used . Urol Oncol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BioLegend CD45 antibody (Biolegend, HI30) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD45 antibody (Biolegend, UCHL1) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend CD45 antibody (BioLegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 4e). J Leukoc Biol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BioLegend CD45 antibody (BioLegend, HI30) was used in flow cytometry on human samples . J Immunol (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; fig 10
BioLegend CD45 antibody (BioLegend, 103208) was used in flow cytometry on mouse samples at 1:500 (fig 10). PLoS ONE (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
BioLegend CD45 antibody (Biolegend, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
Invitrogen
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3m
Invitrogen CD45 antibody (eBioscience, 45-0452-82) was used in flow cytometry on mouse samples (fig 3m). Ann Clin Transl Neurol (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8b
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples (fig 8b). J Exp Med (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 7a
Invitrogen CD45 antibody (Thermo Fisher, RA3-6B2) was used in flow cytometry on mouse samples (fig 7a). PLoS ONE (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5a, s5b, s5c, s5f
Invitrogen CD45 antibody (eBioscience, 17-0452-82) was used in flow cytometry on mouse samples (fig s5a, s5b, s5c, s5f). Sci Immunol (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). Ann Rheum Dis (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:800; loading ...; fig 3a
Invitrogen CD45 antibody (eBioscience, 15-0452-83) was used in flow cytometry on mouse samples at 1:800 (fig 3a). Nat Commun (2022) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s5a
Invitrogen CD45 antibody (Invitrogen, 11-0458-42) was used in flow cytometry on human samples (fig s5a). Mol Cancer (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s1f
Invitrogen CD45 antibody (eBioscience, 17-0452-82) was used in immunohistochemistry - frozen section on mouse samples (fig s1f). Cell Rep (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c, s3a, s3b
Invitrogen CD45 antibody (eBioscience, 47-0452-80) was used in flow cytometry on mouse samples at 1:200 (fig 1c, s3a, s3b). Development (2022) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 4a
Invitrogen CD45 antibody (Thermo Fisher, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 4a). Int J Mol Sci (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1f
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1f). J Exp Med (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3, 4d
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s3, 4d). Int J Mol Sci (2022) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig s2b, s2c
Invitrogen CD45 antibody (Invitrogen, RA3-6B2) was used in flow cytometry on mouse samples at 1:400 (fig s2b, s2c). Immunol Cell Biol (2022) ncbi
mouse monoclonal (HI30)
  • mass cytometry; human; fig 2h
Invitrogen CD45 antibody (eBioscience, (HI30) was used in mass cytometry on human samples (fig 2h). J Immunother Cancer (2021) ncbi
mouse monoclonal (PD7/26/16, 2B11)
  • flow cytometry; human; 1:500; fig 2e
Invitrogen CD45 antibody (Invitrogen, MA5-13197) was used in flow cytometry on human samples at 1:500 (fig 2e). Antioxidants (Basel) (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD45 antibody (eBiosciences, RA36B2) was used in flow cytometry on mouse samples (fig 1a). Aging Dis (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 6k
Invitrogen CD45 antibody (eBioscience, 25-0458-42) was used in flow cytometry on human samples (fig 6k). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (Thermo Fisher Scientific, 15-0452-83) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CD45 antibody (Invitrogen, 2D1) was used in flow cytometry on mouse samples (fig 3d). Nat Commun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; loading ...; fig 1b
Invitrogen CD45 antibody (Invitrogen, 17-0452-83) was used in flow cytometry on mouse samples at 1:500 (fig 1b). Nature (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; tbl 2
Invitrogen CD45 antibody (Thermo Fisher, 17-0452-82) was used in flow cytometry on mouse samples (tbl 2). Int J Mol Sci (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...
Invitrogen CD45 antibody (Thermo Fisher Scientific, HI30) was used in flow cytometry on human samples at 1:50. Nature (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6b
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 6b). Nat Commun (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (Thermo Fisher Scientific, 14-0459-82) was used in flow cytometry on mouse samples . Cell Rep (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
Invitrogen CD45 antibody (Thermo Fisher Scientific, HI30) was used in flow cytometry on human samples . ACS Synth Biol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 7f
Invitrogen CD45 antibody (eBioscience, 48-0452-82) was used in flow cytometry on mouse samples (fig 7f). Nat Commun (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (eBioscience, 11 -0459 - 42) was used in flow cytometry on mouse samples . Adv Sci (Weinh) (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 0.25 ug/ml; loading ...; fig 4m
Invitrogen CD45 antibody (eBioscience, 11-0452-82) was used in flow cytometry on mouse samples at 0.25 ug/ml (fig 4m). J Immunol (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (Thermo Fisher Scientific, RA3-6B2) was used in flow cytometry on mouse samples . J Autoimmun (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100
Invitrogen CD45 antibody (Thermo Fisher Scientific, 13-0452-86) was used in flow cytometry on mouse samples at 1:100. elife (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen CD45 antibody (Thermo Fisher Scientific, RA3-6B2) was used in flow cytometry on mouse samples at 1:200. Nat Immunol (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s9d
Invitrogen CD45 antibody (Thermo Fisher Scientific, 47-0459-42) was used in flow cytometry on human samples (fig s9d). Nature (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:750; loading ...; fig s1g
Invitrogen CD45 antibody (Thermo Fisher Scientific, 25-0452) was used in flow cytometry on mouse samples at 1:750 (fig s1g). Nat Immunol (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
Invitrogen CD45 antibody (eBioscience, 17-9459-42) was used in flow cytometry on human samples . Theranostics (2021) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (Thermo Fisher, RA3-6B2) was used in flow cytometry on mouse samples . Front Immunol (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:200. elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Aging Cell (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2e
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 2e). Cell (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3c
Invitrogen CD45 antibody (eBioscience/Thermo Fisher Scientific, RA3-6B2) was used in flow cytometry on mouse samples (fig s3c). Sci Adv (2020) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig 1c
Invitrogen CD45 antibody (eBioscience, 14-0452) was used in immunohistochemistry on mouse samples (fig 1c). Basic Res Cardiol (2020) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry; human; fig 4g
Invitrogen CD45 antibody (ThermoFisher Scientific, UCHL1) was used in immunohistochemistry on human samples (fig 4g). Nat Commun (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2b
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples (fig 2b). BMC Immunol (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD45 antibody (ThermoFisher, RA3-6B2) was used in flow cytometry on mouse samples (fig 1b). Blood Adv (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3s1
Invitrogen CD45 antibody (eBioscience, 48-0458-42) was used in flow cytometry on human samples (fig 3s1). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig s2d
Invitrogen CD45 antibody (ThermoFisher, 17-0452) was used in flow cytometry on mouse samples at 1:100 (fig s2d). Nat Commun (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). elife (2020) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 7c
Invitrogen CD45 antibody (eBioscience, 48-0458-42) was used in flow cytometry on human samples (fig 7c). Cell Rep (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6
Invitrogen CD45 antibody (eBioscience, 53-0452-82) was used in immunohistochemistry on mouse samples at 1:100 (fig 6). JCI Insight (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig e4d
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig e4d). Nature (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 3h, 6e
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on mouse samples (fig 3h, 6e). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; loading ...; fig e1a
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:100 (fig e1a). Nature (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD45 antibody (eBioscience, 11-0459-42) was used in flow cytometry on human samples (fig s1b). Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
Invitrogen CD45 antibody (eBiosciences, 48-0459-42) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen CD45 antibody (Invitrogen, RA3-6B2) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:500; loading ...; fig 2e
Invitrogen CD45 antibody (eBioscience, 2D1) was used in flow cytometry on human samples at 1:500 (fig 2e). Biomolecules (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
Invitrogen CD45 antibody (eBioscience, 14-0452) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). Cell (2019) ncbi
rat monoclonal (YAML501.4)
  • immunohistochemistry; human; loading ...; fig 2b
Invitrogen CD45 antibody (ThermoFisher, MA5-17687) was used in immunohistochemistry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:200; loading ...; fig 3f
Invitrogen CD45 antibody (eBiosciences, 48-0458-42) was used in flow cytometry on human samples at 1:200 (fig 3f). elife (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD45 antibody (Invitrogen, 47-0452-82) was used in flow cytometry on mouse samples (fig 2a). Int Immunol (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:1000; loading ...; fig e3i
Invitrogen CD45 antibody (eBioscience, 17-0452-83) was used in flow cytometry on mouse samples at 1:1000 (fig e3i). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen CD45 antibody (Thermo Fisher, 56-0452-82) was used in flow cytometry on mouse samples (fig s2a). Cell Rep (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig e3a
Invitrogen CD45 antibody (eBioscience, 48-0452-82) was used in flow cytometry on mouse samples (fig e3a). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig e2j, 4g
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:400 (fig e2j, 4g). Nature (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s7a
Invitrogen CD45 antibody (Thermo Fisher, 47-0459-42) was used in flow cytometry on human samples (fig s7a). Cell (2019) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s4a
Invitrogen CD45 antibody (eBioscience, 14-0459-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s4a). Cancer Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e5c
  • flow cytometry; mouse; loading ...; fig e5b
Invitrogen CD45 antibody (eBioscience, 14-0452-82) was used in immunohistochemistry - paraffin section on mouse samples (fig e5c) and in flow cytometry on mouse samples (fig e5b). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen CD45 antibody (Thermo Fisher Scientific, RA3-6B2) was used in flow cytometry on mouse samples (fig 6b). Cell (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s2a
Invitrogen CD45 antibody (ebioscience, 11-0459-41) was used in flow cytometry on human samples (fig s2a). Nature (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; loading ...; fig s2g
Invitrogen CD45 antibody (eBiosciences, 25-0452) was used in flow cytometry on mouse samples at 1:500 (fig s2g). Nat Immunol (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1e
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1e). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3b
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s3b). Ann Rheum Dis (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig 8c
Invitrogen CD45 antibody (Thermo Fisher, 25-0452-82) was used in flow cytometry on mouse samples at 1:400 (fig 8c). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 5i
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 5i). Genome Biol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen CD45 antibody (eBioscience, 48-0452-82) was used in flow cytometry on mouse samples (fig 6b). Cell Stem Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig ev2c
Invitrogen CD45 antibody (eBioscience, RA3?\6B2) was used in flow cytometry on mouse samples (fig ev2c). EMBO J (2019) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). J Clin Invest (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s4g
Invitrogen CD45 antibody (eBioscience, 45-0459-42) was used in flow cytometry on human samples (fig s4g). Cell Death Differ (2019) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 6c
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 6c). Obesity (Silver Spring) (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s3b
  • flow cytometry; human; loading ...; fig s3b
Invitrogen CD45 antibody (Thermo fisher, 110452) was used in flow cytometry on mouse samples (fig s3b) and in flow cytometry on human samples (fig s3b). Sci Rep (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s7c
Invitrogen CD45 antibody (eBioscience, 12-0452) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s7c). Cell Res (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
Invitrogen CD45 antibody (Invitrogen, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s18b
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples (fig s18b). Science (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:500; loading ...; fig 4c
Invitrogen CD45 antibody (Thermo Fisher Scientific, 45-0452-82) was used in flow cytometry on mouse samples at 1:500 (fig 4c). Nat Commun (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD45 antibody (Thermo Fisher Scientific, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). elife (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1e
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s1e). Cell Stem Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2i
Invitrogen CD45 antibody (eBioscience, 13-0452-82) was used in flow cytometry on mouse samples (fig 2i). J Exp Med (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5d
Invitrogen CD45 antibody (ebioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s5d). Science (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3e). J Virol (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3a
Invitrogen CD45 antibody (Thermo Fisher Scientific, 17-0452-83) was used in immunohistochemistry - frozen section on mouse samples (fig 3a). J Exp Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:400; loading ...; fig s1a
Invitrogen CD45 antibody (eBioscience, 12-0452-85) was used in flow cytometry on mouse samples at 1:400 (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:50; loading ...; fig 7a
Invitrogen CD45 antibody (eBioscience, 85-12-0458-42) was used in flow cytometry on human samples at 1:50 (fig 7a). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD45 antibody (Thermo Fisher, 11-9459-42) was used in flow cytometry on mouse samples (fig 4a). Nat Med (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1a
  • flow cytometry; mouse; loading ...; fig 5b
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 1a) and in flow cytometry on mouse samples (fig 5b). Front Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunocytochemistry; mouse; loading ...; fig 4b
Invitrogen CD45 antibody (Thermo Fisher, RA3-6B2) was used in immunocytochemistry on mouse samples (fig 4b). Sci Rep (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 1:200; fig 1a
Invitrogen CD45 antibody (eBiosciences, MHCD4527) was used in flow cytometry on mouse samples at 1:200 (fig 1a). Int J Mol Med (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1d
Invitrogen CD45 antibody (eBiosciences, 11-9459) was used in flow cytometry on human samples (fig s1d). Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s2d
Invitrogen CD45 antibody (eBiosciences, 11-0452-85) was used in flow cytometry on mouse samples (fig s2d). Cell (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2d). Nat Commun (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 7g
Invitrogen CD45 antibody (Life Technologies, MHCD4530) was used in flow cytometry on human samples (fig 7g). Cell (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 4c). J Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3b
Invitrogen CD45 antibody (Invitrogen, RA3-62B) was used in immunohistochemistry - frozen section on mouse samples (fig 3b). Science (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CD45 antibody (eBioscience, 25-0452-81) was used in flow cytometry on mouse samples (fig 3d). J Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s5a
Invitrogen CD45 antibody (eBioscience, 17-0452) was used in flow cytometry on mouse samples (fig s5a). J Clin Invest (2018) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig s3a
Invitrogen CD45 antibody (ThermoFisher, RA3-6B2) was used in immunohistochemistry on mouse samples (fig s3a). Cell (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on human samples (fig s2). Nat Commun (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1c
In order to investigate the role of apoptosis in microanatomic segregation of B cells in the germinal center, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s1c). Science (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3b
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3b). PLoS Pathog (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 7c
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 7c). Nat Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to investigate the function of histone deacetylase 3 in VDJ recombination and B-cell development, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig 1c
In order to investigate the involvement of achaete-scute complex homologue 2 in the pathogenesis of Sjogren's syndrome-like disease in the NOD/ShiLtJ mouse, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry on mouse samples (fig 1c). Immunol Lett (2017) ncbi
mouse monoclonal (JS-83)
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Invitrogen CD45 antibody (eBiosciences, JS-83) was used . Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2a). Diabetologia (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig s9e
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in immunohistochemistry on mouse samples (fig s9e). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s6g
In order to study the role of reprogrammed BCAA metabolism in the progression of myeloid leukaemia, Invitrogen CD45 antibody (eBiosciences, 6B2) was used in flow cytometry on mouse samples (fig s6g). Nature (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2018) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; tbl s1
In order to elucidate the effect of S100 calcium-binding proteins A8/A9 on thrombocytosis and atherogenesis in diabetes, Invitrogen CD45 antibody (eBioscience, 11-0452-85) was used in flow cytometry on mouse samples (tbl s1). J Clin Invest (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen CD45 antibody (eBiosciences, 11-0452-81) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2
In order to test if high protein affects monocytes during weight loss, Invitrogen CD45 antibody (Invitrogen, MHCD4527) was used in flow cytometry on human samples (fig 2). Nutr Res (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1.4b
In order to investigate the generation of macrophage populations during homeostasis and inflammation, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s1.4b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 7a
In order to test if Trichinella spiralis infection or its derivative stimulate recruitment of CD105+/CD45- cells, Invitrogen CD45 antibody (Thermo Fisher Scientific, MA5-11532) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7a). Exp Mol Pathol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, Invitrogen CD45 antibody (eBiosciences, HI100) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Int J Parasitol (2017) ncbi
rat monoclonal (RA3-6B2)
  • other; mouse; fig s2a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in other on mouse samples (fig s2a). J Clin Invest (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 1
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, Invitrogen CD45 antibody (Invitrogen, MHCD4530) was used in flow cytometry on human samples (tbl 1). J Immunol Methods (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 6d
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD45 antibody (Thermo Fischer Scientific, 48-0457) was used in flow cytometry on human samples (fig 6d). Cell Res (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 6c
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD45 antibody (Thermo Fischer Scientific, 17-9459) was used in flow cytometry on mouse samples (fig 6c). Cell Res (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD45 antibody (eBiosciences, HI100) was used in flow cytometry on human samples (fig 2a). Immun Ageing (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1d
In order to demonstrate that loss of autophagy results in the accumulation of mitochondria and an activated metabolic state of hematopoietic stem cells, Invitrogen CD45 antibody (eBiosciences, 47-0452-82) was used in flow cytometry on mouse samples (fig s1d). Nature (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 6b
In order to study the therapeutic TnP peptide in inflammation and demyelination in a mouse model of multiple sclerosis., Invitrogen CD45 antibody (eBioscience, 15-0452-83) was used in flow cytometry on mouse samples (fig 6b). PLoS ONE (2017) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; loading ...; fig 4i
In order to explore the contribution of epithelial cells to systemic sclerosis pathogenesis, Invitrogen CD45 antibody (eBioscience, 41-0452) was used in immunohistochemistry on mouse samples (fig 4i). J Exp Med (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore the role of Nol3 in myeloproliferative neoplasms, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s5e
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, Invitrogen CD45 antibody (eBiosciences, 11-0458-42) was used in flow cytometry on human samples (fig s5e). Nature (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, Invitrogen CD45 antibody (Invitrogen, MHCD45RA18) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; domestic rabbit; 1:100; loading ...; fig 2
In order to study the mechanisms by which stem cells are capable of unlimited self-renewal and remain undifferentiated for extended periods of time prior to differentiation into specific cell lineages, Invitrogen CD45 antibody (Invitrogen, MHCD4501) was used in flow cytometry on domestic rabbit samples at 1:100 (fig 2). Stem Cell Res Ther (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1d
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen CD45 antibody (eBioscience, 12-0452) was used in flow cytometry on mouse samples (fig 1d). Sci Rep (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if MSI2 modulates FLT3 expression, Invitrogen CD45 antibody (ebioscience, 6B2) was used in flow cytometry on mouse samples (fig 2c). Leuk Res (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (MEM-28)
  • flow cytometry; human; fig s1
In order to show that primary bronchial epithelium expresses HIV receptor CD4 and co-receptors CCR5 and CXCR4 and can be infected by both R5 and X4 tropic strains of HIV, Invitrogen CD45 antibody (Thermo Fisher Scientific, MA1-19569) was used in flow cytometry on human samples (fig s1). PLoS ONE (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 7G
In order to analyze the effects of a loss of autophagy in dendritic cells and B cells in a TLR7-mediated model of autoimmunity, Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples (fig 7G). J Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1h). J Exp Med (2017) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a
  • flow cytometry; human; loading ...; fig st4
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Invitrogen CD45 antibody (eBioscience, HI30) was used in immunohistochemistry - frozen section on human samples (fig 4a) and in flow cytometry on human samples (fig st4). Am J Transplant (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s2a
In order to report the molecular changes involve in stem cell differentiation, Invitrogen CD45 antibody (eBioscience, 17-0452-81) was used in flow cytometry on mouse samples (fig s2a). Nucleic Acids Res (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples (fig 1). J Clin Invest (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen CD45 antibody (ebioscience, HI100) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s7
Invitrogen CD45 antibody (eBiosciences, HI100) was used in flow cytometry on human samples (fig s7). PLoS Pathog (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1a
In order to discuss the contribution of epigenetic changes to the development of type 1 diabetes, Invitrogen CD45 antibody (Invitrogen, MHCD4512) was used in flow cytometry on human samples (fig s1a). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., Invitrogen CD45 antibody (eBioscience, 17-0452-83) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, Invitrogen CD45 antibody (eBioscience, 25-0458-71) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - frozen section; human; loading ...; tbl 2
In order to characterize HLA class I-positive and negative tumors, Invitrogen CD45 antibody (ThermoFisher Scientific, UCHL1) was used in immunohistochemistry - frozen section on human samples (tbl 2). Int J Cancer (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to report a role for plasmalemma vesicle-associated protein in hematopoiesis, Invitrogen CD45 antibody (eBioscience, 6B2) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
In order to explore the role of IL-21-producing T cells in rheumatoid arthritis, Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . J Leukoc Biol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
In order to assess the role of C1q in downregulating allergic inflammation, Invitrogen CD45 antibody (eBiosciences, RA3- 6B2) was used in flow cytometry on mouse samples (fig 1c). Mucosal Immunol (2017) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3c
In order to find genes that alter invariant natural killer T cell development, migration, or function, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 3c). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s3
Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s3b
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig s3b). Oncotarget (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to discuss the potential roles of TSHR and CD40 in thyroid-associated ophthalmopathy, Invitrogen CD45 antibody (Life Technologies, MHCD4531) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1h
In order to characterize side population T cells, Invitrogen CD45 antibody (eBiosciences, HI100) was used in flow cytometry on human samples (fig 1h). J Clin Invest (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to describe a mouse vaccination model to produce HIV neutralizing antibodies., Invitrogen CD45 antibody (eBioscience, 15-0452-83) was used in flow cytometry on mouse samples (fig 4d). Cell (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; tbl 1
  • immunocytochemistry; mouse; 1:200; tbl 1
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (tbl 1) and in immunocytochemistry on mouse samples at 1:200 (tbl 1). Nat Commun (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; fig 2a
In order to study changes in IL-23 and IL-22 after scratching, Invitrogen CD45 antibody (eBioscience, 2D1) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study changes in IL-23 and IL-22 after scratching, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; loading ...; fig 2c
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, Invitrogen CD45 antibody (Life Technologies, MEM-56) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s3
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, Invitrogen CD45 antibody (eBioscience, 11-0452-81) was used in flow cytometry on mouse samples (fig s3). Cell (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 2
In order to identify peanut proteins that can predict peanut allergy., Invitrogen CD45 antibody (Invitrogen, MHCD4530) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 2
Invitrogen CD45 antibody (eBioscience, 11-9459-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen CD45 antibody (eBiosciences, 45-0452-80) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
In order to test if a diet high in fats affects the development of respiratory tolerance, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . elife (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1c
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig ex1b
In order to perform live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 and study how these factors influence early myeloid lineage choice, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig ex1b). Nature (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1b
In order to investigate the impact of Siglec-H on type I IFN responses and virus infection, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s1b). J Exp Med (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 1-s1
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen CD45 antibody (eBiosciences, 13-0452-86) was used in flow cytometry on mouse samples (fig 1-s1). elife (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen CD45 antibody (eBioscience, 56-0452-82) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:20; fig st2
Invitrogen CD45 antibody (eBioscience, 25-0458-42) was used in flow cytometry on human samples at 1:20 (fig st2). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 5). Immunity (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . Nat Med (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 6
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 3d
In order to generate a T-cell receptor-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex and test it in preclinical models of acute myeloid leukemia, Invitrogen CD45 antibody (Thermo Fisher, MEM-56) was used in flow cytometry on human samples (fig 3d). Cytotherapy (2016) ncbi
mouse monoclonal (PD7/26/16, 2B11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen CD45 antibody (Thermo Scientific, PD7/26/16+2B11) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to develop an artificial niche to maintain muscle stem cells in a potent and quiescent state, Invitrogen CD45 antibody (Invitrogen, MHCD4520) was used in flow cytometry on human samples . Nat Biotechnol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1b
In order to assess the use of human adipose-derived stem cells to treat cancer, Invitrogen CD45 antibody (Invitrogen, MHCD4504) was used in flow cytometry on human samples (fig 1b). Cytotherapy (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig S1
In order to analyze the dynamics of genome-wide promoter H3K4me2 and H3K4me3 during activation of human naive and memory CD4 T cells, Invitrogen CD45 antibody (eBioscience, 11-0458-42) was used in flow cytometry on human samples (fig S1). Genes Immun (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig S1
In order to analyze the dynamics of genome-wide promoter H3K4me2 and H3K4me3 during activation of human naive and memory CD4 T cells, Invitrogen CD45 antibody (eBioscience, 25-0457-42) was used in flow cytometry on human samples (fig S1). Genes Immun (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s1
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1
Invitrogen CD45 antibody (eBioscience, 2D1) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl 1
In order to research adipose tissue-derived mesenchymal stem cell proliferation and death with oxysterols, Invitrogen CD45 antibody (Invitrogen, MHCD4504R-PE) was used in flow cytometry on human samples (tbl 1). J Steroid Biochem Mol Biol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig e3c
In order to explore the contribution of Musashi-2 in determining hematopoietic stem cell fate, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (fig e3c). Nature (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to investigate the effects of IL-1 on hematopoietic stem cells, Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples . Nat Cell Biol (2016) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; 1:200; fig 7
Invitrogen CD45 antibody (eBioscience, 13-0452) was used in flow cytometry on human samples at 1:200 (fig 7). Haematologica (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen CD45 antibody (eBioscience, 12-0452) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 4
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 2
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, Invitrogen CD45 antibody (eBioscience, 48-0457-42) was used in flow cytometry on human samples (fig 2). J Clin Invest (2016) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; loading ...; fig 6b
In order to develop a cell sorting technique for use with a suspended microchannel resonator that measures the biophysical characteristics of a single cell, Invitrogen CD45 antibody (Invitrogen, MHCD4520) was used in immunocytochemistry on human samples (fig 6b). Integr Biol (Camb) (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to characterize B and T cells from patients with thrombocytopenia, Invitrogen CD45 antibody (eBioscience, 45-0458) was used in flow cytometry on human samples . Haematologica (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; fig 5
Invitrogen CD45 antibody (eBioscience, 12-0459-42) was used in flow cytometry on mouse samples (fig 5). Genes Dev (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2b). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; fig 1
Invitrogen CD45 antibody (eBioscience, 14-0452-82) was used in immunohistochemistry on mouse samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, Invitrogen CD45 antibody (ebioscience, HI30) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1e
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 1e). Science (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200; fig 2
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:200 (fig 2). Nat Commun (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples . PLoS Pathog (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; fig 8
In order to test if enforced virus replication occurs in the presence of virus-specific antibodies or virus-specific CD8 positive T cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples (fig 8). Sci Rep (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to study epithelial control of gut-associated lymphoid tissue formation via p38alpha-dependent restraint of NF-kappaB signaling, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 1
In order to discuss cell- and tissue-specific changes in DNA methylation in type 1 diabetes, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (tbl 1). Methods Mol Biol (2016) ncbi
mouse monoclonal (HI30)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Invitrogen CD45 antibody (Life Technologies, HI30) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2e
In order to test if NR2F2 contributes to the stemness maintenance of mesenchymal stem cells, Invitrogen CD45 antibody (eBioscience, 12-9459) was used in flow cytometry on human samples (fig 2e). Stem Cells Int (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4
In order to determine how Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from initiation of polyposis, Invitrogen CD45 antibody (eBioscience, 14-0452) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Int J Cancer (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to study the contribution of thyroid stimulating hormone beta-subunit to Listeria monocytogenes infection, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:1000; fig s12
In order to test if GATA5 is a regulator of blood pressure, Invitrogen CD45 antibody (eBioscience, 45-0452-80) was used in flow cytometry on mouse samples at 1:1000 (fig s12). Nat Commun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4b
In order to study heat-shock protein 70 in non-small cell lung cancer cells, Invitrogen CD45 antibody (Caltag/Invitrogen, MHCD 4505) was used in flow cytometry on human samples (fig 4b). Front Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, Invitrogen CD45 antibody (eBioscience, HI 100) was used in flow cytometry on human samples (fig 3a). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 2f
Invitrogen CD45 antibody (eBioscience, 17-0452) was used in flow cytometry on mouse samples (fig 2f). J Exp Med (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 9e
Invitrogen CD45 antibody (eBioscience, 48-9459) was used in flow cytometry on human samples (fig 9e). J Exp Med (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:800
Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples at 1:800. Nat Commun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; human
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on human samples . Science (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to identify the sequence motif of B class phosphodiester oligodeoxyribonucleotides that govern mouse TLR9 activation, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s2a
Invitrogen CD45 antibody (eBioscience, 17-0459-42) was used in flow cytometry on human samples (fig s2a). Nat Med (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD45 antibody (eBiosciences, UCHl-1) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s4
Invitrogen CD45 antibody (eBioscience, 11-9459-42) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s4
Invitrogen CD45 antibody (eBiosciences, 45-0458-42) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:1000; loading ...; fig 3c, 3d
Invitrogen CD45 antibody (eBioscience, 12-0452) was used in flow cytometry on mouse samples at 1:1000 (fig 3c, 3d). Endocrinology (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, Invitrogen CD45 antibody (Invitrogen, Q10156) was used in flow cytometry on human samples (fig 3). Gastroenterology (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 5b
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 5b). Nat Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Science (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to study how CCR2 regulates leukocyte mobilization from the bone marrow, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 8
In order to investigate the contribution of lymphocytes to primary percutaneous coronary intervention, Invitrogen CD45 antibody (Invitrogen, MHCD45RA28) was used in flow cytometry on human samples (fig 8). J Clin Invest (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Leukemia (2016) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 4
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, Invitrogen CD45 antibody (eBiosciences, 47-0452-82) was used in flow cytometry on mouse samples (fig 4). Autophagy (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; loading ...; fig 7
Invitrogen CD45 antibody (eBiosciences, 12-0452) was used in flow cytometry on mouse samples (fig 7). Nat Commun (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to report that alefacept depletes both memory T cells and NK cells, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 5
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (fig 5). Mucosal Immunol (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s4
Invitrogen CD45 antibody (eBioscience, 11-9459) was used in flow cytometry on human samples (fig s4). Stem Cell Reports (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD45 antibody (Life Technologies, MEM-56) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - frozen section; mouse; 1:100; fig e7
In order to investigate the mechanisms that regulate the entrance and exit of immune cells from the central nervous system, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig e7). Nature (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study the effect of ERK1/2 and ERK5 activation on BAFF-induced B cell survival, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
Invitrogen CD45 antibody (eBioscience, 11-9459-41) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, Invitrogen CD45 antibody (Life Sciences/Invitrogen, Q10069) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 2
In order to examine the role of lymphocyte activation gene-3 during HIV infection, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 2:200
In order to study the differences between human and mouse ATOH1 in Wharton's jelly cells, Invitrogen CD45 antibody (Life Technologies, Q10156) was used in flow cytometry on human samples at 2:200. Tissue Eng Part A (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to report that L3MBTL1 represses the ability of stem cells to drive hematopoietic-specific transcriptional programs via SMAD5 and impairing its recruitment to target regulatory regions, Invitrogen CD45 antibody (Invitrogen, MHCD4505) was used in flow cytometry on human samples . Stem Cell Reports (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; 1:200; fig 4
Invitrogen CD45 antibody (eBioscience, 41-0452-80) was used in immunohistochemistry on mouse samples at 1:200 (fig 4). Nagoya J Med Sci (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3A
In order to report a B cell-intrinsic role for Rab7, Invitrogen CD45 antibody (eBioscience, 13-0452) was used in flow cytometry on mouse samples (fig 3A). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; 1:200; fig 7
Invitrogen CD45 antibody (eBioscience, 41-0452-80) was used in immunohistochemistry on mouse samples at 1:200 (fig 7). Immun Ageing (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 4
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig 4). Cancer Immunol Res (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 4
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 4). Cancer Immunol Res (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 5
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD45 antibody (eBioscience, 2D1) was used in flow cytometry on human samples (fig 5). Cancer Immunol Res (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, Invitrogen CD45 antibody (Invitrogen, MHCD45RO04) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
Invitrogen CD45 antibody (eBioscience, 11-0459-42) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s2
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s2). Blood (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry; human
In order to study the role of lymph node in the early rectal cancer, Invitrogen CD45 antibody (Thermo Scientific, UCHL-1) was used in immunohistochemistry on human samples . Dis Markers (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study the contribution of Wip1 to neutrophil function during oxidative stress and inflammation, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Curr Mol Med (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s3
In order to analyze how ordered recombination occurs through the proximal J kappa germline-transcript promoter facilitating receptor editing, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). FASEB J (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
In order to assess the effects of Hspa9 haploinsufficiency on hematopoiesis using zebrafish, Invitrogen CD45 antibody (BD/eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). Exp Hematol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl 2
In order to learn how peritoneal macrophages enhance antibacterial responses by vitamin D supplementation, Invitrogen CD45 antibody (Invitrogen, MHCD-4501) was used in flow cytometry on human samples (tbl 2). PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Development (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig S11
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen CD45 antibody (eBioscience, 11-0452) was used in flow cytometry on mouse samples (fig S11). Nat Biotechnol (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, 12-9459) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). Immunol Lett (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, 47-0459-41) was used in flow cytometry on human samples . Am J Pathol (2015) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; 1:400
In order to examine the response and resistance to endocrine therapy in mice, Invitrogen CD45 antibody (eBioscience, 14-0452) was used in immunohistochemistry on mouse samples at 1:400. Carcinogenesis (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig S9a
Invitrogen CD45 antibody (eBioscience, 45-0452) was used in flow cytometry on mouse samples (fig S9a). Nat Immunol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to isolate and characterize endothelial cells and microparticles obtained directly from the site of cardiac damage, Invitrogen CD45 antibody (Molecular Probes, MHCD4517) was used in flow cytometry on human samples . Thromb Haemost (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 1:200
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 1:200. Methods Mol Biol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4
In order to use the technique of high-throughput tri-colour flow cytometry to analyze Plasmodium falciparum parasitaemia in bioassays, Invitrogen CD45 antibody (Invitrogen, H130) was used in flow cytometry on human samples (fig 4). Malar J (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5
In order to describe the pathogenesis of influenza A virus and Sendai virus in ISG15 knockout mice, Invitrogen CD45 antibody (eBioscience, RA3-682) was used in flow cytometry on mouse samples (fig 5). J Virol (2015) ncbi
mouse monoclonal (2D1)
  • immunohistochemistry - frozen section; mouse
Invitrogen CD45 antibody (Bioscience, 17-9459) was used in immunohistochemistry - frozen section on mouse samples . Stem Cell Res (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3a
In order to investigate the effect of ADAM17 on CSF1R protein expression on hematopoietic progenitors, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3a). Exp Hematol (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5
In order to assess IL-25 and IL-23 and reciprocal regulation of lymphoid tissue development in the large intestine, Invitrogen CD45 antibody (Life technologies, RA3-6B2) was used in flow cytometry on mouse samples (fig 5). Mucosal Immunol (2015) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; baboons; fig 1
In order to study the effect of age, gender, social status and peer group on T cells in baboons, Invitrogen CD45 antibody (Life Technologies, clone MEM-56) was used in flow cytometry on baboons samples (fig 1). PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study IkappaB kinase-induced proteolysis of NF-kappaB1 p105 in B cells using Nfkb1(SSAA/SSAA) mice, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, Invitrogen CD45 antibody (Life Technologies / Invitrogen, MEM-56) was used in flow cytometry on human samples . Immunobiology (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS Genet (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, Invitrogen CD45 antibody (eBioscience, H100) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study why HSC function declines with age, Invitrogen CD45 antibody (eBioscience, 47-0452-82) was used in flow cytometry on mouse samples . Nature (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 5
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, Invitrogen CD45 antibody (Invitrogen, MHCD4530) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study the cell mediated immune response to JCV T-Ag in patients with colorectal adenomatous polyps or cancers, Invitrogen CD45 antibody (Molecular Probes, MHCD4530) was used in flow cytometry on human samples . Gut Microbes (2014) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples . Leukemia (2015) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on human samples . elife (2014) ncbi
mouse monoclonal (MEM-56)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, Invitrogen CD45 antibody (BD, MHCD45RA28) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to characterize CD81(+) and CD63(+) subpopulations of exosomes released from B-cell lymphoma cell lines, Invitrogen CD45 antibody (Invitrogen, MHCD4505) was used in flow cytometry on human samples . Clin Ther (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study Bacillus Calmette-Guerin DeltaureC::hly and the superior protection against tuberculosis caused by central memory CD4+ T cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Infect Dis (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 0.5 ug/ml
Invitrogen CD45 antibody (eBioscience, HI30) was used in flow cytometry on human samples at 0.5 ug/ml. Sci Rep (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to find Munc13-4 is highly expressed in differentiated human natural killer cells and effector CD8(+) T lymphocytes, Invitrogen CD45 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen CD45 antibody (eBioscience, RA36B2) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to report on a case of CD30-positive extranodal natural killer/T-cell lymphoma, Invitrogen CD45 antibody (Zymed, UCHL1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncol Lett (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study how autophagy in memory B cells regulates vaccine responses, Invitrogen CD45 antibody (eBioscience, 45-0452-82) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; 1:200
Invitrogen CD45 antibody (eBioscience, 14-0452-81) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
In order to use localized surface plasmon resonance biosensors to cytokine production by human blood, Invitrogen CD45 antibody (Life Technologies, MHCD4515) was used in flow cytometry on human samples (fig 2). ACS Nano (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to test if pharmacological modulation of SPPL2a can deplete B cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; tbl 1
In order to examine the changes in erythrocytes and T-lymphocytes and to explore the mechanisms involved in stress-induced depression using a rat depression model, Invitrogen CD45 antibody (Invitrogen, clone MEM-56) was used in flow cytometry on human samples (tbl 1). Environ Toxicol Pharmacol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to test the role of T cells in Epstein-Barr virus viral latency regulation in humanized NOD/SCID/IL2Rgamma(-/-) mice, Invitrogen CD45 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to elucidate the immunological pathways that lead to obesity-associated asthma, Invitrogen CD45 antibody (Invitrogen, MHCD4517) was used in flow cytometry on human samples . Nat Med (2014) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of CD4+ T cells in Porphyromonas gingivalis infection, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). Mol Oral Microbiol (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; fig 1
In order to identify CD11b(+) classical dendritic cells as the source of IL-23 in C. rodentium infected mice, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry on mouse samples (fig 1). Nat Immunol (2013) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples . J Immunol (2013) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 2
In order to examine Tregs in patients with Celiac disease, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4
In order to describe a protocol to generated iPSCs from adult mobilized CD34+ and peripheral blood mononuclear cells, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (fig 4). Stem Cells Transl Med (2013) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
  • flow cytometry; mouse; fig 6
In order to investigate the role of HLA molecules during infection using humanized mice, Invitrogen CD45 antibody (Invitrogen Corporation, no) was used in flow cytometry on human samples and in flow cytometry on mouse samples (fig 6). J Immunol (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig s2
In order to generate and characterize Hoxb8-FL cells, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig s2). Nat Methods (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5b
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 5b). PLoS ONE (2013) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 3
In order to determine cytokine profiles of CD4(+) T-helper (h) cells in adults and young children vaccinated with the antigens PspA, PcpA, PhtD, PhtE, Ply, LytB of Streptococcus pneumonia and protein D and OMP26 of non-typeable Haemophilus influenza, Invitrogen CD45 antibody (Invitrogen, clone MEM56) was used in flow cytometry on human samples (fig 3). Vaccine (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to review the role of S1P lyase in T cell-mediated disease, Invitrogen CD45 antibody (ebioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; tbl 1
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (tbl 1). PLoS ONE (2013) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 2
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD45 antibody (Invitrogen, clone UCHL1) was used in flow cytometry on human samples (fig 2). J Immunol (2013) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 3
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD45 antibody (Invitrogen, clone MEM-56) was used in flow cytometry on human samples (fig 3). J Immunol (2013) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to examine the role of IL-17A-producing multifunctional T cells in the pathogenesis of toxic shock syndrome, Invitrogen CD45 antibody (Invitrogen, MEM56) was used in flow cytometry on human samples (fig 1). Clin Immunol (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples . FASEB J (2013) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Exp Med (2013) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, Invitrogen CD45 antibody (Invitrogen, MHCD4530) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS Pathog (2012) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to study the relationship between circulating CD4+ T-cell subsets and atherosclerosis, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples . J Am Heart Assoc (2012) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD45 antibody (CALTAG, MHCD4518) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study the co-culture of mesenchymal stem cells with liver cells in bioartificial liver system, Invitrogen CD45 antibody (Invitrogen, MHCD4506) was used in flow cytometry on human samples . Biotechnol Bioeng (2013) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; fig 6
In order to use neuropilin 1 expression to distinguish n from i T regulatory cells in mouse models of spontaneous autoimmune encephalomyelitis and lung inflammation, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry on mouse samples (fig 6). J Exp Med (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to determine the function and phenotypes of antigen-specific CD4(+) T cells in adults compared to infants upon acellular pertussis vaccine administration, Invitrogen CD45 antibody (Invitrogen, MEM56) was used in flow cytometry on human samples . Clin Exp Immunol (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 6
In order to characterize and study human IFNgamma-producing T regulatory cells, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 6). J Autoimmun (2012) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to investigate the use of FcRL5 antibody-drug conjugates as a treatment for multiple myeloma, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (fig 1). Mol Cancer Ther (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD45 antibody (Invitrogen, clone MEM56) was used in flow cytometry on human samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 4
In order to report results from a pilot study of stereotactic body radiation therapy followed by high-dose interleukin-2 that assessed safety and tumor response rates, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 4). Sci Transl Med (2012) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, 13-0452) was used in flow cytometry on mouse samples . Exp Hematol (2012) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Front Immunol (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD45 antibody (Invitrogen, clone MEM-56) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; tbl 4
In order to study the diagnostic value for detecting early mycosis fungoides of a combination of multiplex PCR analyis of TCRgamma gene rearrangements and laser-capture microdissection, Invitrogen CD45 antibody (Zymed, clone UCHL1) was used in immunohistochemistry - paraffin section on human samples (tbl 4). J Cutan Pathol (2012) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
In order to investigate the role of CD8 and antigen in proliferation of CTLs, Invitrogen CD45 antibody (Invitrogen, Clone UCHL1) was used in flow cytometry on human samples (fig 1). J Immunol (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to investigate the role of CD8 and antigen in proliferation of CTLs, Invitrogen CD45 antibody (Invitrogen, Clone MEM-56) was used in flow cytometry on human samples (fig 1). J Immunol (2012) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
Invitrogen CD45 antibody (eBioscience, 6B2) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2011) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig s1
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2011) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to investigate age- and antigen-specific CD8 T cell responses, Invitrogen CD45 antibody (e-Bioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS Pathog (2011) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:100; tbl 3
In order to characterize extranodal natural killer/T-cell lymphoma, nasal type using patient samples, Invitrogen CD45 antibody (ZYMED, UCHL1) was used in flow cytometry on human samples at 1:100 (tbl 3). Cytopathology (2012) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples . J Exp Med (2011) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 8
In order to clone and functionally assess a human alphabeta TCR specific for the immunodominant epitope of Bet v 1, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 8). J Immunol (2011) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
  • immunohistochemistry; mouse; fig 1g
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples and in immunohistochemistry on mouse samples (fig 1g). Nat Immunol (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD45 antibody (eBioscience, 47-0459-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; tbl .S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD45 antibody (Invitrogen, Q10047) was used in flow cytometry on human samples (tbl .S2). Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, ebio 12-0452) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; rhesus macaque; fig 3
In order to study DNA-based vaccines to treat Rhesus macaques-infected with SIV, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on rhesus macaque samples (fig 3). PLoS ONE (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to study non-cycling acute myeloid leukemia cells, Invitrogen CD45 antibody (Caltag Laboratories, clone HI30) was used in flow cytometry on human samples (fig 1). Br J Haematol (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; rat; 10 ug/ml; tbl 2
In order to characterize bone marrow-derived mesenchymal stem cells from patients with ankylosing spondylitis, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on rat samples at 10 ug/ml (tbl 2). Arthritis Res Ther (2011) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to investigate the regulation of the CD4 and CD8 T cell pools during HIV infection, Invitrogen CD45 antibody (Invitrogen, clone MEM-56) was used in flow cytometry on human samples (fig 1). J Immunol (2011) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to examine T cell subsets in aging CMV seropositive adults, Invitrogen CD45 antibody (Caltag, clone MEM-56) was used in flow cytometry on human samples (fig 1). Immunology (2011) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; tbl 3
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD45 antibody (Invitrogen, clone MEM56) was used in flow cytometry on human samples (tbl 3). Vaccine (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4
In order to discuss the properties and culturing methods of human umbilical cord stromal stem cells, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 4). Placenta (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to investigate the role of specific CD8 T cells in the pathogenesis of psoriasis, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . PLoS ONE (2010) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:20; tbl 1
In order to isolate and characterize human Sertoli cells, Invitrogen CD45 antibody (Invitrogen, MHCD4501) was used in flow cytometry on human samples at 1:20 (tbl 1). Cell Transplant (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to characterize stem cells isolated and expanded from the human dental pulp, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on human samples (fig 3). J Biomed Biotechnol (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1, 2
In order to discuss methods for the in vitro expansion of human Treg cells, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on human samples (fig 1, 2). Methods Mol Biol (2011) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to report that functional circulating hematopoietic stem and progenitor cells can be separated from other cell populations based on AC133 expression, Invitrogen CD45 antibody (Invitrogen, MHCD4527) was used in flow cytometry on human samples (fig 1). Cytometry A (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2010) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; fig 1
In order to examine the migration of tumor-associated macrophages precursors into tumors, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples at 1:50 (fig 1). Immunobiology (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to determine the effect of FTY720 treatment on Th17 cells, Invitrogen CD45 antibody (Caltag Laboratories, MEM-56) was used in flow cytometry on human samples (fig 1). Neurology (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 2
In order to examine the function of K(2P)5.1 in T cells and multiple sclerosis, Invitrogen CD45 antibody (Caltag Laboratories, MEM-56) was used in flow cytometry on human samples (fig 2). Ann Neurol (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2010) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to assess circulating colony forming unit-endothelial cells in adolescents with type 1 diabetes, Invitrogen CD45 antibody (Invitrogen, MHCD4527) was used in flow cytometry on human samples (fig 1). J Pediatr (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 5
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 1
In order to investigate how modulation of reactive oxygen species levels affects Ig class switch recombination, Invitrogen CD45 antibody (Caltag, RA3-6B2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the T cell repertoire in aging primates, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on rhesus macaque samples (fig 3). J Immunol (2010) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to describe a flow cytometry based method to identify rare circulating endothelial colony-forming cell, Invitrogen CD45 antibody (Invitrogen, MHCD4527) was used in flow cytometry on human samples (fig 1). Curr Protoc Cytom (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; rhesus macaque; fig 2
In order to develop a new ex vivo method to study rhesus macaque T cell proliferation, Invitrogen CD45 antibody (Invitrogen, MEM-56) was used in flow cytometry on rhesus macaque samples (fig 2). Cytometry A (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry; mouse; fig 5
In order to elucidate the role of AUF1 in the immune system, Invitrogen CD45 antibody (eBioScience, RA3-6B2) was used in immunohistochemistry on mouse samples (fig 5). BMC Immunol (2010) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2009) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study the role of bone marrow-derived cells in lymphangiogenesis, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . PLoS ONE (2009) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 2
In order to elucidate factors involved in myeloid dendritic cell differentiation, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples (fig 2). Blood (2009) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:500; fig 5
In order to assess the use of human placental hematopoietic cells for transplantation, Invitrogen CD45 antibody (Caltag Laboratories, MHCD4505) was used in flow cytometry on human samples at 1:500 (fig 5). Exp Biol Med (Maywood) (2009) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to study interactions between CD8 T cells, Toxoplasma gondii, and APCs in the brain, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to report that T regulatory cells lose FOXP3 expression and begin to produce pro-inflammatory cytokines when expanded in vitro, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2009) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2a
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 2a). Nat Protoc (2008) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1e
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples (fig 1e). Nat Protoc (2008) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; tbl 1
In order to assess the regulatory function of human CD25+CD4+ T cells at various stages of maturity, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples (tbl 1). Clin Dev Immunol (2008) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; tbl 1
In order to characterize Tregs from older subjects and mice, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples (tbl 1). J Immunol (2008) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 2
In order to examine the role of IL-6 in the development of Th17 cells in experimental autoimmune encephalomyelitis, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2008) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 2
In order to examine the frequency, phenotype, and function of T regulatory cells in patients with systemic lupus erythematosus and inactive disease, Invitrogen CD45 antibody (Caltag, UCHL-1) was used in flow cytometry on human samples (fig 2). Clin Exp Immunol (2008) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2b
In order to demonstrate that aerosolized interferon-gamma results in the transient conversion of sputum smears in multidrug-resistant pulmonary tuberculosis, Invitrogen CD45 antibody (Invitrogen, H130) was used in flow cytometry on human samples (fig 2b). Int J Tuberc Lung Dis (2008) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Nat Immunol (2008) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 2
In order to determine how the proportions of CD4(+) T cell subsets change during HIV infection, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples (fig 2). J Immunol (2008) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to describe a novel technique to isolate viable Th17 cells based on their ability to secrete IL-17, Invitrogen CD45 antibody (Caltag, clone HI30) was used in flow cytometry on human samples (fig 1). J Immunol Methods (2008) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 3A
In order to quantify the prevalence of Th1 and Th17 cells in the joints of rheumatoid arthritis patients, Invitrogen CD45 antibody (e-Bioscience, UCHL1) was used in flow cytometry on human samples (fig 3A). Ann Rheum Dis (2008) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
In order to investigate whether hematopoietic cells transduce canonical Wnt signals in the absence of beta- and gamma-catenin, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Blood (2008) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; fig 3
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in flow cytometry on mouse samples (fig 3). Gene Ther (2007) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; human
In order to discuss the frequency and contribution of CD27- memory B cells to systemic lupus erythematosus, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on human samples . J Immunol (2007) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s1
In order to report that CCN1 promotes integrin-dependent recruitment of CD34+ progenitor cells to endothelial cells, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig s1). Blood (2007) ncbi
mouse monoclonal (HI30)
  • flow cytometry; rhesus macaque; fig 3
In order to characterize rhesus macaque-derived CD8 T+ cell clone specific for the MamuA*01-restricted immunodominant SIV gag epitope CM9 that also express human telomerase reverse transcriptase, Invitrogen CD45 antibody (Invitrogen, HI30) was used in flow cytometry on rhesus macaque samples (fig 3). AIDS Res Hum Retroviruses (2007) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to demonstrate a new way of endothelial differentiation that involves the specific modulation of monocytes by the tumor environment, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 3). Scand J Immunol (2007) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 4
Invitrogen CD45 antibody (eBioscience, UCHL1) was used in flow cytometry on human samples (fig 4). J Immunol (2006) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 4
Invitrogen CD45 antibody (eBioscience, HI100) was used in flow cytometry on human samples (fig 4). J Immunol (2006) ncbi
rat monoclonal (RA3-6B2)
  • immunohistochemistry - paraffin section; mouse; fig 2
In order to identify antigens that result in age-dependent spontaneous loss of tolerance, Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Clin Immunol (2006) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to assess the T cell-stimulatory capacity of mature dendritic cells and macrophages using a model of allogeneic MLR, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to assess the T cell-stimulatory capacity of mature dendritic cells and macrophages using a model of allogeneic MLR, Invitrogen CD45 antibody (Caltag, MEM 56) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to report the expression of chemokine receptors on FOXP3+ T cells, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples (fig 1). Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; African green monkey
  • flow cytometry; rhesus macaque
In order to compare cell cycle dysregulation in simian immunodeficiency virus-infected rhesus macaques and sooty mangabeys, Invitrogen CD45 antibody (Caltag, MEM 56) was used in flow cytometry on African green monkey samples and in flow cytometry on rhesus macaque samples . J Virol (2006) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse; 10 ug/ml
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples at 10 ug/ml. J Immunol (2005) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to elucidate the lineage of central memory T cells and effector memory T cells, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on human samples . J Immunol (2005) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2005) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
In order to elucidate a mechanism for E loss involving antibodies, complement, and phagocytosis, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 3). J Immunol (2005) ncbi
rat monoclonal (RA3-6B2)
  • flow cytometry; mouse
Invitrogen CD45 antibody (eBioscience, RA3-6B2) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to review characteristics of elderly patients with acute myeloid leukemia, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . Haematologica (2005) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD45 antibody (Caltag Laboratories, HI30) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
In order to use flow cytometry to identify markers that distinguish myelodysplastic syndromes from acute myeloid leukemia, Invitrogen CD45 antibody (Caltag Laboratories, HI30) was used in flow cytometry on human samples (fig 1). Clin Cancer Res (2004) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to investigate T cell-mediated transfer of varicella-zoster virus to skin, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples . J Exp Med (2004) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 6
In order to assess the expression of NK cell receptors and cytokines in the human endometrium, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 6). J Leukoc Biol (2004) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study the functional properties of CD14+CD16+ monocytes under myeloablative high-dose chemotherapy and subsequent autologous stem-cell transplantation, Invitrogen CD45 antibody (Zymed Laboratories, #MHCD4505) was used in flow cytometry on human samples . J Leukoc Biol (2004) ncbi
rat monoclonal (RA3-6B2)
  • other; mouse
Invitrogen CD45 antibody (eBiosciences, RA3-6B2) was used in other on mouse samples . Eur J Immunol (2003) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to examine CD10 expression in hairy cell leukemia, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . Am J Clin Pathol (2003) ncbi
mouse monoclonal (MEM55)
  • flow cytometry; human; fig 4
In order to investigate the involvement of the PD-1 system in rheumatoid arthritis, Invitrogen CD45 antibody (Caltag, MEM55) was used in flow cytometry on human samples (fig 4). J Rheumatol (2003) ncbi
mouse monoclonal (MEM-55)
  • flow cytometry; human; fig 4
In order to investigate the involvement of the PD-1 system in rheumatoid arthritis, Invitrogen CD45 antibody (Caltag, MEM55) was used in flow cytometry on human samples (fig 4). J Rheumatol (2003) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to report that EphB6 and its ligands facilitate T cell responses to antigen, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . J Clin Invest (2002) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to report that Varicella-zoster virus infects human tonsillar CD4(+) T cells, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples . J Virol (2002) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 6
In order to discuss the high cost of measuring CD4 T cells by flow cytometry, Invitrogen CD45 antibody (Caltag, HI30) was used in flow cytometry on human samples (fig 6). Cytometry (2002) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 1
In order to identify a mutation in PTPRCas a cause of variant CD45 expression in humans, Invitrogen CD45 antibody (Caltag, MEM 56) was used in flow cytometry on human samples (fig 1). Immunogenetics (2002) ncbi
rat monoclonal (YTH80.103)
  • flow cytometry; human; fig 1
In order to identify a mutation in PTPRCas a cause of variant CD45 expression in humans, Invitrogen CD45 antibody (Biosource, YTH80.103) was used in flow cytometry on human samples (fig 1). Immunogenetics (2002) ncbi
mouse monoclonal (MEM-56)
  • western blot; human; fig 1
In order to study CD45 molecules in B cells, Invitrogen CD45 antibody (Caltag, MEM-56) was used in western blot on human samples (fig 1). Eur J Haematol (2002) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
In order to elucidate the mechanisms that promote recruitment and survival of T cells within the pediatric inflamed joint, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples (fig 1). J Immunol (2001) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to examine the numbers, cellular origin and thrombin-generating properties of microparticles in healthy individuals, Invitrogen CD45 antibody (Biosource, HI30) was used in flow cytometry on human samples . Thromb Haemost (2001) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to determine the developmental pathway of pre-DC2/IPCs, Invitrogen CD45 antibody (Caltag, MEM 56) was used in flow cytometry on human samples . J Exp Med (2000) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to test if type-I interferons influence dendritic cell differentiation and function, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples . Blood (2000) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; sooty mangabey
  • flow cytometry; rhesus macaque
In order to compared the effect of SIV infection on T-cell regeneration in sooty mangabeys and rhesus macaques, Invitrogen CD45 antibody (Caltag, MEM-56) was used in flow cytometry on sooty mangabey samples and in flow cytometry on rhesus macaque samples . J Virol (2000) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to identify the optimal condition for the generation of committed progenitors from cord blood cells without affecting the stem cell compartment, Invitrogen CD45 antibody (Caltag, clone HI30) was used in flow cytometry on human samples . Haematologica (1999) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (MEM-56)
  • western blot; human
In order to investigate the cellular processing of PrP (C) using platelets, Invitrogen CD45 antibody (Caltag, MEM-56) was used in western blot on human samples . Br J Haematol (1998) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to study responses of peripheral blood T cells to malaria antigens, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples . Infect Immun (1998) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; fig 4
In order to determine the functional properties of CK beta-11/MIP-3 beta/ELC, Invitrogen CD45 antibody (Caltag, MEM56) was used in flow cytometry on human samples (fig 4). J Immunol (1998) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 4
In order to determine the functional properties of CK beta-11/MIP-3 beta/ELC, Invitrogen CD45 antibody (Caltag, UCHL1) was used in flow cytometry on human samples (fig 4). J Immunol (1998) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1 ug
In order to study RNA transcripts in patients with Glanzmann thrombasthenia, Invitrogen CD45 antibody (Caltag Laboratories, clone HI30) was used in flow cytometry on human samples at 1 ug. Br J Haematol (1998) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig 4
In order to report that human hematopoietic cells survive and proliferate in severe combined immunodeficient mice treated with busulfan and cyclophosphamide, Invitrogen CD45 antibody (Caltag, HI30) was used in immunocytochemistry on human samples (fig 4). Stem Cells (1997) ncbi
mouse monoclonal (MEM-56)
  • immunocytochemistry; human; fig 2
In order to study CXCR4 and CCR5 expression on different T cell subsets using mAbs, Invitrogen CD45 antibody (Caltag Laboratories, MEM56) was used in immunocytochemistry on human samples (fig 2). Proc Natl Acad Sci U S A (1997) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - frozen section; human; fig 1
  • flow cytometry; human
  • immunoprecipitation; human; fig 2
In order to characterize the monoclonal antibody UCHL1, Invitrogen CD45 antibody (Caltag, UCHL1) was used in immunohistochemistry - frozen section on human samples (fig 1), in flow cytometry on human samples and in immunoprecipitation on human samples (fig 2). Immunology (1986) ncbi
Abcam
mouse monoclonal (MEM-28)
  • immunohistochemistry; human; 1:200; loading ...; fig 2b
Abcam CD45 antibody (Abcam, ab8216) was used in immunohistochemistry on human samples at 1:200 (fig 2b). Bioengineering (Basel) (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5e
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5e). J Neuroinflammation (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:4000; loading ...; fig s3c
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig s3c). Cell Rep (2022) ncbi
domestic rabbit polyclonal
  • flow cytometry; human
Abcam CD45 antibody (Abcam, ab10558) was used in flow cytometry on human samples . Theranostics (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples at 1:100. Stem Cell Res Ther (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s2e
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples (fig s2e). JCI Insight (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4g
  • western blot; mouse; 1:500; loading ...; fig 5b
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4g) and in western blot on mouse samples at 1:500 (fig 5b). Int J Mol Sci (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Front Pharmacol (2021) ncbi
mouse monoclonal (UCH-L1)
  • immunohistochemistry; human; fig 3k
  • western blot; human; fig 3j
Abcam CD45 antibody (Abcam, ab23) was used in immunohistochemistry on human samples (fig 3k) and in western blot on human samples (fig 3j). Aging (Albany NY) (2021) ncbi
mouse monoclonal (MEM-28)
  • immunohistochemistry; human; 1:200; loading ...; fig 4
Abcam CD45 antibody (Abcam, ab8216) was used in immunohistochemistry on human samples at 1:200 (fig 4). Sci Rep (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; 1:100; loading ...
Abcam CD45 antibody (Abcam, AB10558) was used in immunohistochemistry on rat samples at 1:100. Exp Mol Med (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 7b
Abcam CD45 antibody (Abcam, Ab10558) was used in immunohistochemistry on mouse samples (fig 7b). Acta Neuropathol Commun (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:400; loading ...; fig 3e
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on rat samples at 1:400 (fig 3e). Sci Rep (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:50; loading ...; fig s3-2a
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples at 1:50 (fig s3-2a). elife (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4a
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4a). Vascul Pharmacol (2021) ncbi
domestic rabbit monoclonal (EP322Y)
  • immunohistochemistry; human; 1:200; loading ...; fig 8b
Abcam CD45 antibody (Abcam, ab40763) was used in immunohistochemistry on human samples at 1:200 (fig 8b). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 1a
  • western blot; mouse; loading ...; fig 1b
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples at 1:1000 (fig 1a) and in western blot on mouse samples (fig 1b). Front Immunol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; domestic sheep; 1:500; loading ...; fig 3h
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:500 (fig 3h). Front Physiol (2020) ncbi
domestic rabbit monoclonal (EP322Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4e
Abcam CD45 antibody (Abcam, AB40763) was used in immunohistochemistry - paraffin section on human samples (fig 4e). Front Oncol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 1c
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1c). Stem Cell Res Ther (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s13e
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples (fig s13e). Science (2019) ncbi
domestic rabbit monoclonal (EP322Y)
  • flow cytometry; mouse; 1:400; loading ...; fig 1d
Abcam CD45 antibody (Abcam, Ab40763) was used in flow cytometry on mouse samples at 1:400 (fig 1d). Cell Stem Cell (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). Biol Res (2019) ncbi
domestic rabbit polyclonal
  • flow cytometry; mouse; 1:100; loading ...; fig s1
Abcam CD45 antibody (Abcam, ab10558) was used in flow cytometry on mouse samples at 1:100 (fig s1). Bone Res (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3e
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry on mouse samples at 1:200 (fig 3e). Breast Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6a
In order to study the contribution of Id1 to brown adipose tissue thermogenesis and to the regulation of beige adipocytes in white adipose tissue, Abcam CD45 antibody (abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6a). Diabetes (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4e
Abcam CD45 antibody (Abcam, ab10559) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4e). Nat Commun (2017) ncbi
domestic rabbit monoclonal (EP322Y)
  • immunohistochemistry; mouse; 1:25; loading ...; fig s6b
In order to discuss mutations that contribute to atopic dermatitis, Abcam CD45 antibody (Abcam, ab40763) was used in immunohistochemistry on mouse samples at 1:25 (fig s6b). J Allergy Clin Immunol (2017) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; loading ...; fig 3
Abcam CD45 antibody (Abcam, ab10559) was used in flow cytometry on human samples (fig 3). J Cell Mol Med (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:1000; loading ...; fig 6a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, Abcam CD45 antibody (Abcam, AB10559) was used in immunocytochemistry on human samples at 1:1000 (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (A20)
  • immunohistochemistry - paraffin section; mouse; fig 4
Abcam CD45 antibody (Abcam, ab25078) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Oncoimmunology (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 4
Abcam CD45 antibody (Abcam, ab10559) was used in immunocytochemistry on human samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (F10-89-4)
  • immunocytochemistry; human; loading ...; fig 4b
In order to use CA9 and CD147 as capture antigens to isolate circulating tumor cells from patients with renal cell carcinoma, Abcam CD45 antibody (Abcam, ab30470) was used in immunocytochemistry on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (B-A11)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to classify triple-negative breast cancer into subtypes, Abcam CD45 antibody (Abcam, ab27287) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:50; fig 2
  • western blot; rat; 1:1000; fig 2
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 2) and in western blot on rat samples at 1:1000 (fig 2). Physiol Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:100; fig 4
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 4). J Neuroinflammation (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:3000; fig 3
Abcam CD45 antibody (abcam, ab10558) was used in immunohistochemistry on mouse samples at 1:3000 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (MEM-28)
  • immunocytochemistry; human; 2 ug/ml; fig 2
Abcam CD45 antibody (Abcam, ab8216) was used in immunocytochemistry on human samples at 2 ug/ml (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s4
Abcam CD45 antibody (Abcam, ab10558) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s4). Dis Model Mech (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3c
Abcam CD45 antibody (AbCam, ab10558) was used in immunohistochemistry on mouse samples at 1:200 (fig 3c). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:400; fig 2a
Abcam CD45 antibody (Abcam, AB10559) was used in immunocytochemistry on human samples at 1:400 (fig 2a). Ann Oncol (2016) ncbi
mouse monoclonal (MRC OX-22)
  • flow cytometry; rat
Abcam CD45 antibody (Abcam, OX-22) was used in flow cytometry on rat samples . Nature (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; domestic rabbit; fig 1
  • flow cytometry; rat; fig 1
Abcam CD45 antibody (Abcam, ab10558) was used in flow cytometry on domestic rabbit samples (fig 1) and in flow cytometry on rat samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP322Y)
  • immunocytochemistry; human; 1:100; loading ...; fig 5a
In order to develop methods to capture circulating tumor cells using transparent nanomaterials and quantum dots-based multiplexed imaging, Abcam CD45 antibody (Abcam, Ab-40763) was used in immunocytochemistry on human samples at 1:100 (fig 5a). J Cancer (2016) ncbi
domestic rabbit monoclonal (EP322Y)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 2Di
Abcam CD45 antibody (Abcam, Ab40763) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 2Di). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (A20)
  • flow cytometry; mouse; fig 1
Abcam CD45 antibody (Abcam, ab24917) was used in flow cytometry on mouse samples (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (B-A11)
  • immunohistochemistry - paraffin section; human; 1:400
In order to study the claudin expression in fibromatosis-like metaplastic carcinoma of the breast, Abcam CD45 antibody (Abcam, Ab27287) was used in immunohistochemistry - paraffin section on human samples at 1:400. Virchows Arch (2014) ncbi
mouse monoclonal (MEM-28)
  • immunohistochemistry - free floating section; human; 1:500
  • immunocytochemistry; human; 1:500
  • western blot; human
Abcam CD45 antibody (Abcam, ab8216) was used in immunohistochemistry - free floating section on human samples at 1:500, in immunocytochemistry on human samples at 1:500 and in western blot on human samples . Glia (2013) ncbi
Miltenyi Biotec
human monoclonal (REA747)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD45 antibody (Miltenyi, 130-110-637) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
mouse monoclonal (T6D11)
  • flow cytometry; human; loading ...; fig 1c
Miltenyi Biotec CD45 antibody (Miltenyi Biotec, T6D11) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2021) ncbi
human monoclonal (REA562)
  • flow cytometry; human; loading ...; fig 1b
Miltenyi Biotec CD45 antibody (Miltenyi Biotec, 130-113-369) was used in flow cytometry on human samples (fig 1b). Cell (2019) ncbi
mouse monoclonal (T6D11)
  • flow cytometry; human; loading ...
Miltenyi Biotec CD45 antibody (Miltenyi, T6D11) was used in flow cytometry on human samples . BMC Cancer (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
Miltenyi Biotec CD45 antibody (Miltenyi, UCHL1) was used in flow cytometry on human samples . BMC Cancer (2019) ncbi
human monoclonal (REA747)
  • flow cytometry; human; fig 3e
Miltenyi Biotec CD45 antibody (Miltenyi Biotec, REA747) was used in flow cytometry on human samples (fig 3e). N Biotechnol (2018) ncbi
mouse monoclonal (T6D11)
  • flow cytometry; human; loading ...; fig 1a
Miltenyi Biotec CD45 antibody (Miltenyi Biotec, T6D11) was used in flow cytometry on human samples (fig 1a). Brain (2018) ncbi
human monoclonal (REA611)
  • flow cytometry; human; loading ...; fig 1a
Miltenyi Biotec CD45 antibody (Miltenyi Biotec, REA611) was used in flow cytometry on human samples (fig 1a). Brain (2018) ncbi
mouse monoclonal (T6D11)
  • flow cytometry; human; loading ...; fig 5b
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, Miltenyi Biotec CD45 antibody (Miltenyi Biotec, T6D11) was used in flow cytometry on human samples (fig 5b). Clin Exp Immunol (2017) ncbi
mouse monoclonal (T6D11)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, Miltenyi Biotec CD45 antibody (Miltenyi Biotec, T6D11) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
Bio-Rad
mouse monoclonal (L12/201)
  • western blot; domestic rabbit; 1:100; loading ...; fig 4e
Bio-Rad CD45 antibody (Bio-Rad, MCA808GA) was used in western blot on domestic rabbit samples at 1:100 (fig 4e). Invest Ophthalmol Vis Sci (2018) ncbi
mouse monoclonal (IH-1)
  • flow cytometry; guinea pig; loading ...; fig 2c
Bio-Rad CD45 antibody (AbD Serotec, MCA1130) was used in flow cytometry on guinea pig samples (fig 2c). Respir Res (2017) ncbi
mouse monoclonal (L12/201)
  • flow cytometry; domestic rabbit; loading ...; fig s1
In order to use rabbits to assess the effects of platelet-rich fibrin releasate and mesenchymal stem cells on articular cartilage regeneration, Bio-Rad CD45 antibody (Bio-Rad, MCA808GA) was used in flow cytometry on domestic rabbit samples (fig s1). J Biomed Mater Res B Appl Biomater (2017) ncbi
rat monoclonal (YKIX716.13)
  • flow cytometry; dogs; fig s1c
Bio-Rad CD45 antibody (AbD Serotec, MCA1042PE) was used in flow cytometry on dogs samples (fig s1c). Nucleic Acids Res (2016) ncbi
mouse monoclonal (IH-1)
  • immunocytochemistry; human; 1:500; fig 5
In order to evaluate the efficacy of a neural induction method for human induced pluripotent stem cells and transplant these cells into guinea-pig cochleae for replacement of spiral ganglion neurons, Bio-Rad CD45 antibody (Serotec, MCA1130) was used in immunocytochemistry on human samples at 1:500 (fig 5). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (MEM-55)
  • immunocytochemistry; human
Bio-Rad CD45 antibody (AbdSerotec, MCA1114F) was used in immunocytochemistry on human samples . Nanomedicine (2015) ncbi
rat monoclonal (YKIX716.13)
  • flow cytometry; dogs; fig 1
  • immunocytochemistry; dogs; fig 1
Bio-Rad CD45 antibody (AbD Serotec, mca1042a488) was used in flow cytometry on dogs samples (fig 1) and in immunocytochemistry on dogs samples (fig 1). J Cell Mol Med (2015) ncbi
mouse monoclonal (L12/201)
  • flow cytometry; human; 1:100
Bio-Rad CD45 antibody (AbD Serotec, MCA808GA) was used in flow cytometry on human samples at 1:100. Biomaterials (2015) ncbi
mouse monoclonal (F10-89-4)
  • immunocytochemistry; human
Bio-Rad CD45 antibody (AbD serotec, MCA87A647) was used in immunocytochemistry on human samples . Phys Biol (2015) ncbi
mouse monoclonal (F8-11-13)
  • immunocytochemistry; human
In order to compare five SIV vaccine platforms, Bio-Rad CD45 antibody (ABD Serotec, clone F8-11-13) was used in immunocytochemistry on human samples . Clin Immunol (2014) ncbi
mouse monoclonal (F8-11-13)
  • flow cytometry; mouse
In order to study the role of human endogenous retrovirus (HERV) envelope proteins in the uptake of exosomes, Bio-Rad CD45 antibody (ABD Serotec, F8-11-13) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
mouse monoclonal (F8-11-13)
  • flow cytometry; rhesus macaque
In order to compare vaccination with highly conserved gag elements verses full-length gag DNA, Bio-Rad CD45 antibody (ABD Serotec, F8-11-13) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2014) ncbi
rat monoclonal (YKIX716.13)
  • flow cytometry; human
Bio-Rad CD45 antibody (Serotec, YKIX716.13) was used in flow cytometry on human samples . Vet Comp Oncol (2015) ncbi
rat monoclonal (YKIX716.13)
  • flow cytometry; dogs
Bio-Rad CD45 antibody (Serotec, MCA1042PE) was used in flow cytometry on dogs samples . BMC Vet Res (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (3H1362)
  • immunohistochemistry - frozen section; domestic rabbit; 1:100; loading ...; fig 3h
In order to evaluate the efficacy of subconjunctival delivery of TNF-alpha antibodies using a polymer-based drug delivery system, Santa Cruz Biotechnology CD45 antibody (Santa Cruz, SC-70690) was used in immunohistochemistry - frozen section on domestic rabbit samples at 1:100 (fig 3h). Invest Ophthalmol Vis Sci (2017) ncbi
mouse monoclonal (UCH-L1)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, Santa Cruz Biotechnology CD45 antibody (Santa Cruz, UCH-L1) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
rat monoclonal (3H1363)
  • immunocytochemistry; human; loading ...; fig 5a
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, Santa Cruz Biotechnology CD45 antibody (Santa Cruz, 3H1363) was used in immunocytochemistry on human samples (fig 5a). Cancer Res (2017) ncbi
mouse monoclonal (B-8)
  • flow cytometry; human; 1:50; fig 1
Santa Cruz Biotechnology CD45 antibody (Santa Cruz, sc-28369) was used in flow cytometry on human samples at 1:50 (fig 1). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (B-8)
  • western blot; human; fig s5
Santa Cruz Biotechnology CD45 antibody (Santa Cruz, sc-28369) was used in western blot on human samples (fig s5). Autophagy (2016) ncbi
mouse monoclonal (35-Z6)
  • immunocytochemistry; human; loading ...; fig 6b
Santa Cruz Biotechnology CD45 antibody (Santa Cruz Biotechnology, 35-Z6) was used in immunocytochemistry on human samples (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal
  • immunocytochemistry; human; loading ...; fig 6b
Santa Cruz Biotechnology CD45 antibody (Santa Cruz Biotechnology, 35-Z6) was used in immunocytochemistry on human samples (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal (35-Z6)
  • western blot; human; loading ...; fig 8b
In order to discover that CD147-CD98 is a major carrier of poly-N-acetyl-lactosamine on human pre-B cell line, Santa Cruz Biotechnology CD45 antibody (Santa-Cruz, sc-1178) was used in western blot on human samples (fig 8b). J Immunol (2015) ncbi
rat monoclonal (YTH80.103)
  • immunocytochemistry; human
Santa Cruz Biotechnology CD45 antibody (Santa Cruz, SC59071) was used in immunocytochemistry on human samples . Cancer Biol Ther (2015) ncbi
mouse monoclonal (35-Z6)
  • western blot; human
In order to characterize CD81(+) and CD63(+) subpopulations of exosomes released from B-cell lymphoma cell lines, Santa Cruz Biotechnology CD45 antibody (Santa Cruz, sc-1178) was used in western blot on human samples . Clin Ther (2014) ncbi
mouse monoclonal (UCH-L1)
  • immunocytochemistry; human
Santa Cruz Biotechnology CD45 antibody (Santa Cruz Biotechnology, UCH-L1) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (35-Z6)
  • immunohistochemistry; mouse
In order to investigate the role of hepatocyte growth factor receptor, c-met in renoprotection, Santa Cruz Biotechnology CD45 antibody (Santa Cruz, sc-1178) was used in immunohistochemistry on mouse samples . Kidney Int (2013) ncbi
mouse monoclonal (OX33)
  • flow cytometry; mouse; 1:10; fig 6
Santa Cruz Biotechnology CD45 antibody (SCBT, sc-53048) was used in flow cytometry on mouse samples at 1:10 (fig 6). BMC Immunol (2012) ncbi
Novus Biologicals
rat monoclonal (30-F11)
  • immunohistochemistry; mouse; loading ...; fig 5
Novus Biologicals CD45 antibody (Novusbio, 30-F11) was used in immunohistochemistry on mouse samples (fig 5). Sci Rep (2021) ncbi
rat monoclonal (30-F11)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1c
Novus Biologicals CD45 antibody (Novus, NB100-77417) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1c). Clin Exp Metastasis (2021) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; 1:200; fig 3a
Novus Biologicals CD45 antibody (Novus Biologicals, HI30) was used in immunocytochemistry on human samples at 1:200 (fig 3a). PLoS ONE (2019) ncbi
rat monoclonal (30-F11)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s9a
Novus Biologicals CD45 antibody (Novus, 30-F11) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s9a). Science (2018) ncbi
OriGene
mouse monoclonal (MT2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 8e
OriGene CD45 antibody (Origene, AM39022PU-N) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 8e). J Clin Invest (2022) ncbi
mouse monoclonal (OTI2E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
OriGene CD45 antibody (Zhongshan Golden Bridge, OTI2E7) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Cancer Immunol Immunother (2017) ncbi
Beckman Coulter
mouse monoclonal (J33)
  • flow cytometry; human; 1:25; loading ...
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples at 1:25. elife (2020) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; 1:25; loading ...
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples at 1:25. elife (2020) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (J33)
  • flow cytometry; human; 1:20; loading ...; fig 2s1
Beckman Coulter CD45 antibody (Beckman Coulter, B36294) was used in flow cytometry on human samples at 1:20 (fig 2s1). elife (2020) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; fig s4a
Beckman Coulter CD45 antibody (Beckman Coulter, J.33) was used in flow cytometry on human samples (fig s4a). Nat Commun (2020) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; loading ...; fig s8a
Beckman Coulter CD45 antibody (Beckman Coulter, ALB11) was used in flow cytometry on human samples (fig s8a). Nat Commun (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1b
Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD45 antibody (Beckman Coulter, ALB11) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2018) ncbi
mouse monoclonal (Immu19.2)
  • flow cytometry; human; loading ...; fig s1c
Beckman Coulter CD45 antibody (Beckman Coulter Immunotech, IM2652U) was used in flow cytometry on human samples (fig s1c). Nature (2018) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; fig 1c
Beckman Coulter CD45 antibody (Coulter, J33) was used in flow cytometry on human samples (fig 1c). Nature (2017) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; fig 2b
Beckman Coulter CD45 antibody (Beckman Coulter, J.33) was used in flow cytometry on human samples (fig 2b). Int J Cancer (2017) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter CD45 antibody (Beckman Coulter, ALB11) was used in flow cytometry on human samples (fig 5a). Blood (2017) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, Beckman Coulter CD45 antibody (Beckman Coulter, 2H4) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter CD45 antibody (Beckman Coulter (Immunotech), ALB11) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; loading ...; fig s1b
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, Beckman Coulter CD45 antibody (Beckman Coulter, ALB11) was used in flow cytometry on human samples (fig s1b). J Immunol (2017) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; 1:100; fig 1a
In order to investigate the impact of a cancer-specific MUC1 glycoform, Beckman Coulter CD45 antibody (Beckman Coulter, J.33) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (ALB11)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Beckman Coulter CD45 antibody (Beckman Coulter, ALB11) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2a
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; 1:50; fig 1c
In order to report the effects of mesenchymal stem cells derived from the umbilical cord on hepatocellular carcinoma cells, Beckman Coulter CD45 antibody (Beckman Coulter, IM0782U) was used in flow cytometry on human samples at 1:50 (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; fig s9
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples (fig s9). Nat Med (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; tbl 1
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples (tbl 1). Int J Lab Hematol (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize oligopotent progenitors from the fetal liver, Beckman Coulter CD45 antibody (Coulter, IM2653U) was used in flow cytometry on human samples (fig 4a). Science (2016) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman-Coulter, J.33) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human; fig 1
In order to study B cells migration in vivo, Beckman Coulter CD45 antibody (Beckman Coulter, IM27114) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, Beckman Coulter CD45 antibody (Beckman Coulter, clone UCHL1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, IM2653) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (IOtest, IM0782U) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human; loading ...
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, Beckman Coulter CD45 antibody (Beckman Coulter, H4LDH11LDB9) was used in flow cytometry on human samples . Kidney Int (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (BeckmanCoulter, A96416) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the effect of miRNA-155 in IL-21 signaling in white cells and it role in systemic lupues erythematosus., Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2015) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, 2H4LDH11LDB9) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, 96416) was used in flow cytometry on human samples . Arthritis Res Ther (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the impact of N-methyl-d-aspartate receptor on erythropoiesis, Beckman Coulter CD45 antibody (Beckman Coulter, J.33) was used in flow cytometry on human samples (fig 1b). Am J Physiol Cell Physiol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig s3
Beckman Coulter CD45 antibody (Beckman Coulter, UCH1) was used in flow cytometry on human samples (fig s3). Infect Immun (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; tbl s4
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (tbl s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human; fig 2
In order to evaluate the potency of program death ligand 1 and 2-silenced dendritic cell vaccines for ex vivo priming and in vivo boosting of minor histocompatibility antigen-specific CD8 positive T cell responses, Beckman Coulter CD45 antibody (Beckman Coulter, 2H4LDH11LDB9) was used in flow cytometry on human samples (fig 2). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; fig s2
In order to evaluate the potency of program death ligand 1 and 2-silenced dendritic cell vaccines for ex vivo priming and in vivo boosting of minor histocompatibility antigen-specific CD8 positive T cell responses, Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples (fig s2). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; tbl s5
In order to investigate when Vgamma9Vdelta2 T cells develop, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, PN A96416) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman-Coulter, J.33) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman-Coulter, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human; loading ...; tbl 1
Beckman Coulter CD45 antibody (Immunotech, J33) was used in flow cytometry on human samples (tbl 1). J Transl Med (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s1
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples (fig s1). Blood (2014) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, 2H4) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, H4LDH11LDB9) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (BC, A96416) was used in flow cytometry on human samples . Cryobiology (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, IM2710U) was used in flow cytometry on human samples . Contemp Oncol (Pozn) (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, UCHL1) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (J.33)
  • flow cytometry; human
Beckman Coulter CD45 antibody (Beckman Coulter, J33) was used in flow cytometry on human samples . Hematology (2015) ncbi
mouse monoclonal (2H4LDH11LDB9)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Beckman Coulter CD45 antibody (Beckman, 2H4LDH11LDB9(2H4)) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Dako
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 14
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry on mouse samples at 1:500 (fig 14). Biomedicines (2021) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 5
Dako CD45 antibody (DAKO, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 5). EBioMedicine (2021) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; African green monkey; 1 ug/ml; loading ...; fig s1d
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on African green monkey samples at 1 ug/ml (fig s1d). Commun Biol (2021) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 5a
Dako CD45 antibody (Dako, 0701) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5a). Ann Clin Transl Neurol (2020) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; 1:2500; loading ...; fig s9c
Dako CD45 antibody (Dako, M0742) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (fig s9c). Nat Commun (2019) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:100; loading ...; fig s9c
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry on human samples at 1:100 (fig s9c). J Clin Invest (2019) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1g
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples (fig 1g). Cell (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s1
Dako CD45 antibody (Dako, UCHL1) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; mouse; loading ...; fig 2a
Dako CD45 antibody (Dako/Agilent, M070129-2) was used in immunohistochemistry on mouse samples (fig 2a). Cell Stem Cell (2017) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - frozen section; human; loading ...; fig 4
In order to suggest that fibroblasts exert a strong positive regulatory influence on myogenic precursor cell activity, Dako CD45 antibody (Dako, M070129-2) was used in immunohistochemistry - frozen section on human samples (fig 4). J Physiol (2017) ncbi
mouse monoclonal (4KB5)
  • immunohistochemistry; human; 1:50; loading ...; fig 2a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Dako CD45 antibody (Dako, M0754) was used in immunohistochemistry on human samples at 1:50 (fig 2a). Cell Res (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:200; loading ...; fig s1
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Dako CD45 antibody (Dako, M0742) was used in flow cytometry on human samples at 1:200 (fig s1). Cell Res (2017) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:1500; fig 1c
In order to measure neuropeptide Y, NPY receptor 1, and NPY receptor 2 expression in infantile haemangiomas, Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:1500 (fig 1c). Acta Paediatr (2017) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1h
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Dako CD45 antibody (Dako, PD7/26) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1h). Glia (2017) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
In order to characterize cases of recurrent panniculitis in children with lipoatrophy, Dako CD45 antibody (DAKO, UCHL-1) was used in immunohistochemistry - paraffin section on human samples (tbl 3). J Eur Acad Dermatol Venereol (2017) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; loading ...; fig 2c
Dako CD45 antibody (Dako, 2B11) was used in immunohistochemistry on human samples (fig 2c). Inflamm Res (2016) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:1000; fig 2c
In order to develop and characterize a humanized ossicle xenotransplantation approach, Dako CD45 antibody (Dako, 2B11) was used in immunohistochemistry on human samples at 1:1000 (fig 2c). Nat Med (2016) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Dako CD45 antibody (DAKO, 2B11) was used in immunohistochemistry - paraffin section on human samples (fig 2). Int J STD AIDS (2017) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - frozen section; African green monkey; 1:100; fig 3
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - frozen section on African green monkey samples at 1:100 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; 1:300; fig 6a
In order to assess the role of TLR3 in enterocytic CCL20 signaling, Dako CD45 antibody (Dako, M0742) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 6a). PLoS ONE (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 7a
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 7a). PLoS ONE (2015) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry; human
Dako CD45 antibody (Dako, UCHL1) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; fig 8
In order to study the increase in stromal collagen and immune cells within the mammary epithelium shown as high mammographic density, Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples (fig 8). Breast Cancer Res (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunocytochemistry; human; fig 2
Dako CD45 antibody (DakoCytomation, M 0701) was used in immunocytochemistry on human samples (fig 2). BMC Cancer (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:50; fig 6
Dako CD45 antibody (DAKO, M0701) was used in immunohistochemistry on human samples at 1:50 (fig 6). Lab Invest (2015) ncbi
mouse monoclonal (4KB5)
  • immunohistochemistry; human; 1:100
In order to describe the gluteal lesions of a patient with pagetoid reticulosis, Dako CD45 antibody (Dako, 4 KB5) was used in immunohistochemistry on human samples at 1:100. J Cutan Pathol (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:100. Diabetologia (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:200
In order to describe a new method for immunohistochemistry optimization, Dako CD45 antibody (DakoCytomation, M0701) was used in immunohistochemistry on human samples at 1:200. Histopathology (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:600; fig 1
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:400
In order to describe the post-mortem neuropathological characteristics of five EHEC patients, Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry on human samples at 1:400. Brain Pathol (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:50
Dako CD45 antibody (Dako, 2B11) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Cancer (2015) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human
Dako CD45 antibody (Abcam, M0701) was used in immunohistochemistry - paraffin section on human samples . Diabetes (2014) ncbi
mouse monoclonal (UCHL1)
  • immunohistochemistry - paraffin section; human; 1:5; loading ...; fig 2a
Dako CD45 antibody (Dako, UCHL) was used in immunohistochemistry - paraffin section on human samples at 1:5 (fig 2a). Diabetol Metab Syndr (2014) ncbi
mouse monoclonal (UCHL1)
  • blocking or activating experiments; human
Dako CD45 antibody (Dako, M0742) was used in blocking or activating experiments on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human
In order to define the cellular phenotype of maternal microchimeric cells in control and type 1 diabetes pancreas, Dako CD45 antibody (DAKO, M0701) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
In order to characterize two patients with multinodular and vacuolating neuronal tumors, Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100
Dako CD45 antibody (Dako, M070) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Biol Chem (2014) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:100
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Dako CD45 antibody (Dako, PD7/26 +2B11) was used in immunohistochemistry on human samples at 1:100. Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry; human; 1:200
Dako CD45 antibody (Dako, M0701) was used in immunohistochemistry on human samples at 1:200. Pain (2013) ncbi
mouse monoclonal (PD7/26 + 2B11)
  • immunohistochemistry - paraffin section; human; 1:100
Dako CD45 antibody (DAKO, M0701) was used in immunohistochemistry - paraffin section on human samples at 1:100. Glia (2012) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D9M8I)
  • immunohistochemistry; rhesus macaque; 1:1000; fig 4a
Cell Signaling Technology CD45 antibody (Cell Signaling, 13917S) was used in immunohistochemistry on rhesus macaque samples at 1:1000 (fig 4a). BMC Biol (2021) ncbi
domestic rabbit monoclonal (D9M8I)
  • immunohistochemistry - paraffin section; human; fig 1a
Cell Signaling Technology CD45 antibody (CST, 13917) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D9M8I)
  • immunocytochemistry; human; loading ...; fig 1
Cell Signaling Technology CD45 antibody (Cell Signaling, 13917) was used in immunocytochemistry on human samples (fig 1). Int J Mol Sci (2017) ncbi
domestic rabbit monoclonal (D9M8I)
  • immunohistochemistry - frozen section; human; 1:200; loading ...; tbl 1
In order to examine immune cells and chemokines present in human second-trimester fetal skin, Cell Signaling Technology CD45 antibody (Cell signaling, D9M8I) was used in immunohistochemistry - frozen section on human samples at 1:200 (tbl 1). Wound Repair Regen (2016) ncbi
Tonbo Biosciences
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 1a
Tonbo Biosciences CD45 antibody (Tonbo Biosciences, HI30) was used in flow cytometry on mouse samples (fig 1a). J Virol (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:66; loading ...; fig 3b
Tonbo Biosciences CD45 antibody (Tonbo biosciences, 65-0459-T100) was used in flow cytometry on human samples at 1:66 (fig 3b). elife (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Tonbo Biosciences CD45 antibody (Tonbo Biosciences, HI100) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
Exbio
mouse monoclonal (HI30)
  • flow cytometry; human; fig 9
Exbio CD45 antibody (Exbio, HI30) was used in flow cytometry on human samples (fig 9). Immunol Lett (2018) ncbi
mouse monoclonal (MEM-56)
  • flow cytometry; human; loading ...; fig 3a
Exbio CD45 antibody (Exbio, MEM-56) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (MEM-28)
  • flow cytometry; human; loading ...
Exbio CD45 antibody (EXBIO, MEM-28) was used in flow cytometry on human samples . Cell Death Dis (2016) ncbi
mouse monoclonal (MEM-28)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Exbio CD45 antibody (Exbio Praha a.s., MEM-28) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
Ventana
mouse monoclonal (2B11 & PD7/26)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
Ventana CD45 antibody (Ventana, PD7/26) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Mol Sci (2016) ncbi
mouse monoclonal (RP2/18)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
In order to determine the effects of PD-0360324, a fully human immunoglobulin G2 monoclonal antibody against macrophage colony-stimulating factor, in patients with cutaneous lupus erythematosus, Ventana CD45 antibody (Ventana, RP2/18) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Clin Exp Immunol (2016) ncbi
Cytognos
monoclonal (ML2)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, Cytognos CD45 antibody (Cytognos, ML2) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
BD Biosciences
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; fig s1b
BD Biosciences CD45 antibody (BD Pharmingen, 560777) was used in flow cytometry on human samples at 1:100 (fig s1b). Nat Commun (2022) ncbi
mouse monoclonal (5H9)
  • flow cytometry; mouse
BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on mouse samples . Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s3b, s5e, 5e
BD Biosciences CD45 antibody (BD Biosciences, 557833) was used in flow cytometry on human samples (fig s3b, s5e, 5e). Sci Adv (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 2d). Med Oncol (2022) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; fig s3
BD Biosciences CD45 antibody (BD Biosciences, 557833) was used in flow cytometry on human samples at 1:100 (fig s3). EMBO Mol Med (2022) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples at 1:100 (fig 1a). Stem Cell Res Ther (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3f
BD Biosciences CD45 antibody (BD Bioscience, HI100) was used in flow cytometry on human samples (fig 3f). J Immunother Cancer (2021) ncbi
mouse monoclonal (HI100)
  • flow cytometry; mouse; 1:1000; loading ...
BD Biosciences CD45 antibody (BD Biosciences, 562885) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 7
BD Biosciences CD45 antibody (BD Bioscience, 339192) was used in flow cytometry on human samples (fig 7). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD45 antibody (BD Biosciences, HI-30) was used in flow cytometry on human samples (fig s4a). Int J Mol Sci (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:1000; loading ...; fig 2b
BD Biosciences CD45 antibody (BD Pharmingen, 560367) was used in flow cytometry on human samples at 1:1000 (fig 2b). Cells (2021) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples (fig 2a). Acta Neuropathol (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences CD45 antibody (BD Biosciences, 562279) was used in flow cytometry on mouse samples (fig 2c). J Autoimmun (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:20; fig 1d
BD Biosciences CD45 antibody (BD Biosciences, 560976) was used in flow cytometry on human samples at 1:20 (fig 1d). Nat Neurosci (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:300; fig s7b
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples at 1:300 (fig s7b). Nature (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 1:1000; loading ...
BD Biosciences CD45 antibody (BD Biosciences, 560973) was used in flow cytometry on mouse samples at 1:1000. Clin Cancer Res (2021) ncbi
mouse monoclonal (L48)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD45 antibody (BD, L48) was used in flow cytometry on human samples (fig 1c). EMBO Mol Med (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD45 antibody (Becton Dickinson, 555482) was used in flow cytometry on human samples (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 6i
BD Biosciences CD45 antibody (BD Biosciences, 563204) was used in flow cytometry on human samples (fig 6i). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c, 3a
BD Biosciences CD45 antibody (BD Biosciences, 562279) was used in flow cytometry on human samples (fig 1c, 3a). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:30; loading ...; fig 1g
BD Biosciences CD45 antibody (BD Pharmingen, 557833) was used in flow cytometry on human samples at 1:30 (fig 1g). elife (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD Biosciences, 555488) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
BD Biosciences CD45 antibody (BD Biosciences, 555492) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BD Biosciences CD45 antibody (BD Biosciences, 563204) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1c
BD Biosciences CD45 antibody (Becton Dickinson, 564914) was used in flow cytometry on human samples (fig s1c). Cell (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:200; loading ...; fig 1a
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples at 1:200 (fig 1a). J Clin Invest (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2s5a
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD45 antibody (BD Biosciences, 555482) was used in flow cytometry on human samples (fig s2a). Nucleic Acids Res (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig s3a
BD Biosciences CD45 antibody (BD, 560976) was used in flow cytometry on human samples at 1:100 (fig s3a). Nat Commun (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig 3b). Antioxidants (Basel) (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 1:500; loading ...; fig 3d
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on mouse samples at 1:500 (fig 3d). Blood (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:25; loading ...; fig 1f
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples at 1:25 (fig 1f). elife (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD Bioscience, 555483) was used in flow cytometry on human samples (fig 3a). World J Stem Cells (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig 1a). Rheumatology (Oxford) (2020) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 2a). J Extracell Vesicles (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 3f
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on mouse samples (fig 3f). Blood Adv (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD45 antibody (BD Biosciences, 555482) was used in flow cytometry on human samples (fig s1). Int J Mol Sci (2020) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . J Immunother Cancer (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s2a
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig s2a) and in flow cytometry on mouse samples (fig s2a). Nature (2020) ncbi
monoclonal (5H9)
  • flow cytometry; human; 1:250; loading ...
BD Biosciences CD45 antibody (BD Biosciences, 740424) was used in flow cytometry on human samples at 1:250. Nature (2020) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD, 347464) was used in flow cytometry on human samples (fig 1). J Cancer (2020) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1c
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig 1c). Nature (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD45 antibody (BioLegend, 560608) was used in flow cytometry on human samples (fig s1b). J Exp Med (2020) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; rat; loading ...; fig 3
BD Biosciences CD45 antibody (BD, 560975) was used in flow cytometry on rat samples (fig 3). Biosci Rep (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 1s2, 1s3a
BD Biosciences CD45 antibody (BD, RRID:AB_396891) was used in flow cytometry on human samples (fig 1s2, 1s3a). elife (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; loading ...; fig 2d
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples at 1:100 (fig 2d). Nat Commun (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD45 antibody (BD Pharmingen, 560975) was used in flow cytometry on human samples (fig 1b). Sci Rep (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig ex1
BD Biosciences CD45 antibody (BD Bioscience, HI30) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:17; fig 5b
BD Biosciences CD45 antibody (BD Biosciences, 560674) was used in flow cytometry on human samples at 1:17 (fig 5b). Nat Commun (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:10; loading ...; fig 2g
BD Biosciences CD45 antibody (BD, 560367) was used in flow cytometry on human samples at 1:10 (fig 2g). Nature (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD45 antibody (BD Pharmingen, 555485) was used in flow cytometry on human samples (fig 4a). Front Immunol (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD45 antibody (BD, 560673) was used in flow cytometry on human samples (tbl 1). J Exp Med (2019) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig 2a). JCI Insight (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s8
BD Biosciences CD45 antibody (BD Horizon, HI3a) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD45 antibody (BD Biosciences, 563870) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s6b
BD Biosciences CD45 antibody (BD, 563792) was used in flow cytometry on human samples (fig s6b). J Clin Invest (2019) ncbi
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD, 340910) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:50; loading ...; fig 6c
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples at 1:50 (fig 6c). Gastroenterology (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD, 564357) was used in flow cytometry on human samples (fig 2a). Cell (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD Horizon, 563791) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 10b
BD Biosciences CD45 antibody (BD Biosciences, 564357) was used in flow cytometry on human samples (fig 10b). J Exp Med (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD45 antibody (BD Pharmingen, 555482) was used in flow cytometry on human samples (fig 3c). BMC Immunol (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD45 antibody (BD Biosciences, 560674) was used in flow cytometry on human samples (fig 3c). BMC Immunol (2019) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2f
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 2f). J Immunol (2019) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s2b
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig s2b). Nat Med (2019) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:40; loading ...; fig s1c
BD Biosciences CD45 antibody (BD, 555483) was used in flow cytometry on human samples at 1:40 (fig s1c). Life Sci Alliance (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD, 560566) was used in flow cytometry on human samples (fig 3a). Cell Rep (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; 1:100; loading ...
BD Biosciences CD45 antibody (BD pharmingen, HI30) was used in flow cytometry on mouse samples at 1:100. Nature (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1c
BD Biosciences CD45 antibody (BD Biosciences, 560675) was used in flow cytometry on human samples (fig s1c). Cell (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD45 antibody (BD Biosciences, 560607) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 2d). J Clin Invest (2018) ncbi
monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD45 antibody (BD, 564914) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD45 antibody (BD Bioscience, 562327) was used in flow cytometry on human samples (fig s3a). J Clin Invest (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 7b
BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples (fig 7b). J Immunol (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD45 antibody (BD Biosciences, 560178) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 3d). Clin Exp Immunol (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD Biosciences, 561864) was used in flow cytometry on human samples (fig 3a). Stem Cell Reports (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples (fig 5a). Cancer Res (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 2a). Nat Med (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 1b
BD Biosciences CD45 antibody (BD Bioscience, 555485) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig s4b). J Clin Invest (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 5c
BD Biosciences CD45 antibody (BD Pharmingen, 557833) was used in flow cytometry on mouse samples (fig 5c). Stem Cells Transl Med (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s9b
BD Biosciences CD45 antibody (BD Biosciences, 555485) was used in flow cytometry on human samples (fig s9b). Nat Commun (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD Biosciences, 561887) was used in flow cytometry on human samples (fig 3a). Oncotarget (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD45 antibody (BD Biosciences, 555488) was used in flow cytometry on human samples (fig 3a). Oncotarget (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s1c
BD Biosciences CD45 antibody (BD Biosciences, 557833) was used in flow cytometry on human samples (fig s1c). Nature (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1a
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD Bioscience, HI100) was used in flow cytometry on human samples (fig 1a). Biol Blood Marrow Transplant (2018) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig 2b). Nat Med (2018) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD45 antibody (BD Biosciences, 557748) was used in flow cytometry on mouse samples (fig 3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD45 antibody (BD, 563879) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; loading ...; fig 4a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples at 1:100 (fig 4a). Front Immunol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1e
In order to study the involvement of interleukin-8 on T lymphocytes growth and function, BD Biosciences CD45 antibody (BD Pharmingen, HI100) was used in flow cytometry on human samples (fig 1e). Int Immunopharmacol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s10a
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig s10a). Nature (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1a
In order to investigate the expression of Toll-like receptors in satellite glial cells, BD Biosciences CD45 antibody (BD Bioscience, 2D1) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig 1a). J Exp Med (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig 1a). J Exp Med (2017) ncbi
mouse monoclonal (5H9)
  • flow cytometry; human; loading ...; fig 2a
In order to map the lineage of human dendritic cells, BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on human samples (fig 2a). Science (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2a
In order to map the lineage of human dendritic cells, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 2a). Science (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 3d
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, BD Biosciences CD45 antibody (BD Biosciences, 339192) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3d
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, BD Biosciences CD45 antibody (BD Biosciences, 563204) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2b
In order to explore the contribution of CD105 to leukemogenesis, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 2b). Blood (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD45 antibody (BD Biosciences, 563204) was used in flow cytometry on human samples (fig 6a). Mol Ther Methods Clin Dev (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BD Biosciences CD45 antibody (BD, 563031) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:50; loading ...; tbl 1
BD Biosciences CD45 antibody (Becton, 555483) was used in flow cytometry on human samples at 1:50 (tbl 1). Sci Rep (2017) ncbi
mouse monoclonal (5H9)
  • flow cytometry; African green monkey; loading ...; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BD Biosciences CD45 antibody (BD, 5H9) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3a
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (fig 3a). J Leukoc Biol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig s4
BD Biosciences CD45 antibody (BD Biosciences, 555483) was used in flow cytometry on mouse samples (fig s4). Nat Commun (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD45 antibody (BD Biosciences, UCHL-1) was used in flow cytometry on human samples (fig s1b). Immun Ageing (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 2b
BD Biosciences CD45 antibody (BD Bioscience, 2D1) was used in flow cytometry on human samples (fig 2b). Int J Cancer (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1a
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig s1a). Int J Mol Sci (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1g
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences CD45 antibody (BD Bioscience, H100) was used in flow cytometry on human samples (fig s1g). Immunity (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD45 antibody (BD Biosciences, 340438) was used in flow cytometry on human samples (fig 3e). Oncoimmunology (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences CD45 antibody (BD Biosciences, 555483) was used in flow cytometry on human samples (fig 1e). Stem Cell Reports (2017) ncbi
mouse monoclonal (5H9)
  • flow cytometry; rhesus macaque; loading ...; fig 4b
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on rhesus macaque samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
In order to determine that human basal stem cells isolated from heavy smokers proliferate extensively, whereas their alveolar progenitor cell counterparts have limited colony-forming capacity, BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples (fig 1a). PLoS Biol (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
BD Biosciences CD45 antibody (Pharmingen, 2D1) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1b
In order to evaluate the myogenic potential and proliferative capacity of human alveolar mucosa cells, BD Biosciences CD45 antibody (BD Pharmingen, 555482) was used in flow cytometry on human samples (fig 1b). Cell Cycle (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:100; loading ...; fig s2
BD Biosciences CD45 antibody (BD Pharmingen, HI100) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
In order to investigate DNA repair in CD44+/CD24- cells, BD Biosciences CD45 antibody (BD Bioscience, 562279) was used in flow cytometry on human samples . elife (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2c
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, BD Biosciences CD45 antibody (BD Bioscience, HI30) was used in flow cytometry on human samples (fig 2c). Stem Cells (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD45 antibody (BD Bioscience, UCHL1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s1a
In order to assess the human hematopoietic stem cell self-renewal potential and quiescence in an in vitro leukemic niche without leukemic cells, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig s1a). Exp Hematol Oncol (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2c
  • immunohistochemistry; human; loading ...; fig 1g
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD45 antibody (BD Bioscience, 564105) was used in flow cytometry on human samples (fig 2c) and in immunohistochemistry on human samples (fig 1g). Sci Rep (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 2i
In order to establish a method to isolate apoptotic bodies from cultured cells to 99% purity, BD Biosciences CD45 antibody (BD Biosciences, 557748) was used in flow cytometry on human samples (fig 2i). Sci Rep (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD45 antibody (BD Bioscience, 2D1) was used in flow cytometry on human samples (fig s1). Haematologica (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s4f
BD Biosciences CD45 antibody (BD, 555482) was used in flow cytometry on human samples (fig s4f). Nat Commun (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; tbl 1
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (tbl 1). J Exp Med (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; tbl 1
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples (tbl 1). J Exp Med (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples . J Immunol Res (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 1). J Immunol Res (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; fig s1c
BD Biosciences CD45 antibody (BD, 340943) was used in flow cytometry on human samples at 1:100 (fig s1c). Nature (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples . Cell Death Dis (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; domestic sheep; loading ...
  • flow cytometry; human; loading ...; fig st4
In order to discuss methods to generate ovine mesenchymal stromal cells, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on domestic sheep samples and in flow cytometry on human samples (fig st4). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig s12a
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig s12a). J Clin Invest (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
In order to measure cell size and cell surface markers of human MSCs after intravenous injection in immune competent mice, BD Biosciences CD45 antibody (Becton, Dickinson, and Company, 2D1) was used in flow cytometry on human samples . Cytotherapy (2017) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig e6a
In order to report preclinical studies using a CRISPR-based methodology to target hematopoietic stem cells to treat beta-haemoglobinopathies, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig e6a). Nature (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 3
In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi
mouse monoclonal (69/CD45)
  • immunohistochemistry; mouse; loading ...; fig 1g
In order to research the damaging effect of Zika virus on rodent testes, BD Biosciences CD45 antibody (BD Bioscience, 610266) was used in immunohistochemistry on mouse samples (fig 1g). Nature (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 4d
In order to study the contribution of T follicular helper cells to islet autoimmunity, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 4d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD45 antibody (BD Biosciences, 560976) was used in flow cytometry on human samples (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:20; loading ...; fig 1c
BD Biosciences CD45 antibody (BD Biosciences, 347464) was used in flow cytometry on human samples at 1:20 (fig 1c). Nat Commun (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1a
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1a). Int J Cancer (2017) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig s12
In order to develop a new multiplex dSTORM imaging strategy to localize epitopes on activated T-cells, BD Biosciences CD45 antibody (BD Biosciences, 555480) was used in immunocytochemistry on human samples (fig s12). Mol Biol Cell (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (Beckton Dickinson, 555482) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD45 antibody (BD Biosciences, 560777) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD45 antibody (BD, Hl100) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1h
In order to characterize side population T cells, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 1h). J Clin Invest (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:1000; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 555485) was used in flow cytometry on human samples at 1:1000 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD Pharmingen, 557748) was used in flow cytometry on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig s1a). Sci Rep (2016) ncbi
mouse monoclonal (HI30)
  • other; human; loading ...
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in other on human samples . Nature (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2F
BD Biosciences CD45 antibody (BD, 560367) was used in flow cytometry on human samples (fig 2F). Reproduction (2016) ncbi
mouse monoclonal (69/CD45)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5k
In order to determine the responses induced by known platelet-derived growth factor isoforms in the adult mouse heart during adenovirus vector-mediated inflammation, BD Biosciences CD45 antibody (BD Biosciences, 610266) was used in immunohistochemistry - frozen section on mouse samples (fig 5k). PLoS ONE (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a
In order to report the composition and temporal dynamics of the Epstein-Barr virus-specific T-cell receptor repertoire in immunocompromised transplant patients, BD Biosciences CD45 antibody (BD Biosciences, 555488) was used in flow cytometry on human samples (fig s1a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 4b
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 4b). PLoS Pathog (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s4a
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1b
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 1b). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 4a
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples (fig 4a). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 1). Clin Cancer Res (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD45 antibody (BD Pharmingen, 2D1) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD45 antibody (BD Pharmingen, UCHL1) was used in flow cytometry on human samples (fig 3a). Clin Cancer Res (2017) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD45 antibody (BD Pharmingen, HI100) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples (fig 2). Cytotherapy (2016) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig 2a
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in immunocytochemistry on human samples (fig 2a). BMC Cancer (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, BD Biosciences CD45 antibody (BD, 560674) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 560178) was used in flow cytometry on human samples . Nat Commun (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1d
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 1d). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CD45 antibody (BD Biosciences, 337168) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 3b
In order to study the function of desmoglein-2 and generate knockout mice, BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig 3b). Angiogenesis (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; rhesus macaque; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on rhesus macaque samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BD Biosciences CD45 antibody (BD Bioscience, 555488) was used in flow cytometry on human samples . Science (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BD Biosciences CD45 antibody (BD Bioscience, 559865) was used in flow cytometry on human samples . Science (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BD Biosciences CD45 antibody (BD Bioscience, UCHL-1) was used in flow cytometry on human samples (fig 2). J Clin Invest (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD45 antibody (BD, UCHL-1) was used in flow cytometry on human samples (fig s2a). J Clin Invest (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 1
In order to assess the feasibility of a non-fluorescent aerolysin approach as well as other strategies to identify patients with paroxysmal nocturnal hemoglobinuria, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences CD45 antibody (BD Biosciences, HI 100) was used in flow cytometry on human samples (fig 2). J Transl Med (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD45 antibody (BD Pharmingen, UCHL1) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD45 antibody (BD Pharmingen, HI100) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 5c). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:25; fig 1b
In order to develop and characterize a humanized ossicle xenotransplantation approach, BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples at 1:25 (fig 1b). Nat Med (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig s10
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig s10). JCI Insight (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; fig 1
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, BD Biosciences CD45 antibody (Becton Dickinson, 2D1) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (fig 1). JCI Insight (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig e1c
In order to explore the contribution of Musashi-2 in determining hematopoietic stem cell fate, BD Biosciences CD45 antibody (BD biosciences, HI100) was used in flow cytometry on human samples (fig e1c). Nature (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 560363) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3b
In order to investigate if ectopic expression of CX3CR1 enhances the homing of adoptively transferred T cells towards CX3CL1-producing tumors, resulting in increased T cell infiltration in tumor tissues, BD Biosciences CD45 antibody (BD Biosciences, 560973) was used in flow cytometry on human samples (fig 3b). J Immunother Cancer (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 2a
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 1). Stem Cells Int (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 7d
BD Biosciences CD45 antibody (BD Biosciences, 557748) was used in flow cytometry on human samples (fig 7d). J Biol Chem (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 7
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, BD Biosciences CD45 antibody (BD Biosciences, 560777) was used in flow cytometry on human samples (fig 7). J Clin Invest (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 3c
In order to develop a cell sorting technique for use with a suspended microchannel resonator that measures the biophysical characteristics of a single cell, BD Biosciences CD45 antibody (BD Biosciences, 562279) was used in flow cytometry on human samples (fig 3c). Integr Biol (Camb) (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, BD Biosciences CD45 antibody (BD, UCHL-1) was used in flow cytometry on human samples (fig 2a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...
In order to compare the immune compartmentalization between ileum and colon in healthy and inflamed mucosa, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples . J Crohns Colitis (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD45 antibody (BD, 555493) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD45 antibody (BD, 555489) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD45 antibody (BD, 555483) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (MT4)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD45 antibody (BD, 555904) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
In order to determine mucosal characteristics of lymphocytic and collagenous colitis, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples . J Crohns Colitis (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples . BMC Musculoskelet Disord (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD, 555482) was used in flow cytometry on human samples (fig 1). Nat Biotechnol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 4a
  • immunohistochemistry; human; loading ...; fig 5e
In order to optimize myeloid engraftment for humanized mice, BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (fig 4a) and in immunohistochemistry on human samples (fig 5e). Stem Cells Dev (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 5a
In order to develop the first bioreactor system that allows the integrated three dimensional biomechanical stimulation of a whole-heart construct while allowing for simultaneous controlled perfusion of the coronary system, BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (fig 1a) and in immunohistochemistry on human samples (fig 5a). Methods Mol Biol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD45 antibody (BD Pharmingen, BD555482) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD45 antibody (BD Pharmingen, BD560674) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 560779) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 2a). J Immunol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences CD45 antibody (BD Biosciences, Hl100) was used in flow cytometry on human samples (fig 2a). J Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 5
BD Biosciences CD45 antibody (BD Bioscience, UCHL1) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1d). PLoS Pathog (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD45 antibody (BD Pharmingen, UCHL1) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2b
In order to Targeting CD8(+) T cells prevents psoriasis development, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 2b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 4
BD Biosciences CD45 antibody (BD Pharmingen, 555483) was used in flow cytometry on human samples (fig 4). Stem Cell Reports (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig S1A
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig S1A). J Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 5c
In order to study the role of polo-like kinase 1 in essential functions of alloreactive T cells, BD Biosciences CD45 antibody (BD biosciences, UCHL-1) was used in flow cytometry on human samples (fig 5c). Immunol Res (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 2
In order to study human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue, BD Biosciences CD45 antibody (BD Pharmingen, 561866) was used in flow cytometry on human samples (tbl 2). Int J Mol Med (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Pharmingen, 347463) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig 5
BD Biosciences CD45 antibody (BD Biosciences, 562279) was used in immunocytochemistry on human samples (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 8
In order to identify the source of obesity-induced MCP-1 and identify molecular regulators mediating MCP-1 production, BD Biosciences CD45 antibody (BD Bioscience, 2D1) was used in flow cytometry on human samples (fig 8). Mol Metab (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s2a
In order to study mitochondria of effector memory CD4+ T cells in normoxic and hypoxic conditions, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig s2a). J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; fig 2g
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples at 1:100 (fig 2g). Stem Cells Transl Med (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:200; fig 1d
BD Biosciences CD45 antibody (BD Pharmingen, 561640) was used in flow cytometry on human samples at 1:200 (fig 1d). Eur J Immunol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl 1
In order to determine support for heparin-free mesenchymal stem cell propagation in human platelet lysate by mechanical fibrinogen-depletion, BD Biosciences CD45 antibody (Becton Dickinson, HI30) was used in flow cytometry on human samples (tbl 1). J Transl Med (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig s1a, s1b, s1c
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD45 antibody (BD, 555488) was used in flow cytometry on human samples (fig s1a, s1b, s1c). Science (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 3a
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD45 antibody (BD, 347463) was used in flow cytometry on human samples (fig 3a). Science (2016) ncbi
mouse monoclonal (5H9)
  • flow cytometry; rhesus macaque
In order to describe a selective CD28 antagonist for treatment of rheumatoid arthritis, BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on rhesus macaque samples . Clin Exp Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, BD Biosciences CD45 antibody (BD Bioscience, UCHL1) was used in flow cytometry on human samples (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, BD Biosciences CD45 antibody (BD Bioscience, HI100) was used in flow cytometry on human samples (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 10c
In order to study functional receptors for cholera toxin by fucosylation and protein glycosylation, BD Biosciences CD45 antibody (BD Biosciences, clone 2D1) was used in flow cytometry on human samples (fig 10c). elife (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig s1e
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig s1e). J Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 560607) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 560675) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; mouse; loading ...; fig s2c
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on mouse samples (fig s2c). Nat Chem Biol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig e4a
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig e4a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD45 antibody (BD PharMingen, UCHL1) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1a
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
BD Biosciences CD45 antibody (BD Biosciences, 560368) was used in flow cytometry on human samples (fig 2). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (5H9)
  • flow cytometry; marmosets; loading ...
In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on marmosets samples . J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; tbl 2
BD Biosciences CD45 antibody (BD Biosciences, 555485) was used in flow cytometry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (HI100)
  • immunocytochemistry; human; fig 6
In order to elucidate the mechanism by which NHE-1 expression is inhibited by JAK2V617F, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in immunocytochemistry on human samples (fig 6). Oncogene (2016) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 2
BD Biosciences CD45 antibody (BD Biosciences, 560777) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100; fig 3
BD Biosciences CD45 antibody (BD Bioscience, 555485) was used in flow cytometry on human samples at 1:100 (fig 3). Stem Cells Int (2015) ncbi
mouse monoclonal (HI30)
  • immunocytochemistry; human; fig s1
BD Biosciences CD45 antibody (BD Biosciences, 560975) was used in immunocytochemistry on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1e
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 1e). Cytotherapy (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to study T cell subtypes in breast cancer patients with and without high levels of autoimmune thyroid antibodies, BD Biosciences CD45 antibody (BD Pharmingen, 555493) was used in flow cytometry on human samples . Cent Eur J Immunol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:20
BD Biosciences CD45 antibody (BD Biosciences, 562885) was used in flow cytometry on human samples at 1:20. Nat Commun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples . J Immunol Res (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 2
In order to characterize gut-associated gammadelta T-cells in HIV-infected individuals, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Biosciences, 555485) was used in flow cytometry on human samples (fig 3). Mol Ther Methods Clin Dev (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Bioscience, 555482) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD Pharmingen, 555484) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD Pharmingen, 557833) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3,4,5
BD Biosciences CD45 antibody (BD, 555482) was used in flow cytometry on human samples (fig 3,4,5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences CD45 antibody (BD Biosciences, 555482) was used in flow cytometry on human samples . Nat Genet (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Biosciences, 560368) was used in flow cytometry on human samples (fig 3). Stem Cell Rev (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences CD45 antibody (BD Biosciences, clone HI100) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (HI100)
  • immunoprecipitation; human
  • western blot; human
BD Biosciences CD45 antibody (BD Bioscience, Hl100) was used in immunoprecipitation on human samples and in western blot on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 1
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CD45 antibody (BD Pharmingen, HI100) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences CD45 antibody (BD Bioscience, 2D1) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig s1). J Infect Dis (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 4
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, clone 2D1) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
In order to discuss methods and reagents used to examine endothelial cells by flow cytometry, BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples . Rev Bras Hematol Hemoter (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 560673) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 555485) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1f
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples (fig 1f). J Immunol (2015) ncbi
mouse monoclonal (2D1)
  • immunohistochemistry; human
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in immunohistochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig s1). Immunol Cell Biol (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
In order to describe procedures to establish and maintain primary acute lymphoblastic leukemia xenograft panels, BD Biosciences CD45 antibody (Becton Dickinson, 340664) was used in flow cytometry on human samples . Curr Protoc Pharmacol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:50
BD Biosciences CD45 antibody (BD, 555488) was used in flow cytometry on human samples at 1:50. Cell Stem Cell (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Biosciences, 560362) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; mouse; fig 8
BD Biosciences CD45 antibody (BD Pharmingen, 555488) was used in flow cytometry on mouse samples (fig 8). J Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; mouse; fig 8
BD Biosciences CD45 antibody (BD Pharmingen, 559865) was used in flow cytometry on mouse samples (fig 8). J Immunol (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (B.D. Biosciences, 560976) was used in flow cytometry on human samples . World J Stem Cells (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Bioscience, HI30) was used in flow cytometry on human samples (fig 3). Arthritis Rheumatol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 3). Diabetes (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 3
BD Biosciences CD45 antibody (BD Biosciences, H100) was used in flow cytometry on human samples (fig 3). Diabetes (2015) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry - paraffin section; rat; fig  6
BD Biosciences CD45 antibody (BD Biosciences, 555482) was used in immunohistochemistry - paraffin section on rat samples (fig  6). J Control Release (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples . Blood Cells Mol Dis (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:10
In order to characterize human tracheal basal cells, BD Biosciences CD45 antibody (BD Pharmingen, 555485) was used in flow cytometry on human samples at 1:10. Respir Res (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; 1:20
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples at 1:20. Autoimmun Rev (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; 1:20
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples at 1:20. Autoimmun Rev (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (Becton Dickinson, 2D1) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 0.5:100
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, BD Biosciences CD45 antibody (BD, 560178) was used in flow cytometry on human samples at 0.5:100. Cytometry A (2015) ncbi
mouse monoclonal (5H9)
  • flow cytometry; crab eating macaque; fig s2
BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on crab eating macaque samples (fig s2). J Autoimmun (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 5
In order to test if flow cytometry can be used to find mantle cell lymphoma, BD Biosciences CD45 antibody (BD Bioscience, HI30) was used in flow cytometry on human samples (fig 5). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, HI 100) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 1:100; fig s1
BD Biosciences CD45 antibody (BD, 340664) was used in flow cytometry on human samples at 1:100 (fig s1). J Clin Invest (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (HI100)
  • immunohistochemistry; mouse; 1:100
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences CD45 antibody (BD, Hl100) was used in immunohistochemistry on mouse samples at 1:100. Nat Immunol (2015) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig s1
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on human samples (fig s1). J Infect Dis (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; mouse; loading ...; fig 6c
  • flow cytometry; human; fig 3d
BD Biosciences CD45 antibody (BD, 2D1) was used in flow cytometry on mouse samples (fig 6c) and in flow cytometry on human samples (fig 3d). Cancer Immunol Res (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 4
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 4). Cancer Discov (2015) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry; human
BD Biosciences CD45 antibody (BD Biosciences, 555480) was used in immunohistochemistry on human samples . Br J Cancer (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples . Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 4
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences CD45 antibody (BD Pharmingen, 2D1) was used in flow cytometry on human samples (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; 5 ul/test
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples at 5 ul/test. Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study the effect of mesenchymal stem cells on the anti-bacterial activity of neutrophil granulocytes, BD Biosciences CD45 antibody (BD Bioscience, HI30) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 557833) was used in flow cytometry on human samples . J Vis Exp (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, UCHL-1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:100
In order to evaluate the osteogenic capacity of bone marrow mesenchymal stream cells and gingiva-derived mesenchymal stromal cells, BD Biosciences CD45 antibody (BD, 555482) was used in flow cytometry on human samples at 1:100. Biomed Mater (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 7
In order to characterize VLA-4 blockade and promotion of differential routes into human CNS involving MCAM-adhesion of TH17 cells and PSGL-1 rolling of T cells, BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples (fig 7). J Exp Med (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (5H9)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, BD Biosciences CD45 antibody (Becton Dickinson, 2D1) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; fig 5
BD Biosciences CD45 antibody (Pharmingen, HI100) was used in flow cytometry on human samples (fig 5). Immunology (2015) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; 1:20
BD Biosciences CD45 antibody (BD Biosciences, 560777) was used in flow cytometry on human samples at 1:20. J Immunol (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, HI30) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BD Biosciences CD45 antibody (BD Bioscience, HI 100) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (5H9)
  • immunocytochemistry; human
BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in immunocytochemistry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 4
BD Biosciences CD45 antibody (BD Bioscience, HI100) was used in flow cytometry on human samples (fig 4). J Immunol (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; loading ...; fig 4
BD Biosciences CD45 antibody (BD Bioscience, UCHL1) was used in flow cytometry on human samples (fig 4). J Immunol (2014) ncbi
mouse monoclonal (5H9)
  • flow cytometry; rhesus macaque
BD Biosciences CD45 antibody (BD Biosciences, 5H9) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD, 340943) was used in flow cytometry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Bioscience, clone UCHL1) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Pharmingen, HI30) was used in flow cytometry on human samples . Cytokine (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (Becton Dickinson, 2D1) was used in flow cytometry on human samples . Hematology (2015) ncbi
mouse monoclonal (2D1)
  • immunocytochemistry; human; 1:100
BD Biosciences CD45 antibody (BD Biosciences, 347463) was used in immunocytochemistry on human samples at 1:100. PLoS ONE (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, BD Biosciences CD45 antibody (BD, HI100) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, BD Biosciences CD45 antibody (BD, UCHL1) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; loading ...; fig 2a
In order to screen for and assess myeloma plasma cell markers, BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 2a). Blood (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD/Pharmingen, HI100) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (HI100)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BD Biosciences CD45 antibody (BD Biosciences, HI100) was used in flow cytometry on human samples (fig 3a). J Infect Dis (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (BD Biosciences, 2D1) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD45 antibody (BD, clone 2D1) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human; fig 1
BD Biosciences CD45 antibody (Becton-Dickinson, 560777) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HI30)
  • immunohistochemistry; human
In order to investigate the thymus development, BD Biosciences CD45 antibody (BD, HI30) was used in immunohistochemistry on human samples . Development (2013) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD BioscienceS, 339192) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
In order to identify the mesenchymal markers on human adipose stem/progenitor cells, BD Biosciences CD45 antibody (BD, 348805) was used in flow cytometry on human samples . Cytometry A (2013) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, HI30) was used in flow cytometry on human samples . Blood (2013) ncbi
mouse monoclonal (2D1)
  • flow cytometry; human
BD Biosciences CD45 antibody (BD Biosciences, 347464) was used in flow cytometry on human samples . Invest Ophthalmol Vis Sci (2012) ncbi
mouse monoclonal (MT4)
  • immunohistochemistry - frozen section; human; 1:10
BD Biosciences CD45 antibody (Pharmingen, 555904) was used in immunohistochemistry - frozen section on human samples at 1:10. J Appl Physiol (1985) (2012) ncbi
mouse monoclonal (UCHL1)
  • flow cytometry; human; fig 6
In order to determine the expression of CD39 in mouse and human T cells, BD Biosciences CD45 antibody (BD Biosciences, UCHL1) was used in flow cytometry on human samples (fig 6). Blood (2007) ncbi
mouse monoclonal (HI30)
  • flow cytometry; human
BD Biosciences CD45 antibody (PharMingen, HI30) was used in flow cytometry on human samples . Clin Cancer Res (2004) ncbi
Leica Biosystems
monoclonal (UCHL1)
  • immunocytochemistry; human; loading ...; fig 1d
Leica Biosystems CD45 antibody (Leica Microsystems, PA0151) was used in immunocytochemistry on human samples (fig 1d). Int J Oncol (2015) ncbi
monoclonal (UCHL1)
  • immunohistochemistry; human
Leica Biosystems CD45 antibody (Novocastra, UCHL-1) was used in immunohistochemistry on human samples . Int J Hematol (2014) ncbi
Articles Reviewed
  1. Duplancic R, Roguljić M, Bozić D, Kero D. Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans. Bioengineering (Basel). 2022;9: pubmed publisher
  2. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  3. Hamdi L, Nabat H, Goldberg Y, Fainstein N, Segal S, Mediouni E, et al. Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis. Ann Clin Transl Neurol. 2022;9:1792-1806 pubmed publisher
  4. Kaminski M, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, et al. TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. J Immunother Cancer. 2022;10: pubmed publisher
  5. Dagkonaki A, Papalambrou A, Avloniti M, Gkika A, Evangelidou M, Androutsou M, et al. Maturation of circulating Ly6ChiCCR2+ monocytes by mannan-MOG induces antigen-specific tolerance and reverses autoimmune encephalomyelitis. Front Immunol. 2022;13:972003 pubmed publisher
  6. Dong N, Zhou P, Li D, Zhu H, Liu L, Ma H, et al. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways. World J Stem Cells. 2022;14:556-576 pubmed publisher
  7. Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, et al. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther. 2022;13:465 pubmed publisher
  8. Lin J, Lv J, Yu S, Chen Y, Wang H, Chen J. Transcript Engineered Extracellular Vesicles Alleviate Alloreactive Dynamics in Renal Transplantation. Adv Sci (Weinh). 2022;9:e2202633 pubmed publisher
  9. Lee A, Pingali S, Pinilla Ibarz J, Atchison M, Koumenis C, Argon Y, et al. Loss of AID exacerbates the malignant progression of CLL. Leukemia. 2022;36:2430-2442 pubmed publisher
  10. Smith K, Minns D, McHugh B, Holloway R, O CONNOR R, Williams A, et al. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20:e3001554 pubmed publisher
  11. Piliponsky A, Sharma K, Quach P, Brokaw A, Nguyen S, Orvis A, et al. Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections. J Clin Invest. 2022;132: pubmed publisher
  12. Coy S, Wang S, Stopka S, Lin J, Yapp C, Ritch C, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814 pubmed publisher
  13. Zhu Y, Gu H, Yang L, Li N, Chen Q, Kang D, et al. Involvement of MST1/mTORC1/STAT1 activity in the regulation of B-cell receptor signalling by chemokine receptor 2. Clin Transl Med. 2022;12:e887 pubmed publisher
  14. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed publisher
  15. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed publisher
  16. Sie C, Kant R, Peter C, Muschaweckh A, Pfaller M, Nirschl L, et al. IL-24 intrinsically regulates Th17 cell pathogenicity in mice. J Exp Med. 2022;219: pubmed publisher
  17. Huang C, Schuring J, Skinner J, Mok L, Chong M. MYL9 deficiency is neonatal lethal in mice due to abnormalities in the lung and the muscularis propria of the bladder and intestine. PLoS ONE. 2022;17:e0270820 pubmed publisher
  18. Iwahashi N, Umakoshi H, Seki T, Gomez Sanchez C, Mukai K, Suematsu M, et al. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. J Clin Endocrinol Metab. 2022;107:2439-2448 pubmed publisher
  19. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  20. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  21. Wang H, Chen L, Qi L, Jiang N, Zhang Z, Guo H, et al. A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma. Mol Cell Proteomics. 2022;21:100258 pubmed publisher
  22. Yang K, Han J, Gill J, Park J, Sathe M, Gattineni J, et al. The mammalian SKIV2L RNA exosome is essential for early B cell development. Sci Immunol. 2022;7:eabn2888 pubmed publisher
  23. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  24. Qin L, Wang L, Zhang J, Zhou H, Yang Z, Wang Y, et al. Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer. Sci Adv. 2022;8:eabn3774 pubmed publisher
  25. Yue X, Yin J, Wang X, Heidecke H, Hackel A, Dong X, et al. Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching. Ann Rheum Dis. 2022;81:1281-9 pubmed publisher
  26. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  27. Liu Y, Deguchi Y, Wei D, Liu F, Moussalli M, Deguchi E, et al. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nat Commun. 2022;13:2665 pubmed publisher
  28. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  29. Omatsu Y, Aiba S, Maeta T, Higaki K, Aoki K, Watanabe H, et al. Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. Nat Commun. 2022;13:2654 pubmed publisher
  30. Hickman T, Choi E, Whiteman K, Muralidharan S, Pai T, Johnson T, et al. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS ONE. 2022;17:e0266980 pubmed publisher
  31. Li H, Liu Z, Liu L, Zhang H, Han C, Girard L, et al. AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells. Cell Rep Med. 2022;3:100554 pubmed publisher
  32. Omari S, Geraghty D, Khalafallah A, Venkat P, Shegog Y, Ragg S, et al. Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Med Oncol. 2022;39:81 pubmed publisher
  33. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  34. Jung K, Son M, Lee S, Kim J, Ko D, Yoo S, et al. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy. Mol Cancer. 2022;21:102 pubmed publisher
  35. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  36. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  37. Satofuka H, Abe S, Moriwaki T, Okada A, Kazuki K, Tanaka H, et al. Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci. Nat Commun. 2022;13:1841 pubmed publisher
  38. Xiong W, Gao X, Zhang T, Jiang B, Hu M, Bu X, et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13:1700 pubmed publisher
  39. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  40. Wu X, Xia T, Shin W, Yu K, Jung W, Herrmann A, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13:e0040222 pubmed publisher
  41. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  42. Tacke S, Chunder R, Schropp V, Urich E, Kuerten S. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. Int J Mol Sci. 2022;23: pubmed publisher
  43. Wemlinger S, Parker Harp C, Yu B, Hardy I, Seefeldt M, Matsuda J, et al. Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. J Immunol. 2022;208:1566-1584 pubmed publisher
  44. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  45. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed publisher
  46. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed publisher
  47. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  48. Gao X, Li W, Syed F, Yuan F, Li P, Yu Q. PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury. J Neuroinflammation. 2022;19:43 pubmed publisher
  49. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  50. Osokine I, Siewiera J, Rideaux D, Ma S, Tsukui T, Erlebacher A. Gene silencing by EZH2 suppresses TGF-β activity within the decidua to avert pregnancy-adverse wound healing at the maternal-fetal interface. Cell Rep. 2022;38:110329 pubmed publisher
  51. Gopal A, Ibrahim R, Fuller M, Umlandt P, Parker J, Tran J, et al. TIRAP drives myelosuppression through an Ifnγ-Hmgb1 axis that disrupts the endothelial niche in mice. J Exp Med. 2022;219: pubmed publisher
  52. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  53. Clayer E, Frank D, Anderton H, Zhang S, Kueh A, Heim V, et al. ZC3H12C expression in dendritic cells is necessary to prevent lymphadenopathy of skin-draining lymph nodes. Immunol Cell Biol. 2022;100:160-173 pubmed publisher
  54. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  55. Zhang Q, Hresko M, Picton L, Su L, Hollander M, Nunez Cruz S, et al. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13:eabg6986 pubmed publisher
  56. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  57. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  58. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  59. Arinrad S, Wilke J, Seelbach A, Doeren J, Hindermann M, Butt U, et al. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance. Mol Psychiatry. 2021;: pubmed publisher
  60. Sasamoto Y, Lee C, Yoshihara M, Martin G, Ksander B, Frank M, et al. High expression of SARS-CoV2 viral entry-related proteins in human limbal stem cells. Ocul Surf. 2022;23:197-200 pubmed publisher
  61. Elhussieny A, Nogami K, Sakai Takemura F, Maruyama Y, Takemura N, Soliman W, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR). Stem Cell Res Ther. 2021;12:532 pubmed publisher
  62. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  63. Zhang S, Zhu D, Li Z, Huang K, Hu S, Lutz H, et al. A stem cell-derived ovarian regenerative patch restores ovarian function and rescues fertility in rats with primary ovarian insufficiency. Theranostics. 2021;11:8894-8908 pubmed publisher
  64. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  65. Lin J, Liu H, Fukumoto T, Zundell J, Yan Q, Tang C, et al. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer. Nat Commun. 2021;12:5321 pubmed publisher
  66. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  67. Lim K, Dayem A, Choi Y, Lee Y, An J, Gil M, et al. High Therapeutic and Esthetic Properties of Extracellular Vesicles Produced from the Stem Cells and Their Spheroids Cultured from Ocular Surgery-Derived Waste Orbicularis Oculi Muscle Tissues. Antioxidants (Basel). 2021;10: pubmed publisher
  68. Hülser M, Luo Y, Frommer K, Hasseli R, Köhler K, Diller M, et al. Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model. Sci Rep. 2021;11:17001 pubmed publisher
  69. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  70. Hoffman R, Huang S, Chalasani G, Vallejo A. Disparate Recruitment and Retention of Plasmacytoid Dendritic Cells to The Small Intestinal Mucosa between Young and Aged Mice. Aging Dis. 2021;12:1183-1196 pubmed publisher
  71. Goonetilleke M, Kuk N, Correia J, Hodge A, Moore G, Gantier M, et al. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells. Stem Cell Res Ther. 2021;12:429 pubmed publisher
  72. Gao D, Salomonis N, Henderlight M, Woods C, Thakkar K, Grom A, et al. IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome. JCI Insight. 2021;6: pubmed publisher
  73. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  74. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  75. Okamura T, Hashimoto Y, Mori J, Yamaguchi M, Majima S, Senmaru T, et al. ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat. Front Immunol. 2021;12:669629 pubmed publisher
  76. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  77. Wang L, Li X, Hanada Y, Hasuzawa N, Moriyama Y, Nomura M, et al. Dynamin-related protein 1 deficiency accelerates lipopolysaccharide-induced acute liver injury and inflammation in mice. Commun Biol. 2021;4:894 pubmed publisher
  78. Wutschka J, Kast B, Sator Schmitt M, Appak Baskoy S, Hess J, Sinn H, et al. JUNB suppresses distant metastasis by influencing the initial metastatic stage. Clin Exp Metastasis. 2021;38:411-423 pubmed publisher
  79. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  80. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  81. Wilke J, Hindermann M, Moussavi A, Butt U, Dadarwal R, Berghoff S, et al. Inducing sterile pyramidal neuronal death in mice to model distinct aspects of gray matter encephalitis. Acta Neuropathol Commun. 2021;9:121 pubmed publisher
  82. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  83. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  84. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  85. Khan I, Del Guzzo C, Shao A, Cho J, Du R, Cohen A, et al. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Cancer Res. 2021;81:5021-5032 pubmed publisher
  86. Rosenkrantz J, Gaffney J, Roberts V, Carbone L, CHAVEZ S. Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation. BMC Biol. 2021;19:127 pubmed publisher
  87. Ecker V, Stumpf M, Brandmeier L, Neumayer T, Pfeuffer L, Engleitner T, et al. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Nat Commun. 2021;12:3526 pubmed publisher
  88. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  89. Xu J, Xu K, Jung S, Conte A, Lieberman J, Muecksch F, et al. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021;595:278-282 pubmed publisher
  90. West J, Austin E, Rizzi E, Yan L, Tanjore H, Crabtree A, et al. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models. Int J Mol Sci. 2021;22: pubmed publisher
  91. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  92. Mou S, Zhou Z, Feng H, Zhang N, Lin Z, Aiyasiding X, et al. Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway. Front Pharmacol. 2021;12:648688 pubmed publisher
  93. Marozin S, Simon Nobbe B, Irausek S, Chung L, Lepperdinger G. Kinship of conditionally immortalized cells derived from fetal bone to human bone-derived mesenchymal stroma cells. Sci Rep. 2021;11:10933 pubmed publisher
  94. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  95. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed publisher
  96. Roca C, Burton O, Gergelits V, Prezzemolo T, Whyte C, Halpert R, et al. AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data. Nat Commun. 2021;12:2890 pubmed publisher
  97. Tichy E, Ma N, Sidibe D, Loro E, Kocan J, Chen D, et al. Persistent NF-κB activation in muscle stem cells induces proliferation-independent telomere shortening. Cell Rep. 2021;35:109098 pubmed publisher
  98. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  99. Lin T, Quellier D, Lamb J, Voisin T, Baral P, Bock F, et al. Pseudomonas aeruginosa-induced nociceptor activation increases susceptibility to infection. PLoS Pathog. 2021;17:e1009557 pubmed publisher
  100. Geng G, Liu J, Xu C, Pei Y, Chen L, Mu C, et al. Receptor-mediated mitophagy regulates EPO production and protects against renal anemia. elife. 2021;10: pubmed publisher
  101. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  102. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  103. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  104. Duplancic R, Kero D. Novel approach for quantification of multiple immunofluorescent signals using histograms and 2D plot profiling of whole-section panoramic images. Sci Rep. 2021;11:8619 pubmed publisher
  105. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  106. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  107. Jhala G, Selck C, Chee J, Kwong C, Pappas E, Thomas H, et al. Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice. Front Immunol. 2021;12:645817 pubmed publisher
  108. Yang J, Chung S, Yun K, Kim B, So S, Kang S, et al. Long-term effects of human induced pluripotent stem cell-derived retinal cell transplantation in Pde6b knockout rats. Exp Mol Med. 2021;53:631-642 pubmed publisher
  109. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  110. Qanash H, Li Y, Smith R, Linask K, Young Baird S, Hakami W, et al. Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia. Cells. 2021;10: pubmed publisher
  111. Samdal H, Olsen L, Grøn K, Røyset E, Høiem T, Nervik I, et al. Establishment of a Patient-Derived Xenograft Model of Colorectal Cancer in CIEA NOG Mice and Exploring Smartfish Liquid Diet as a Source of Omega-3 Fatty Acids. Biomedicines. 2021;9: pubmed publisher
  112. Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940 pubmed publisher
  113. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  114. Sugita J, Fujiu K, Nakayama Y, Matsubara T, Matsuda J, Oshima T, et al. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021;12:1910 pubmed publisher
  115. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  116. Chioh F, Fong S, Young B, Wu K, Siau A, Krishnan S, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. elife. 2021;10: pubmed publisher
  117. Reyes J, Ekmark Lewén S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathol Commun. 2021;9:46 pubmed publisher
  118. Goncalves S, Yin K, Ito Y, Chan A, Olan I, Gough S, et al. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep. 2021;34:108860 pubmed publisher
  119. Bi X, Du C, Wang X, Wang X, Han W, Wang Y, et al. Mitochondrial Damage-Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease-Associated Plaque Vulnerability. Adv Sci (Weinh). 2021;8:2002738 pubmed publisher
  120. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  121. Mehatre S, Roy I, Biswas A, Prit D, Schouteden S, Huelsken J, et al. Niche-Mediated Integrin Signaling Supports Steady-State Hematopoiesis in the Spleen. J Immunol. 2021;206:1549-1560 pubmed publisher
  122. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  123. Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, et al. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. J Autoimmun. 2021;119:102610 pubmed publisher
  124. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  125. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  126. de Groot A, Saito Y, Kawakami E, Hashimoto M, Aoki Y, Ono R, et al. Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia. EBioMedicine. 2021;64:103235 pubmed publisher
  127. Liu M, Li N, Qu C, Gao Y, Wu L, Hu L. Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates. Commun Biol. 2021;4:188 pubmed publisher
  128. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  129. Helms T, Mullins R, Thomas Ahner J, Kulp S, Campbell M, Lucas F, et al. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks. Sci Rep. 2021;11:3646 pubmed publisher
  130. GUTTIKONDA S, Sikkema L, Tchieu J, Saurat N, Walsh R, Harschnitz O, et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease. Nat Neurosci. 2021;24:343-354 pubmed publisher
  131. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
  132. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  133. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  134. Nagle V, Henry K, Hertz C, Graham M, Campos C, Parada L, et al. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET. Clin Cancer Res. 2021;27:1958-1966 pubmed publisher
  135. Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591:124-130 pubmed publisher
  136. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  137. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  138. Bullerwell C, Robichaud P, Deprez P, Joy A, Wajnberg G, D Souza D, et al. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Sci Rep. 2021;11:1537 pubmed publisher
  139. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  140. Wu C, Dicks A, Steward N, Tang R, Katz D, Choi Y, et al. Single cell transcriptomic analysis of human pluripotent stem cell chondrogenesis. Nat Commun. 2021;12:362 pubmed publisher
  141. Rivas M, Meydan C, Chin C, Challman M, Kim D, Bhinder B, et al. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. Nat Immunol. 2021;22:240-253 pubmed publisher
  142. Huang Y, Cai K, Xu P, Wang L, Huang C, Fang Y, et al. CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. Signal Transduct Target Ther. 2021;6:10 pubmed publisher
  143. Aslam M, Alemdehy M, Kwesi Maliepaard E, Muhaimin F, Caganova M, Pardieck I, et al. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. EMBO Rep. 2021;22:e51184 pubmed publisher
  144. Wen Y, Hou Y, Yi X, Sun S, Guo J, He X, et al. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics. 2021;11:1795-1813 pubmed publisher
  145. Kaur S, Sehgal A, Wu A, Millard S, Batoon L, Sandrock C, et al. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice. J Hematol Oncol. 2021;14:3 pubmed publisher
  146. Luo R, Cheng Y, Chang D, Liu T, Liu L, Pei G, et al. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A. Theranostics. 2021;11:117-131 pubmed publisher
  147. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  148. Gumber D, Do M, Suresh Kumar N, Sonavane P, Wu C, Cruz L, et al. Selective activation of FZD7 promotes mesendodermal differentiation of human pluripotent stem cells. elife. 2020;9: pubmed publisher
  149. Li X, Zhang M, Huang X, Liang W, Li G, Lu X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun. 2020;11:6364 pubmed publisher
  150. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  151. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  152. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  153. Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. elife. 2020;9: pubmed publisher
  154. Li N, Rignault Clerc S, Bielmann C, Bon Mathier A, Déglise T, Carboni A, et al. Increasing heart vascularisation after myocardial infarction using brain natriuretic peptide stimulation of endothelial and WT1+ epicardial cells. elife. 2020;9: pubmed publisher
  155. Ding Y, Li X, Zhou M, Cai L, Tang H, Xie T, et al. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation. Vascul Pharmacol. 2021;136:106818 pubmed publisher
  156. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  157. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed publisher
  158. Xu A, Barbosa R, Calado D. Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover. elife. 2020;9: pubmed publisher
  159. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  160. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  161. Xu J, Wang Y, Hsu C, Negri S, Tower R, Gao Y, et al. Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells. elife. 2020;9: pubmed publisher
  162. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  163. Ishii K, Pouzolles M, Chien C, Erwin Cohen R, Kohler M, Qin H, et al. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. J Clin Invest. 2020;130:5425-5443 pubmed publisher
  164. Ortiz Otero N, Marshall J, Lash B, King M. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873 pubmed publisher
  165. Xu T, Wang Z, Dong M, Wu D, Liao S, Li X. Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer. Aging (Albany NY). 2020;12:17305-17327 pubmed publisher
  166. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed publisher
  167. Dumitrescu M, Trusca V, Savu L, Stancu I, Ratiu A, Simionescu M, et al. Adenovirus-Mediated FasL Minigene Transfer Endows Transduced Cells with Killer Potential. Int J Mol Sci. 2020;21: pubmed publisher
  168. Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, et al. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer. 2020;8: pubmed publisher
  169. Ricci B, Tycksen E, Celik H, Belle J, Fontana F, Civitelli R, et al. Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics. elife. 2020;9: pubmed publisher
  170. Florian M, Leins H, Gobs M, Han Y, Marka G, Soller K, et al. Inhibition of Cdc42 activity extends lifespan and decreases circulating inflammatory cytokines in aged female C57BL/6 mice. Aging Cell. 2020;:e13208 pubmed publisher
  171. Azar A, Michie A, Tarafdar A, Malik N, Menon G, Till K, et al. A novel transgenic mouse strain expressing PKCβII demonstrates expansion of B1 and marginal zone B cell populations. Sci Rep. 2020;10:13156 pubmed publisher
  172. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89-94 pubmed publisher
  173. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  174. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  175. Ferrara M, Chialli G, Ferreira L, Ruggieri E, Careccia G, Preti A, et al. Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions. Front Immunol. 2020;11:1122 pubmed publisher
  176. Kaaij M, van Tok M, Blijdorp I, Ambarus C, Stock M, Pots D, et al. Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis. J Exp Med. 2020;217: pubmed publisher
  177. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  178. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  179. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  180. Perkail S, Andricovich J, Kai Y, Tzatsos A. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun. 2020;11:3018 pubmed publisher
  181. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  182. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  183. Oh D, Kwek S, Raju S, Li T, McCarthy E, Chow E, et al. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181:1612-1625.e13 pubmed publisher
  184. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  185. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  186. Bekeschus S, Clemen R, Nießner F, Sagwal S, Freund E, Schmidt A. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Adv Sci (Weinh). 2020;7:1903438 pubmed publisher
  187. Hu H, Ji Q, Song M, Ren J, Liu Z, Wang Z, et al. ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin. Nucleic Acids Res. 2020;48:6001-6018 pubmed publisher
  188. Kim J, Yang Y, Park K, Ge X, Xu R, Li N, et al. A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun. 2020;11:2289 pubmed publisher
  189. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  190. Dmitrieva N, Walts A, Nguyen D, Grubb A, Zhang X, Wang X, et al. Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome. J Clin Invest. 2020;130:4167-4181 pubmed publisher
  191. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  192. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  193. Bekeschus S, Ressel V, Freund E, Gelbrich N, Mustea A, Stope M. Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity. Antioxidants (Basel). 2020;9: pubmed publisher
  194. Wong S, Lenzini S, Cooper M, Mooney D, Shin J. Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and trafficking. Sci Adv. 2020;6:eaaw0158 pubmed publisher
  195. Ray S, Chee L, Matson D, Palermo N, Bresnick E, Hewitt K. Sterile α-motif domain requirement for cellular signaling and survival. J Biol Chem. 2020;295:7113-7125 pubmed publisher
  196. Gang E, Kim H, Hsieh Y, Ruan Y, Ogana H, Lee S, et al. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020;136:210-223 pubmed publisher
  197. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  198. Gao K, He S, Kumar P, Farmer D, Zhou J, Wang A. Clonal isolation of endothelial colony-forming cells from early gestation chorionic villi of human placenta for fetal tissue regeneration. World J Stem Cells. 2020;12:123-138 pubmed publisher
  199. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  200. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  201. Smith M, Chan K, Papagianis P, Nitsos I, Zahra V, Allison B, et al. Umbilical Cord Blood Cells Do Not Reduce Ventilation-Induced Lung Injury in Preterm Lambs. Front Physiol. 2020;11:119 pubmed publisher
  202. Beltran Camacho L, Jimenez Palomares M, Rojas Torres M, Sánchez Gomar I, Rosal Vela A, Eslava Alcon S, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11:106 pubmed publisher
  203. Zang M, Guo J, Liu L, Jin F, Feng X, An G, et al. Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. Oncogenesis. 2020;9:31 pubmed publisher
  204. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed publisher
  205. Witalis M, Chang J, Zhong M, Bouklouch Y, Panneton V, Li J, et al. Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk. Blood Adv. 2020;4:868-879 pubmed publisher
  206. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed publisher
  207. Fu W, Wang W, Li H, Jiao Y, Weng J, Huo R, et al. High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas. Front Oncol. 2020;10:78 pubmed publisher
  208. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  209. Clark D, Brazina S, Yang F, Hu D, Hsieh C, Niemi E, et al. Age-related changes to macrophages are detrimental to fracture healing in mice. Aging Cell. 2020;19:e13112 pubmed publisher
  210. Lee L, Krupski C, Clark J, Wunderlich M, Lorsbach R, Grimley M, et al. High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy. Blood Adv. 2020;4:717-727 pubmed publisher
  211. Zhang Q, Xiang L, Zaman M, Dong W, He G, Deng G. Predominant Role of Immunoglobulin G in the Pathogenesis of Splenomegaly in Murine Lupus. Front Immunol. 2019;10:3020 pubmed publisher
  212. Minervina A, Pogorelyy M, Komech E, Karnaukhov V, Bacher P, Rosati E, et al. Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones. elife. 2020;9: pubmed publisher
  213. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  214. Forbester J, Clement M, Wellington D, Yeung A, Dimonte S, Marsden M, et al. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models. J Virol. 2020;94: pubmed publisher
  215. Adams C, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, et al. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours. Int J Mol Sci. 2020;21: pubmed publisher
  216. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  217. Alvarez Quilón A, Terron Bautista J, Delgado Sainz I, Serrano Benítez A, Romero Granados R, Martínez García P, et al. Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency. Nat Commun. 2020;11:910 pubmed publisher
  218. Hou M, Han J, Li G, Kwon M, Jiang J, Emani S, et al. Multipotency of mouse trophoblast stem cells. Stem Cell Res Ther. 2020;11:55 pubmed publisher
  219. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  220. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  221. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  222. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  223. Uckelmann H, Kim S, Wong E, Hatton C, Giovinazzo H, Gadrey J, et al. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. Science. 2020;367:586-590 pubmed publisher
  224. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  225. Panda S, Wigerblad G, Jiang L, Jiménez Andrade Y, Iyer V, Shen Y, et al. IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints. Proc Natl Acad Sci U S A. 2020;117:3103-3113 pubmed publisher
  226. Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020;578:160-165 pubmed publisher
  227. Wolf N, Breur M, Plug B, Beerepoot S, Westerveld A, van Rappard D, et al. Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction. Ann Clin Transl Neurol. 2020;7:169-180 pubmed publisher
  228. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  229. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  230. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  231. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
  232. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed publisher
  233. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  234. Hurrell B, Galle Treger L, Jahani P, Howard E, Helou D, Banie H, et al. TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity. Cell Rep. 2019;29:4509-4524.e5 pubmed publisher
  235. Tian Y, Seumois G, De Oliveira Pinto L, Mateus J, Herrera de la Mata S, Kim C, et al. Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease. Cell Rep. 2019;29:4482-4495.e4 pubmed publisher
  236. Mesin L, Schiepers A, Ersching J, Barbulescu A, Cavazzoni C, Angelini A, et al. Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting. Cell. 2020;180:92-106.e11 pubmed publisher
  237. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  238. Wang B, Saito Y, Nishimura M, Ren Z, Tjan L, Refaat A, et al. An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis. J Virol. 2020;94: pubmed publisher
  239. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  240. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  241. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  242. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher
  243. Ward L, Lee D, Sharma A, Wang A, Naouar I, Ma X, et al. Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight. 2020;5: pubmed publisher
  244. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  245. Bokun V, Moore J, Moore R, Smallcombe C, Harford T, Rezaee F, et al. Respiratory syncytial virus exhibits differential tropism for distinct human placental cell types with Hofbauer cells acting as a permissive reservoir for infection. PLoS ONE. 2019;14:e0225767 pubmed publisher
  246. Callender L, Carroll E, Bober E, Akbar A, Solito E, Henson S. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:e13067 pubmed publisher
  247. Vagnozzi R, Maillet M, Sargent M, Khalil H, Johansen A, Schwanekamp J, et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2020;577:405-409 pubmed publisher
  248. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  249. Luque Martin R, Van den Bossche J, Furze R, Neele A, van der Velden S, Gijbels M, et al. Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis. Front Pharmacol. 2019;10:1242 pubmed publisher
  250. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  251. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed publisher
  252. Yukawa M, Jagannathan S, Vallabh S, Kartashov A, Chen X, Weirauch M, et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J Exp Med. 2020;217: pubmed publisher
  253. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  254. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  255. Yoshimi A, Lin K, Wiseman D, Rahman M, Pastore A, Wang B, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019;574:273-277 pubmed publisher
  256. Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;39: pubmed publisher
  257. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  258. Chen M, Reed R, Lane A. Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense. Cell Stem Cell. 2019;25:501-513.e5 pubmed publisher
  259. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  260. Shao Q, Esseltine J, Huang T, Novielli Kuntz N, Ching J, SAMPSON J, et al. Connexin43 is Dispensable for Early Stage Human Mesenchymal Stem Cell Adipogenic Differentiation But is Protective against Cell Senescence. Biomolecules. 2019;9: pubmed publisher
  261. Xu J, Wang Y, Hsu C, Gao Y, Meyers C, Chang L, et al. Human perivascular stem cell-derived extracellular vesicles mediate bone repair. elife. 2019;8: pubmed publisher
  262. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  263. Nagai M, Noguchi R, Takahashi D, Morikawa T, Koshida K, Komiyama S, et al. Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses. Cell. 2019;178:1072-1087.e14 pubmed publisher
  264. Solis A, Bielecki P, Steach H, Sharma L, Harman C, Yun S, et al. Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. Nature. 2019;573:69-74 pubmed publisher
  265. Serra Peinado C, Grau Expósito J, Luque Ballesteros L, Astorga Gamaza A, Navarro J, Gallego Rodriguez J, et al. Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nat Commun. 2019;10:3705 pubmed publisher
  266. Mathsyaraja H, Freie B, Cheng P, Babaeva E, Catchpole J, Janssens D, et al. Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis. Genes Dev. 2019;33:1252-1264 pubmed publisher
  267. Culemann S, Grüneboom A, Nicolás Ávila J, Weidner D, Lämmle K, Rothe T, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572:670-675 pubmed publisher
  268. Wei J, Luo C, Wang Y, Guo Y, Dai H, Tong C, et al. PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity. J Immunother Cancer. 2019;7:209 pubmed publisher
  269. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  270. Smillie C, Biton M, Ordovas Montanes J, Sullivan K, Burgin G, Graham D, et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019;178:714-730.e22 pubmed publisher
  271. Wang H, Shen L, Sun X, Liu F, Feng W, Jiang C, et al. Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nat Commun. 2019;10:3254 pubmed publisher
  272. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed publisher
  273. Dulken B, Buckley M, Navarro Negredo P, Saligrama N, Cayrol R, Leeman D, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205-210 pubmed publisher
  274. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher
  275. Lau E, Carroll E, Callender L, Hood G, Berryman V, Pattrick M, et al. Type 2 diabetes is associated with the accumulation of senescent T cells. Clin Exp Immunol. 2019;197:205-213 pubmed publisher
  276. Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed publisher
  277. Rothweiler S, Feldbrügge L, Jiang Z, Csizmadia E, Longhi M, Vaid K, et al. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis. Purinergic Signal. 2019;15:375-385 pubmed publisher
  278. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  279. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed publisher
  280. Liu D, Yin X, Olyha S, Nascimento M, Chen P, White T, et al. IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection. Immunity. 2019;: pubmed publisher
  281. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed publisher
  282. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  283. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  284. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  285. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  286. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  287. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  288. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  289. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed publisher
  290. Fenwick C, Loredo Varela J, Joo V, Pellaton C, Farina A, Rajah N, et al. Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway. J Exp Med. 2019;: pubmed publisher
  291. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  292. Gao Y, Wei L, Wang C, Huang Y, Li W, Li T, et al. Chronic prostatitis alters the prostatic microenvironment and accelerates preneoplastic lesions in C57BL/6 mice. Biol Res. 2019;52:30 pubmed publisher
  293. Sharma N, Vacher J, Allison J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019;116:10453-10462 pubmed publisher
  294. Takagaki S, Yamashita R, Hashimoto N, Sugihara K, Kanari K, Tabata K, et al. Galactosyl carbohydrate residues on hematopoietic stem/progenitor cells are essential for homing and engraftment to the bone marrow. Sci Rep. 2019;9:7133 pubmed publisher
  295. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  296. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed publisher
  297. Staessens S, Denorme F, Francois O, Desender L, Dewaele T, Vanacker P, et al. Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica. 2019;: pubmed publisher
  298. Yen W, Sharma R, Cols M, Lau C, Chaudhry A, Chowdhury P, et al. Distinct Requirements of CHD4 during B Cell Development and Antibody Response. Cell Rep. 2019;27:1472-1486.e5 pubmed publisher
  299. Zimmermann M, Rose N, Lindner J, Kim H, Gonçalves A, Callegari I, et al. Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells. Front Immunol. 2019;10:829 pubmed publisher
  300. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  301. Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher
  302. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  303. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  304. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  305. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  306. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  307. Jacome Galarza C, Percin G, Muller J, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568:541-545 pubmed publisher
  308. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  309. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  310. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  311. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  312. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  313. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  314. Oda H, Beck D, Kuehn H, Sampaio Moura N, Hoffmann P, Ibarra M, et al. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC. Front Immunol. 2019;10:479 pubmed publisher
  315. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  316. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  317. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  318. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  319. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  320. Bergqvist F, Carr A, Wheway K, Watkins B, Oppermann U, Jakobsson P, et al. Divergent roles of prostacyclin and PGE2 in human tendinopathy. Arthritis Res Ther. 2019;21:74 pubmed publisher
  321. Finney O, Brakke H, Rawlings Rhea S, Hicks R, Doolittle D, López M, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129:2123-2132 pubmed publisher
  322. Marcandalli J, Fiala B, Ols S, Perotti M, De van der Schueren W, Snijder J, et al. Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus. Cell. 2019;176:1420-1431.e17 pubmed publisher
  323. Dey A, Yang W, Gegonne A, Nishiyama A, Pan R, Yagi R, et al. BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. EMBO J. 2019;38: pubmed publisher
  324. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  325. Ludwig L, Lareau C, Ulirsch J, Christian E, Muus C, Li L, et al. Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics. Cell. 2019;176:1325-1339.e22 pubmed publisher
  326. Halvarsson C, Rörby E, Eliasson P, Lang S, Soneji S, Jönsson J. Putative role of NF-kB but not HIF-1α in hypoxia-dependent regulation of oxidative stress in hematopoietic stem and progenitor cells. Antioxid Redox Signal. 2019;: pubmed publisher
  327. Grootjans J, Krupka N, Hosomi S, Matute J, Hanley T, Saveljeva S, et al. Epithelial endoplasmic reticulum stress orchestrates a protective IgA response. Science. 2019;363:993-998 pubmed publisher
  328. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  329. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  330. Graf R, Seagal J, Otipoby K, Lam K, Ayoub S, Zhang B, et al. BCR-dependent lineage plasticity in mature B cells. Science. 2019;363:748-753 pubmed publisher
  331. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  332. Po J, Ma Y, Balakrishna B, Brungs D, Azimi F, De Souza P, et al. Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status. PLoS ONE. 2019;14:e0211866 pubmed publisher
  333. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  334. Rowe R, Lummertz da Rocha E, Sousa P, Missios P, Morse M, Marion W, et al. The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia. J Exp Med. 2019;216:527-538 pubmed publisher
  335. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  336. Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216:688-703 pubmed publisher
  337. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  338. Franco L, Gadkari M, Howe K, Sun J, Kardava L, Kumar P, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med. 2019;216:384-406 pubmed publisher
  339. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  340. Chi V, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, et al. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer. 2019;19:81 pubmed publisher
  341. Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505-510 pubmed publisher
  342. Das S, Bar Sagi D. BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis. Oncogene. 2019;38:3316-3324 pubmed publisher
  343. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  344. Gkountela S, Castro Giner F, Szczerba B, Vetter M, Landin J, Scherrer R, et al. Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell. 2019;176:98-112.e14 pubmed publisher
  345. Xiao X, Lai W, Xie H, Liu Y, Guo W, Liu Y, et al. Targeting JNK pathway promotes human hematopoietic stem cell expansion. Cell Discov. 2019;5:2 pubmed publisher
  346. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed publisher
  347. Chopin M, Lun A, Zhan Y, Schreuder J, Coughlan H, D Amico A, et al. Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT. Immunity. 2019;50:77-90.e5 pubmed publisher
  348. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  349. Shishido T, Kohyama M, Nakai W, Matsumoto M, Miyata H, Suenaga T, et al. Invariant chain p41 mediates production of soluble MHC class II molecules. Biochem Biophys Res Commun. 2018;: pubmed publisher
  350. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  351. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  352. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  353. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  354. Hatzi K, Geng H, Doane A, Meydan C, LaRiviere R, Cárdenas M, et al. Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. Nat Immunol. 2019;20:86-96 pubmed publisher
  355. Percin G, Eitler J, Kranz A, Fu J, Pollard J, Naumann R, et al. CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages. Nat Commun. 2018;9:5279 pubmed publisher
  356. Chen X, Zhi X, Wang J, Su J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 2018;6:34 pubmed publisher
  357. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  358. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  359. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  360. Saikia P, Thangavadivel S, Medeiros C, Lassance L, de Oliveira R, Wilson S. IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells. Invest Ophthalmol Vis Sci. 2018;59:5589-5598 pubmed publisher
  361. Nayar S, Campos J, Smith C, Iannizzotto V, Gardner D, Colafrancesco S, et al. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome. Ann Rheum Dis. 2019;78:249-260 pubmed publisher
  362. Sharma D, Malik A, Guy C, Vogel P, Kanneganti T. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy. J Clin Invest. 2019;129:150-162 pubmed publisher
  363. Zhuang L, Lawlor K, Schlueter H, Pieterse Z, Yu Y, Kaur P. Pericytes promote skin regeneration by inducing epidermal cell polarity and planar cell divisions. Life Sci Alliance. 2018;1:e201700009 pubmed publisher
  364. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  365. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  366. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  367. Chinta K, Rahman M, Saini V, Glasgow J, Reddy V, Lever J, et al. Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis. Cell Rep. 2018;25:1938-1952.e5 pubmed publisher
  368. Choi H, Suwanpradid J, Kim I, Staats H, Haniffa M, Macleod A, et al. Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles. Science. 2018;362: pubmed publisher
  369. Grigoryan A, Guidi N, Senger K, Liehr T, Soller K, Marka G, et al. LaminA/C regulates epigenetic and chromatin architecture changes upon aging of hematopoietic stem cells. Genome Biol. 2018;19:189 pubmed publisher
  370. Hsu J, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F, et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018;23:700-713.e6 pubmed publisher
  371. Cai Y, Abdel Mohsen M, Tomescu C, Xue F, Wu G, Howell B, et al. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation. J Virol. 2019;93: pubmed publisher
  372. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  373. Meyer I, Goetzke C, Kespohl M, Sauter M, Heuser A, Eckstein V, et al. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis. Front Immunol. 2018;9:2303 pubmed publisher
  374. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  375. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  376. Peng Y. B cell responses to apoptotic cells in MFG-E8-/- mice. PLoS ONE. 2018;13:e0205172 pubmed publisher
  377. Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, et al. Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival. J Clin Invest. 2018;128:4770-4786 pubmed publisher
  378. Kinchen J, Chen H, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;175:372-386.e17 pubmed publisher
  379. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  380. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed publisher
  381. Stephens J, Bailey J, Hang H, Rittell V, Dietrich M, Mynatt R, et al. Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice. Obesity (Silver Spring). 2018;26:1439-1447 pubmed publisher
  382. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  383. Jelcić I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, et al. Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis. Cell. 2018;175:85-100.e23 pubmed publisher
  384. Rodríguez Baena F, Redondo García S, Peris Torres C, Martino Echarri E, Fernández Rodríguez R, Plaza Calonge M, et al. ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response. Sci Rep. 2018;8:13103 pubmed publisher
  385. Chen J, Cai Z, Bai M, Yu X, Zhang C, Cao C, et al. The RNA-binding protein ROD1/PTBP3 cotranscriptionally defines AID-loading sites to mediate antibody class switch in mammalian genomes. Cell Res. 2018;28:981-995 pubmed publisher
  386. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  387. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  388. Keszei M, Record J, Kritikou J, Wurzer H, Geyer C, Thiemann M, et al. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive. J Clin Invest. 2018;128:4115-4131 pubmed publisher
  389. Cao A, Alluqmani N, Buhari F, Wasim L, Smith L, Quaile A, et al. Galectin-9 binds IgM-BCR to regulate B cell signaling. Nat Commun. 2018;9:3288 pubmed publisher
  390. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed publisher
  391. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  392. Lin Y, Pecetta S, Steichen J, Kratochvil S, Melzi E, Arnold J, et al. One-step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock-in mice. EMBO J. 2018;37: pubmed publisher
  393. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  394. Levin M, Kroehl M, Johnson M, Hammes A, Reinhold D, Lang N, et al. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018;128:4429-4440 pubmed publisher
  395. Wan X, Zinselmeyer B, Zakharov P, Vomund A, Taniguchi R, Santambrogio L, et al. Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature. 2018;560:107-111 pubmed publisher
  396. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  397. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  398. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  399. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  400. Hartana C, Ahlén Bergman E, Broome A, Berglund S, Johansson M, Alamdari F, et al. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer. Clin Exp Immunol. 2018;194:39-53 pubmed publisher
  401. Zhao Y, Harrison D, Song Y, Ji J, Huang J, Hui E. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Cell Rep. 2018;24:379-390.e6 pubmed publisher
  402. Webster P, Dawes J, Dewchand H, Takacs K, Iadarola B, Bolt B, et al. Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates. Nat Commun. 2018;9:2649 pubmed publisher
  403. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed publisher
  404. Chute C, Yang X, Meyer K, Yang N, O Neil K, Kasza I, et al. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases. Breast Cancer Res. 2018;20:66 pubmed publisher
  405. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  406. Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24:1151-1156 pubmed publisher
  407. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed publisher
  408. Murakami T, Kim J, Li Y, Green G, Shikanov A, Ono A. Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions. Nat Commun. 2018;9:2436 pubmed publisher
  409. Casey A, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol. 2018;217:2951-2974 pubmed publisher
  410. Webster B, Werneke S, Zafirova B, This S, Coléon S, Decembre E, et al. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses. elife. 2018;7: pubmed publisher
  411. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  412. Kim S, Knight D, Jones L, Vervoort S, Ng A, Seymour J, et al. JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias. Genes Dev. 2018;32:849-864 pubmed publisher
  413. Jensen C, Åhsberg J, Sommarin M, Strid T, Somasundaram R, Okuyama K, et al. Dissection of progenitor compartments resolves developmental trajectories in B-lymphopoiesis. J Exp Med. 2018;215:1947-1963 pubmed publisher
  414. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  415. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed publisher
  416. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  417. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  418. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  419. Scelsi M, Khan R, Lorenzi M, Christopher L, Greicius M, Schott J, et al. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci. Brain. 2018;141:2167-2180 pubmed publisher
  420. Wang B, Zuo J, Kang W, Wei Q, Li J, Wang C, et al. Generation of Hutat2:Fc Knockin Primary Human Monocytes Using CRISPR/Cas9. Mol Ther Nucleic Acids. 2018;11:130-141 pubmed publisher
  421. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  422. Oda A, Tezuka T, Ueno Y, Hosoda S, Amemiya Y, Notsu C, et al. Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1. Sci Rep. 2018;8:8308 pubmed publisher
  423. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  424. Jun H, Yu H, Gong J, Jiang J, Qiao X, Perkey E, et al. An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling. Nat Med. 2018;24:814-822 pubmed publisher
  425. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  426. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher
  427. Robak O, Heimesaat M, Kruglov A, Prepens S, Ninnemann J, Gutbier B, et al. Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia. J Clin Invest. 2018;128:3535-3545 pubmed publisher
  428. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  429. Thomson C, van de Pavert S, Stakenborg M, Labeeuw E, Matteoli G, Mowat A, et al. Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators. J Immunol. 2018;201:215-229 pubmed publisher
  430. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  431. Liao Y, Ivanova L, Sivalenka R, Plumer T, Zhu H, Zhang X, et al. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model. Stem Cells Transl Med. 2018;7:530-542 pubmed publisher
  432. Donaldson G, Ladinsky M, Yu K, Sanders J, Yoo B, Chou W, et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science. 2018;360:795-800 pubmed publisher
  433. Georgiev H, Ravens I, Papadogianni G, Halle S, Malissen B, Loots G, et al. Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer's Patches. Front Immunol. 2018;9:714 pubmed publisher
  434. Sevin M, Kubovcakova L, Pernet N, Causse S, Vitte F, Villeval J, et al. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nat Commun. 2018;9:1431 pubmed publisher
  435. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  436. Harker J, Wong K, Dallari S, Bao P, Dolgoter A, Jo Y, et al. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018;92: pubmed publisher
  437. Chen Y, Chaudhary N, Yang N, Granato A, Turner J, Howard S, et al. Microbial symbionts regulate the primary Ig repertoire. J Exp Med. 2018;215:1397-1415 pubmed publisher
  438. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed publisher
  439. Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine T, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018;128:2487-2499 pubmed publisher
  440. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  441. Bröker K, Figge J, Magnusen A, Manz R, Köhl J, Karsten C. A Novel Role for C5a in B-1 Cell Homeostasis. Front Immunol. 2018;9:258 pubmed publisher
  442. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  443. Tang C, Chang S, Paton A, Paton J, Gabrilovich D, Ploegh H, et al. Phosphorylation of IRE1 at S729 regulates RIDD in B cells and antibody production after immunization. J Cell Biol. 2018;217:1739-1755 pubmed publisher
  444. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  445. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  446. Yeh C, Nojima T, Kuraoka M, Kelsoe G. Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density. Nat Commun. 2018;9:928 pubmed publisher
  447. Nadafi R, Koning J, Veninga H, Stachtea X, Konijn T, Zwiers A, et al. Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity Magnitude. Front Immunol. 2018;9:206 pubmed publisher
  448. Kanayama M, Kato Y, Tsuji T, Konoeda Y, Hashimoto A, Kanauchi O, et al. Enhancement of immunomodulative effect of lactic acid bacteria on plasmacytoid dendritic cells with sucrose palmitate. Sci Rep. 2018;8:3147 pubmed publisher
  449. Zhang H, Song Y, Yang H, Liu Z, Gao L, Liang X, et al. Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis. Oncogene. 2018;37:2456-2468 pubmed publisher
  450. Luo B, Chen K, Feng Q, Xiao W, Ma D, Yang H, et al. The interplay of BMP4 and IL?7 regulates the apoptosis of intestinal intraepithelial lymphocytes under conditions of ischemia?reperfusion. Int J Mol Med. 2018;41:2640-2650 pubmed publisher
  451. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  452. Carisey A, Mace E, Saeed M, Davis D, Orange J. Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells. Curr Biol. 2018;28:489-502.e9 pubmed publisher
  453. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  454. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  455. Tang H, Liang Y, Anders R, Taube J, Qiu X, Mulgaonkar A, et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest. 2018;128:580-588 pubmed publisher
  456. Christ A, Günther P, Lauterbach M, Duewell P, Biswas D, Pelka K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162-175.e14 pubmed publisher
  457. Clarke A, Riffelmacher T, Braas D, Cornall R, Simon A. B1a B cells require autophagy for metabolic homeostasis and self-renewal. J Exp Med. 2018;215:399-413 pubmed publisher
  458. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  459. Stremmel C, Schuchert R, Wagner F, Thaler R, Weinberger T, Pick R, et al. Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. Nat Commun. 2018;9:75 pubmed publisher
  460. Mazor R, King E, Onda M, Cuburu N, Addissie S, Crown D, et al. Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity. Proc Natl Acad Sci U S A. 2018;115:E733-E742 pubmed publisher
  461. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  462. Guarnerio J, Mendez L, Asada N, Menon A, Fung J, Berry K, et al. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. Nat Commun. 2018;9:66 pubmed publisher
  463. Kurkewich J, Boucher A, Klopfenstein N, Baskar R, Kapur R, Dahl R. The mirn23a and mirn23b microrna clusters are necessary for proper hematopoietic progenitor cell production and differentiation. Exp Hematol. 2018;59:14-29 pubmed publisher
  464. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  465. Rudolf Oliveira R, Auat M, Cardoso C, Santos Pirath I, Lange B, Pires Silva J, et al. Determination of normal expression patterns of CD86, CD210a, CD261, CD262, CD264, CD358, and CD361 in peripheral blood and bone marrow cells by flow cytometry. Immunol Lett. 2018;194:44-55 pubmed publisher
  466. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
  467. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  468. Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher
  469. Matsuo K, Nagakubo D, Yamamoto S, Shigeta A, Tomida S, Fujita M, et al. CCL28-Deficient Mice Have Reduced IgA Antibody-Secreting Cells and an Altered Microbiota in the Colon. J Immunol. 2018;200:800-809 pubmed publisher
  470. Medaglia C, Giladi A, Stoler Barak L, De Giovanni M, Salame T, Biram A, et al. Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science. 2017;358:1622-1626 pubmed publisher
  471. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed publisher
  472. Iseka F, Goetz B, Mushtaq I, An W, Cypher L, Bielecki T, et al. Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol. 2018;200:483-499 pubmed publisher
  473. Zhao B, Mei Y, Cao L, Zhang J, Sumagin R, Yang J, et al. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest. 2018;128:125-140 pubmed publisher
  474. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  475. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  476. Cai L, Bai H, Mahairaki V, Gao Y, He C, Wen Y, et al. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease. Stem Cells Transl Med. 2018;7:87-97 pubmed publisher
  477. Ring N, Herndler Brandstetter D, Weiskopf K, Shan L, Volkmer J, George B, et al. Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proc Natl Acad Sci U S A. 2017;114:E10578-E10585 pubmed publisher
  478. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed publisher
  479. Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557 pubmed publisher
  480. Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. 2017;7:15580 pubmed publisher
  481. Tsai F, Homan P, Agrawal H, Misharin A, Abdala Valencia H, Haines G, et al. Bim suppresses the development of SLE by limiting myeloid inflammatory responses. J Exp Med. 2017;214:3753-3773 pubmed publisher
  482. Sakamoto A, Matsuda T, Kawaguchi K, Takaoka A, Maruyama M. Involvement of Zizimin2/3 in the age-related defect of peritoneal B-1a cells as a source of anti-bacterial IgM. Int Immunol. 2017;29:431-438 pubmed publisher
  483. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  484. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  485. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  486. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed publisher
  487. Mayer C, Gazumyan A, Kara E, Gitlin A, Golijanin J, Viant C, et al. The microanatomic segregation of selection by apoptosis in the germinal center. Science. 2017;358: pubmed publisher
  488. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  489. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  490. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  491. Degn S, van der Poel C, Firl D, Ayoglu B, Al Qureshah F, Bajic G, et al. Clonal Evolution of Autoreactive Germinal Centers. Cell. 2017;170:913-926.e19 pubmed publisher
  492. Kumar B, Garcia M, Weng L, Jung X, Murakami J, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32:575-587 pubmed publisher
  493. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  494. Minguet S, Kläsener K, Schaffer A, Fiala G, Osteso Ibanez T, Raute K, et al. Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance. Nat Immunol. 2017;18:1150-1159 pubmed publisher
  495. Chang S, Kohlgruber A, Mizoguchi F, Michelet X, Wolf B, Wei K, et al. Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. J Clin Invest. 2017;127:3300-3312 pubmed publisher
  496. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  497. Stengel K, Barnett K, Wang J, Liu Q, Hodges E, Hiebert S, et al. Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development. Proc Natl Acad Sci U S A. 2017;114:8608-8613 pubmed publisher
  498. Kim S, Kwon J, Park J, Seo H, Jung K, Moon Y, et al. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse. Immunol Lett. 2017;190:26-33 pubmed publisher
  499. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  500. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  501. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  502. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  503. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed publisher
  504. Hannibal T, Schmidt Christensen A, Nilsson J, Fransén Pettersson N, Hansen L, Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60:2033-2041 pubmed publisher
  505. Zhang X, Hofmann S, Rack B, Harbeck N, Jeschke U, Sixou S. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients. Int J Mol Sci. 2017;18: pubmed publisher
  506. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  507. Anderson D, Grajales Reyes G, Satpathy A, Vasquez Hueichucura C, Murphy T, Murphy K. Revisiting the specificity of the MHC class?II transactivator CIITA in classical murine dendritic cells in vivo. Eur J Immunol. 2017;47:1317-1323 pubmed publisher
  508. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  509. Xie M, Koh B, Hollister K, Wu H, Sun J, Kaplan M, et al. Bcl6 promotes follicular helper T-cell differentiation and PD-1 expression in a Blimp1-independent manner in mice. Eur J Immunol. 2017;47:1136-1141 pubmed publisher
  510. Nielsen C, van Putten S, Lund I, Melander M, Nørregaard K, Jürgensen H, et al. The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers. Oncotarget. 2017;8:44605-44624 pubmed publisher
  511. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  512. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  513. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  514. Mildner A, Schönheit J, Giladi A, David E, Lara Astiaso D, Lorenzo Vivas E, et al. Genomic Characterization of Murine Monocytes Reveals C/EBP? Transcription Factor Dependence of Ly6C- Cells. Immunity. 2017;46:849-862.e7 pubmed publisher
  515. Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500-504 pubmed publisher
  516. Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495-499 pubmed publisher
  517. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  518. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  519. Jinnohara T, Kanaya T, Hase K, Sakakibara S, Kato T, Tachibana N, et al. IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake. J Exp Med. 2017;214:1607-1618 pubmed publisher
  520. Mitterreiter J, Ouwendijk W, van Velzen M, van Nierop G, Osterhaus A, Verjans G. Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors. Eur J Immunol. 2017;47:1181-1187 pubmed publisher
  521. Schulten V, Tripple V, Seumois G, Qian Y, Scheuermann R, Fu Z, et al. Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells. J Allergy Clin Immunol. 2018;141:775-777.e6 pubmed publisher
  522. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed publisher
  523. Zhang C, Feng J, Du J, Zhuo Z, Yang S, Zhang W, et al. Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity. Cell Mol Immunol. 2018;15:973-982 pubmed publisher
  524. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  525. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  526. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  527. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  528. Kim J, Lin G, Zhou J, Mund J, Case J, Campbell W. Weight loss achieved using an energy restriction diet with normal or higher dietary protein decreased the number of CD14++CD16+ proinflammatory monocytes and plasma lipids and lipoproteins in middle-aged, overweight, and obese adults. Nutr Res. 2017;40:75-84 pubmed publisher
  529. Becker M, Hobeika E, Jumaa H, Reth M, Maity P. CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor. Proc Natl Acad Sci U S A. 2017;114:5231-5236 pubmed publisher
  530. Audzevich T, Bashford Rogers R, Mabbott N, Frampton D, Freeman T, Potocnik A, et al. Pre/pro-B cells generate macrophage populations during homeostasis and inflammation. Proc Natl Acad Sci U S A. 2017;114:E3954-E3963 pubmed publisher
  531. Hasby Saad M, Hasby E. Trichinella Spiralis Impact on Mesenchymal Stem Cells: Immunohistochemical Study by Image Analyzer in Murine Model. Exp Mol Pathol. 2017;102:396-407 pubmed publisher
  532. Acharya N, Penukonda S, Shcheglova T, Hagymasi A, Basu S, Srivastava P. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A. 2017;114:5005-5010 pubmed publisher
  533. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  534. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed publisher
  535. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  536. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  537. Huang A, Postow M, Orlowski R, Mick R, Bengsch B, Manne S, et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature. 2017;545:60-65 pubmed publisher
  538. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  539. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  540. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  541. Mackey A, Magnan M, Chazaud B, Kjaer M. Human skeletal muscle fibroblasts stimulate in vitro myogenesis and in vivo muscle regeneration. J Physiol. 2017;595:5115-5127 pubmed publisher
  542. Turner V, Mabbott N. Ageing adversely affects the migration and function of marginal zone B cells. Immunology. 2017;151:349-362 pubmed publisher
  543. Le Noir S, Boyer F, Lecardeur S, Brousse M, Oruc Z, Cook Moreau J, et al. Functional anatomy of the immunoglobulin heavy chain 3? super-enhancer needs not only core enhancer elements but also their unique DNA context. Nucleic Acids Res. 2017;45:5829-5837 pubmed publisher
  544. Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz V. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214:1269-1280 pubmed publisher
  545. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed publisher
  546. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  547. Sindhava V, Oropallo M, Moody K, Naradikian M, Higdon L, Zhou L, et al. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest. 2017;127:1651-1663 pubmed publisher
  548. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed publisher
  549. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  550. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed publisher
  551. Wolf Y, Shemer A, Polonsky M, Gross M, Mildner A, Yona S, et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J Exp Med. 2017;214:905-917 pubmed publisher
  552. Tura Ceide O, Lobo B, Paul T, Puig Pey R, Coll Bonfill N, García Lucio J, et al. Cigarette smoke challenges bone marrow mesenchymal stem cell capacities in guinea pig. Respir Res. 2017;18:50 pubmed publisher
  553. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  554. Kostarnoy A, Gancheva P, Lepenies B, Tukhvatulin A, Dzharullaeva A, Polyakov N, et al. Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate. Proc Natl Acad Sci U S A. 2017;114:E2758-E2765 pubmed publisher
  555. Di Maggio N, Martella E, Frismantiene A, Resink T, Schreiner S, Lucarelli E, et al. Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells. Sci Rep. 2017;7:44398 pubmed publisher
  556. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  557. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  558. Schuh E, Musumeci A, Thaler F, Laurent S, Ellwart J, Hohlfeld R, et al. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement. J Immunol. 2017;198:3081-3088 pubmed publisher
  559. Lima P, Chen Z, Tayab A, Murphy M, Pudwell J, Smith G, et al. Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study. PLoS ONE. 2017;12:e0172988 pubmed publisher
  560. Patil M, Sharma B, Elattar S, Chang J, Kapil S, Yuan J, et al. Id1 Promotes Obesity by Suppressing Brown Adipose Thermogenesis and White Adipose Browning. Diabetes. 2017;66:1611-1625 pubmed publisher
  561. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  562. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  563. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed publisher
  564. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  565. Millrud C, Kågedal A, Kumlien Georén S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557-2567 pubmed publisher
  566. Ho T, Warr M, Adelman E, Lansinger O, Flach J, Verovskaya E, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543:205-210 pubmed publisher
  567. Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T, et al. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017;543:265-269 pubmed publisher
  568. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  569. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed publisher
  570. Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, et al. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med. 2017;214:1129-1151 pubmed publisher
  571. Stanley R, Piszczatowski R, Bartholdy B, Mitchell K, McKimpson W, Narayanagari S, et al. A myeloid tumor suppressor role for NOL3. J Exp Med. 2017;214:753-771 pubmed publisher
  572. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  573. Sanges S, Jendoubi M, Kavian N, Hauspie C, Speca S, Crave J, et al. B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis. Front Immunol. 2017;8:53 pubmed publisher
  574. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  575. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed publisher
  576. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  577. Gallagher S, Turman S, Lekstrom K, Wilson S, Herbst R, Wang Y. CD47 limits antibody dependent phagocytosis against non-malignant B cells. Mol Immunol. 2017;85:57-65 pubmed publisher
  578. Turner V, Mabbott N. Structural and functional changes to lymph nodes in ageing mice. Immunology. 2017;151:239-247 pubmed publisher
  579. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  580. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  581. Lang S, Harre U, Purohit P, Dietel K, Kienhöfer D, Hahn J, et al. Neurodegeneration Enhances the Development of Arthritis. J Immunol. 2017;198:2394-2402 pubmed publisher
  582. Martínez Martín N, Maldonado P, Gasparrini F, Frederico B, Aggarwal S, Gaya M, et al. A switch from canonical to noncanonical autophagy shapes B cell responses. Science. 2017;355:641-647 pubmed publisher
  583. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  584. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  585. Borghesi J, Mario L, Carreira A, Miglino M, Favaron P. Phenotype and multipotency of rabbit (Oryctolagus cuniculus) amniotic stem cells. Stem Cell Res Ther. 2017;8:27 pubmed publisher
  586. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  587. Tsai T, Li W. Identification of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration. Stem Cell Reports. 2017;8:387-400 pubmed publisher
  588. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  589. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  590. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  591. Oh J, Oh D, Jung H, Lee H. A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract. Proc Natl Acad Sci U S A. 2017;114:E1188-E1195 pubmed publisher
  592. Weeden C, Chen Y, Ma S, Hu Y, Ramm G, Sutherland K, et al. Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway. PLoS Biol. 2017;15:e2000731 pubmed publisher
  593. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  594. Dakin S, Buckley C, Al Mossawi M, Hedley R, Martinez F, Wheway K, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19:16 pubmed publisher
  595. Zorin V, Pulin A, Eremin I, Korsakov I, Zorina A, Khromova N, et al. Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 2017;16:545-555 pubmed publisher
  596. Zhou C, Robert M, Kapoulea V, Lei F, Stagner A, Jakobiec F, et al. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye. Invest Ophthalmol Vis Sci. 2017;58:96-105 pubmed publisher
  597. Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47-54 pubmed publisher
  598. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  599. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  600. Pal D, Pertot A, Shirole N, Yao Z, Anaparthy N, Garvin T, et al. TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. elife. 2017;6: pubmed publisher
  601. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed publisher
  602. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  603. Vanegas N, Vernot J. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche. Exp Hematol Oncol. 2017;6:2 pubmed publisher
  604. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  605. Chinnapaiyan S, Parira T, Dutta R, Agudelo M, Morris A, Nair M, et al. HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus. PLoS ONE. 2017;12:e0169161 pubmed publisher
  606. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  607. Atkin Smith G, Paone S, Zanker D, Duan M, Phan T, Chen W, et al. Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep. 2017;7:39846 pubmed publisher
  608. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed publisher
  609. Cañete A, Carmona R, Ariza L, Sanchez M, Rojas A, Muñoz Chápuli R. A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice. Haematologica. 2017;102:647-655 pubmed publisher
  610. Tang J, Shen D, Caranasos T, Wang Z, Vandergriff A, Allen T, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:13724 pubmed publisher
  611. Fujikura D, Ikesue M, Endo T, Chiba S, Higashi H, Uede T. Death receptor 6 contributes to autoimmunity in lupus-prone mice. Nat Commun. 2017;8:13957 pubmed publisher
  612. Rychtarčíková Z, Lettlova S, Tomkova V, Korenkova V, Langerova L, Simonova E, et al. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism. Oncotarget. 2017;8:6376-6398 pubmed publisher
  613. Weindel C, Richey L, Mehta A, Shah M, Huber B. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. J Immunol. 2017;198:1081-1092 pubmed publisher
  614. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  615. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  616. Tancharoen W, Aungsuchawan S, Pothacharoen P, Markmee R, Narakornsak S, Kieodee J, et al. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochem. 2017;119:113-121 pubmed publisher
  617. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  618. Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire L, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Res. 2017;45:1281-1296 pubmed publisher
  619. Wahl S, Drong A, Lehne B, Loh M, Scott W, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81-86 pubmed publisher
  620. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  621. Wu Y, Stubbington M, Daly M, Teichmann S, Rada C. Intrinsic transcriptional heterogeneity in B cells controls early class switching to IgE. J Exp Med. 2017;214:183-196 pubmed publisher
  622. Park R, Wang T, Koundakjian D, Hultquist J, Lamothe Molina P, Monel B, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49:193-203 pubmed publisher
  623. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  624. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  625. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  626. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  627. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  628. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed publisher
  629. Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, et al. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2017;66:343-354 pubmed publisher
  630. Yanagisawa H, Hashimoto M, Minagawa S, Takasaka N, Ma R, Moermans C, et al. Role of IL-17A in murine models of COPD airway disease. Am J Physiol Lung Cell Mol Physiol. 2017;312:L122-L130 pubmed publisher
  631. Naeem A, Tommasi C, Cole C, Brown S, Zhu Y, Way B, et al. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic d. J Allergy Clin Immunol. 2017;139:1228-1241 pubmed publisher
  632. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  633. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  634. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, S rnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  635. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed publisher
  636. Shen Z, Zeng D, Wang X, Ma Y, Zhang X, Kong P. Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds. Oncol Lett. 2016;12:3278-3284 pubmed
  637. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  638. Paul D, Teschendorff A, Dang M, Lowe R, Hawa M, Ecker S, et al. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nat Commun. 2016;7:13555 pubmed publisher
  639. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  640. Forster M, Farrington K, Petrov J, Belle J, Mindt B, Witalis M, et al. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response. J Leukoc Biol. 2017;101:643-654 pubmed publisher
  641. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed publisher
  642. Tan E, Blackwell M, Dunne J, Marsh R, Tan S, Itinteang T. Neuropeptide Y receptor 1 is expressed by B and T lymphocytes and mast cells in infantile haemangiomas. Acta Paediatr. 2017;106:292-297 pubmed publisher
  643. Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, et al. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017;91: pubmed publisher
  644. Yu V, Yusuf R, Oki T, Wu J, Saez B, Wang X, et al. Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells. Cell. 2016;167:1310-1322.e17 pubmed publisher
  645. Caminal M, Velez R, Rabanal R, Vivas D, Batlle Morera L, Aguirre M, et al. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies. J Tissue Eng Regen Med. 2017;11:3408-3416 pubmed publisher
  646. Zhang G, Zhang J, Zhu C, Lin L, Wang J, Zhang H, et al. MicroRNA-98 regulates osteogenic differentiation of human bone mesenchymal stromal cells by targeting BMP2. J Cell Mol Med. 2017;21:254-264 pubmed publisher
  647. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  648. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  649. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  650. Leibacher J, Dauber K, Ehser S, Brixner V, Kollar K, Vogel A, et al. Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. Cytotherapy. 2017;19:61-74 pubmed publisher
  651. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  652. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed publisher
  653. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed publisher
  654. Kirschbaum K, Sonner J, Zeller M, Deumelandt K, Bode J, Sharma R, et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proc Natl Acad Sci U S A. 2016;113:13227-13232 pubmed
  655. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  656. Govero J, Esakky P, Scheaffer S, Fernandez E, Drury A, Platt D, et al. Zika virus infection damages the testes in mice. Nature. 2016;540:438-442 pubmed publisher
  657. Teng O, Chen S, Hsu T, Sia S, Cole S, Valkenburg S, et al. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol. 2017;91: pubmed publisher
  658. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed publisher
  659. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  660. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  661. Perea F, Bernal M, Sánchez Palencia A, Carretero J, Torres C, Bayarri C, et al. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration. Int J Cancer. 2017;140:888-899 pubmed publisher
  662. Yu Z, Zou Y, Fan J, Li C, Ma L. Notch1 is associated with the differentiation of human bone marrow?derived mesenchymal stem cells to cardiomyocytes. Mol Med Rep. 2016;14:5065-5071 pubmed publisher
  663. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  664. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed publisher
  665. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  666. Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218 pubmed
  667. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  668. Elgueta R, Tse D, Deharvengt S, Luciano M, CARRIERE C, Noelle R, et al. Endothelial Plasmalemma Vesicle-Associated Protein Regulates the Homeostasis of Splenic Immature B Cells and B-1 B Cells. J Immunol. 2016;197:3970-3981 pubmed
  669. Lebre M, Vieira P, Tang M, Aarrass S, Helder B, Newsom Davis T, et al. Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes. J Leukoc Biol. 2017;101:775-783 pubmed publisher
  670. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  671. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  672. Lopez Guadamillas E, Fernandez Marcos P, Pantoja C, Muñoz Martin M, Martinez D, Gomez Lopez G, et al. p21Cip1 plays a critical role in the physiological adaptation to fasting through activation of PPAR?. Sci Rep. 2016;6:34542 pubmed publisher
  673. Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
  674. Sochalska M, Schuler F, Weiss J, Prchal Murphy M, Sexl V, Villunger A. MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis. Oncogene. 2017;36:2066-2073 pubmed publisher
  675. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  676. Muñoz López A, Romero Moya D, Prieto C, Ramos Mejia V, Agraz Doblas A, Varela I, et al. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency. Stem Cell Reports. 2016;7:602-618 pubmed publisher
  677. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  678. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  679. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  680. Milanovic M, Heise N, De Silva N, Anderson M, Silva K, Carette A, et al. Differential requirements for the canonical NF-?B transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol. 2017;95:261-271 pubmed publisher
  681. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  682. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  683. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  684. Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, et al. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep. 2016;6:33612 pubmed publisher
  685. Mester T, Raychaudhuri N, Gillespie E, Chen H, Smith T, Douglas R. CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation. PLoS ONE. 2016;11:e0162994 pubmed publisher
  686. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  687. Tian M, Cheng C, Chen X, Duan H, Cheng H, Dao M, et al. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires. Cell. 2016;166:1471-1484.e18 pubmed publisher
  688. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  689. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  690. Tyurin Kuzmin P, Fadeeva J, Kanareikina M, Kalinina N, Sysoeva V, Dyikanov D, et al. Activation of ?-adrenergic receptors is required for elevated ?1A-adrenoreceptors expression and signaling in mesenchymal stromal cells. Sci Rep. 2016;6:32835 pubmed publisher
  691. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  692. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  693. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  694. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  695. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  696. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed publisher
  697. Zhong W, Yi Q, Xu B, Li S, Wang T, Liu F, et al. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival. Nat Commun. 2016;7:12702 pubmed publisher
  698. Olsson A, Venkatasubramanian M, Chaudhri V, Aronow B, Salomonis N, Singh H, et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature. 2016;537:698-702 pubmed publisher
  699. Pageon S, Tabarin T, Yamamoto Y, Ma Y, Nicovich P, Bridgeman J, et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proc Natl Acad Sci U S A. 2016;113:E5454-63 pubmed publisher
  700. Kong S, Yang Y, Xu Y, Wang Y, Zhang Y, Melo Cardenas J, et al. Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas. Proc Natl Acad Sci U S A. 2016;113:10394-9 pubmed publisher
  701. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  702. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  703. Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102-106 pubmed publisher
  704. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed publisher
  705. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  706. Wu S, Majeed S, Evans T, Camus M, Wong N, Schollmeier Y, et al. Clathrin light chains' role in selective endocytosis influences antibody isotype switching. Proc Natl Acad Sci U S A. 2016;113:9816-21 pubmed publisher
  707. Loegl J, Hiden U, Nussbaumer E, Schliefsteiner C, Cvitic S, Lang I, et al. Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. Reproduction. 2016;152:447-55 pubmed publisher
  708. He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum R, et al. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499 pubmed publisher
  709. Daud A, Loo K, Pauli M, Sanchez Rodriguez R, Sandoval P, Taravati K, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126:3447-52 pubmed publisher
  710. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  711. Schade H, Sen S, Neff C, Freed B, Gao D, Gutman J, et al. Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;22:2172-2179 pubmed publisher
  712. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed publisher
  713. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed publisher
  714. Gallini R, Huusko J, Yla Herttuala S, Betsholtz C, Andrae J. Isoform-Specific Modulation of Inflammation Induced by Adenoviral Mediated Delivery of Platelet-Derived Growth Factors in the Adult Mouse Heart. PLoS ONE. 2016;11:e0160930 pubmed publisher
  715. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed publisher
  716. Nguyen T, Bird N, Grant E, Miles J, Thomas P, Kotsimbos T, et al. Maintenance of the EBV-specific CD8+ TCR?? repertoire in immunosuppressed lung transplant recipients. Immunol Cell Biol. 2017;95:77-86 pubmed publisher
  717. You L, Li L, Zou J, Yan K, Belle J, Nijnik A, et al. BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest. 2016;126:3247-62 pubmed publisher
  718. Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. 2016;7:59877-59891 pubmed publisher
  719. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  720. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  721. Tang Y, Bao W, Yang J, Ma L, Yang J, Xu Y, et al. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep. 2016;14:2717-24 pubmed publisher
  722. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  723. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed publisher
  724. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  725. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed publisher
  726. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  727. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  728. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  729. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed publisher
  730. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  731. Aryal B, Rotllan N, Araldi E, Ramírez C, He S, Chousterman B, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun. 2016;7:12313 pubmed publisher
  732. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  733. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  734. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  735. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  736. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  737. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed publisher
  738. Codinach M, Blanco M, Ortega I, Lloret M, Reales L, Coca M, et al. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells. Cytotherapy. 2016;18:1197-208 pubmed publisher
  739. Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
  740. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  741. Hoppe P, Schwarzfischer M, Loeffler D, Kokkaliaris K, Hilsenbeck O, Moritz N, et al. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Nature. 2016;535:299-302 pubmed publisher
  742. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  743. Dorrell C, Schug J, Canaday P, Russ H, Tarlow B, Grompe M, et al. Human islets contain four distinct subtypes of ? cells. Nat Commun. 2016;7:11756 pubmed publisher
  744. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  745. Schmitt H, Sell S, Koch J, Seefried M, Sonnewald S, Daniel C, et al. Siglec-H protects from virus-triggered severe systemic autoimmunity. J Exp Med. 2016;213:1627-44 pubmed publisher
  746. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  747. Ellebrecht C, Bhoj V, Nace A, Choi E, Mao X, Cho M, et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 2016;353:179-84 pubmed publisher
  748. Bai H, Wang M, Foster T, Hu H, He H, Hashimoto T, et al. Pericardial patch venoplasty heals via attraction of venous progenitor cells. Physiol Rep. 2016;4: pubmed publisher
  749. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  750. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed publisher
  751. Hu J, Yang Z, Li X, Lu H. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment. J Neuroinflammation. 2016;13:162 pubmed publisher
  752. Modulevsky D, Cuerrier C, Pelling A. Biocompatibility of Subcutaneously Implanted Plant-Derived Cellulose Biomaterials. PLoS ONE. 2016;11:e0157894 pubmed publisher
  753. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  754. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  755. Albarrán Juárez J, Kaur H, Grimm M, Offermanns S, Wettschureck N. Lineage tracing of cells involved in atherosclerosis. Atherosclerosis. 2016;251:445-453 pubmed publisher
  756. Terashima A, Okamoto K, Nakashima T, Akira S, Ikuta K, Takayanagi H. Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency. Immunity. 2016;44:1434-43 pubmed publisher
  757. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  758. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  759. Kubyshkin A, Aliev L, Fomochkina I, Kovalenko Y, Litvinova S, Filonenko T, et al. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia. Inflamm Res. 2016;65:785-94 pubmed publisher
  760. Hanssen A, Wagner J, Gorges T, Taenzer A, Uzunoglu F, Driemel C, et al. Characterization of different CTC subpopulations in non-small cell lung cancer. Sci Rep. 2016;6:28010 pubmed publisher
  761. Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, et al. Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cells. Stem Cell Res Ther. 2016;7:83 pubmed publisher
  762. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  763. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  764. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  765. Marinov I, Illingworth A, Benko M, Sutherland D. Performance Characteristics of a Non-Fluorescent Aerolysin-Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Assay for Simultaneous Evaluation of PNH Neutrophils and PNH Monocytes by Flow Cytometry, Following Published PNH Guidelines. Cytometry B Clin Cytom. 2018;94:257-263 pubmed publisher
  766. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  767. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  768. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  769. Ma Q, Garber H, Lu S, He H, Tallis E, Ding X, et al. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016;18:985-94 pubmed publisher
  770. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  771. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  772. Quarta M, Brett J, DiMarco R, de Morrée A, Boutet S, Chacon R, et al. An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nat Biotechnol. 2016;34:752-9 pubmed publisher
  773. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  774. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  775. Chen X, Kong X, Liu D, Gao P, Zhang Y, Li P, et al. In vitro differentiation of endometrial regenerative cells into smooth muscle cells: ? potential approach for the management of pelvic organ prolapse. Int J Mol Med. 2016;38:95-104 pubmed publisher
  776. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  777. Onzi G, Ledur P, Hainzenreder L, Bertoni A, Silva A, Lenz G, et al. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment. Cytotherapy. 2016;18:828-37 pubmed publisher
  778. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  779. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  780. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  781. LaMere S, Thompson R, Komori H, Mark A, Salomon D. Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cells. Genes Immun. 2016;17:283-97 pubmed publisher
  782. Wang D, Zheng Y, Zeng D, Yang Y, Zhang X, Feng Y, et al. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma. Int J STD AIDS. 2017;28:380-388 pubmed publisher
  783. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  784. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  785. Parafioriti A, Bason C, Armiraglio E, Calciano L, Daolio P, Berardocco M, et al. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue. Int J Mol Sci. 2016;17: pubmed publisher
  786. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed publisher
  787. Xu X, Meng Q, Erben U, Wang P, Glauben R, Kuhl A, et al. Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner. Cell Mol Immunol. 2017;14:597-606 pubmed publisher
  788. Silva S, Levy D, Ruiz J, de Melo T, Isaac C, Fidelis M, et al. Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death. J Steroid Biochem Mol Biol. 2017;169:164-175 pubmed publisher
  789. Wu C, Sheu S, Hsu L, Yang K, Tseng C, Kuo T. Intra-articular Injection of platelet-rich fibrin releasates in combination with bone marrow-derived mesenchymal stem cells in the treatment of articular cartilage defects: An in vivo study in rabbits. J Biomed Mater Res B Appl Biomater. 2017;105:1536-1543 pubmed publisher
  790. Strappazzon F, Di Rita A, Cianfanelli V, D Orazio M, Nazio F, Fimia G, et al. Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy. 2016;12:963-75 pubmed publisher
  791. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed publisher
  792. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed publisher
  793. Pietras E, Mirantes Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607-18 pubmed publisher
  794. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  795. Seita Y, Tsukiyama T, Iwatani C, Tsuchiya H, Matsushita J, Azami T, et al. Generation of transgenic cynomolgus monkeys that express green fluorescent protein throughout the whole body. Sci Rep. 2016;6:24868 pubmed publisher
  796. Nel I, Gauler T, Bublitz K, Lazaridis L, Goergens A, Giebel B, et al. Circulating Tumor Cell Composition in Renal Cell Carcinoma. PLoS ONE. 2016;11:e0153018 pubmed publisher
  797. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed publisher
  798. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  799. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  800. Narakornsak S, Poovachiranon N, Peerapapong L, Pothacharoen P, Aungsuchawan S. Mesenchymal stem cells differentiated into chondrocyte-Like cells. Acta Histochem. 2016;118:418-29 pubmed publisher
  801. Kurkewich J, Bikorimana E, Nguyen T, Klopfenstein N, Zhang H, Hallas W, et al. The mirn23a microRNA cluster antagonizes B cell development. J Leukoc Biol. 2016;100:665-677 pubmed
  802. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  803. Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8 pubmed publisher
  804. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  805. Saito H, Okita K, Fusaki N, Sabel M, Chang A, Ito F. Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells. Stem Cells Int. 2016;2016:8394960 pubmed publisher
  806. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed publisher
  807. Yin Y, Ren X, Smith C, Guo Q, Malabunga M, Guernah I, et al. Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody. Dis Model Mech. 2016;9:563-71 pubmed publisher
  808. Del Bel Belluz L, Guidi R, Pateras I, Levi L, Mihaljevic B, Rouf S, et al. The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection. PLoS Pathog. 2016;12:e1005528 pubmed publisher
  809. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  810. Damle S, Martin R, Cross J, Conrad D. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunol. 2017;10:205-214 pubmed publisher
  811. Du C, Duan Y, Wei W, Cai Y, Chai H, Lv J, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nat Commun. 2016;7:11120 pubmed publisher
  812. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed publisher
  813. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed publisher
  814. Morrow C, Trapani F, Metcalf R, Bertolini G, Hodgkinson C, Khandelwal G, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol. 2016;27:1155-60 pubmed publisher
  815. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  816. Cordeiro O, Chypre M, Brouard N, Rauber S, Alloush F, Romera Hernandez M, et al. Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL. PLoS ONE. 2016;11:e0151848 pubmed publisher
  817. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed publisher
  818. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  819. Shaw Bagnall J, Byun S, Miyamoto D, Kang J, Maheswaran S, Stott S, et al. Deformability-based cell selection with downstream immunofluorescence analysis. Integr Biol (Camb). 2016;8:654-64 pubmed publisher
  820. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed publisher
  821. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed publisher
  822. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  823. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  824. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  825. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  826. Benyoucef A, Palii C, Wang C, Porter C, Chu A, Dai F, et al. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia. Genes Dev. 2016;30:508-21 pubmed publisher
  827. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  828. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  829. Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, et al. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016;5:e1025194 pubmed
  830. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed publisher
  831. Pilge H, Fröbel J, Mrotzek S, Fischer J, Prodinger P, Zilkens C, et al. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban. BMC Musculoskelet Disord. 2016;17:108 pubmed publisher
  832. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  833. Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, et al. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun. 2016;7:10761 pubmed publisher
  834. Coughlan A, Harmon C, Whelan S, O Brien E, O Reilly V, Crotty P, et al. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain. Stem Cells Dev. 2016;25:530-41 pubmed publisher
  835. Walraven M, Talhout W, Beelen R, van Egmond M, Ulrich M. Healthy human second-trimester fetal skin is deficient in leukocytes and associated homing chemokines. Wound Repair Regen. 2016;24:533-41 pubmed publisher
  836. Hülsmann J, Aubin H, Wehrmann A, Jenke A, Lichtenberg A, Akhyari P. Whole-Heart Construct Cultivation Under 3D Mechanical Stimulation of the Left Ventricle. Methods Mol Biol. 2016;1502:181-94 pubmed publisher
  837. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  838. Chen J, Miyanishi M, Wang S, Yamazaki S, Sinha R, Kao K, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530:223-7 pubmed publisher
  839. Schläger C, Körner H, Krueger M, Vidoli S, Haberl M, Mielke D, et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature. 2016;530:349-53 pubmed publisher
  840. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  841. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  842. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  843. Muntión S, Ramos T, Diez Campelo M, Rosón B, Sánchez Abarca L, Misiewicz Krzeminska I, et al. Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients. PLoS ONE. 2016;11:e0146722 pubmed publisher
  844. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  845. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  846. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  847. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed publisher
  848. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  849. Somasundaram V, Soni S, Chopra A, Rai S, Mahapatra M, Kumar R, et al. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016;38:141-50 pubmed publisher
  850. Foks A, Engelbertsen D, Kuperwaser F, Alberts Grill N, Gonen A, Witztum J, et al. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol. 2016;36:456-65 pubmed publisher
  851. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  852. Aloulou M, Carr E, Gador M, Bignon A, Liblau R, Fazilleau N, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016;7:10579 pubmed publisher
  853. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  854. Duhan V, Khairnar V, Friedrich S, Zhou F, Gassa A, Honke N, et al. Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control. Sci Rep. 2016;6:19191 pubmed publisher
  855. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  856. Caballero Franco C, Guma M, Choo M, Sano Y, Enzler T, Karin M, et al. Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38?-Dependent Restraint of NF-?B Signaling. J Immunol. 2016;196:2368-76 pubmed publisher
  857. Dang M, Bradford C, Pozzilli P, Leslie R. Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. Methods Mol Biol. 2016;1433:143-51 pubmed publisher
  858. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  859. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  860. Zhu N, Wang H, Wang B, Wei J, Shan W, Feng J, et al. A Member of the Nuclear Receptor Superfamily, Designated as NR2F2, Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:5687589 pubmed publisher
  861. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed publisher
  862. Kyttälä A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy K, et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports. 2016;6:200-12 pubmed publisher
  863. Allaire J, Roy S, Ouellet C, Lemieux Ã, Jones C, Paquet M, et al. Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation. Int J Cancer. 2016;138:2700-12 pubmed publisher
  864. Montufar Solis D, Klein J. Splenic Leukocytes Traffic to the Thyroid and Produce a Novel TSHβ Isoform during Acute Listeria monocytogenes Infection in Mice. PLoS ONE. 2016;11:e0146111 pubmed publisher
  865. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  866. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  867. Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196:1558-67 pubmed publisher
  868. Zhang X, Ma Y, Fu X, Liu Q, Shao Z, Dai L, et al. Runx2-Modified Adipose-Derived Stem Cells Promote Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction. Sci Rep. 2016;6:19073 pubmed publisher
  869. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed publisher
  870. Chen Y, Cheng B, He Z, Wang S, Wang Z, Sun M, et al. Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging. J Cancer. 2016;7:69-79 pubmed publisher
  871. Heo J, Choi Y, Kim H, Kim H. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25 pubmed publisher
  872. Guan X, Wang N, Cui F, Liu Y, Liu P, Zhao J, et al. Caveolin-1 is essential in the differentiation of human adipose-derived stem cells into hepatocyte-like cells via an MAPK pathway-dependent mechanism. Mol Med Rep. 2016;13:1487-94 pubmed publisher
  873. Weinstein S, Toker I, Emmanuel R, Ramishetti S, Hazan Halevy I, Rosenblum D, et al. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proc Natl Acad Sci U S A. 2016;113:E16-22 pubmed publisher
  874. Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein N, et al. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0144535 pubmed publisher
  875. Loperfido M, Jarmin S, Dastidar S, Di Matteo M, Perini I, Moore M, et al. piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts. Nucleic Acids Res. 2016;44:744-60 pubmed publisher
  876. Shaw Bagnall J, Byun S, Begum S, Miyamoto D, Hecht V, Maheswaran S, et al. Deformability of Tumor Cells versus Blood Cells. Sci Rep. 2015;5:18542 pubmed publisher
  877. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  878. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  879. Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher
  880. Kaplan J, Marshall M, C McSkimming C, Harmon D, Garmey J, Oldham S, et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab. 2015;4:779-94 pubmed publisher
  881. Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug G, Sauder U, et al. The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol. 2016;196:106-14 pubmed publisher
  882. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed publisher
  883. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  884. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed publisher
  885. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed publisher
  886. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed publisher
  887. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed publisher
  888. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed publisher
  889. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed publisher
  890. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed publisher
  891. Skovdahl H, Granlund A, Østvik A, Bruland T, Bakke I, Torp S, et al. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells. PLoS ONE. 2015;10:e0141710 pubmed publisher
  892. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed publisher
  893. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  894. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  895. Judd L, Heine R, Menheniott T, Buzzelli J, O Brien Simpson N, Pavlic D, et al. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice. Am J Physiol Gastrointest Liver Physiol. 2016;310:G13-25 pubmed publisher
  896. Wands A, Fujita A, McCombs J, Cervin J, Dedic B, Rodriguez A, et al. Fucosylation and protein glycosylation create functional receptors for cholera toxin. elife. 2015;4:e09545 pubmed publisher
  897. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  898. Bhat N, Adams C, Chen Y, Bieber M, Teng N. Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies. J Immunol. 2015;195:5178-88 pubmed publisher
  899. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  900. Lim H, Cordoba S, Dushek O, Goyette J, Taylor A, Rudd C, et al. Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand. J Immunol. 2015;195:5432-9 pubmed publisher
  901. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  902. Varney M, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, et al. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. J Exp Med. 2015;212:1967-85 pubmed publisher
  903. Alvarez S, Diaz M, Flach J, Rodriguez Acebes S, López Contreras A, Martinez D, et al. Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality. Nat Commun. 2015;6:8548 pubmed publisher
  904. Rodda L, Bannard O, Ludewig B, Nagasawa T, Cyster J. Phenotypic and Morphological Properties of Germinal Center Dark Zone Cxcl12-Expressing Reticular Cells. J Immunol. 2015;195:4781-91 pubmed publisher
  905. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  906. Jones D, Wilmore J, Allman D. Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells. J Immunol. 2015;195:4753-9 pubmed publisher
  907. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  908. Dai B, Chen A, Corkum C, Peroutka R, Landon A, Houng S, et al. Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene. 2016;35:2979-90 pubmed publisher
  909. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  910. Sewald X, Ladinsky M, Uchil P, Beloor J, Pi R, Herrmann C, et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science. 2015;350:563-567 pubmed publisher
  911. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  912. Pohar J, Lainšček D, Fukui R, Yamamoto C, Miyake K, Jerala R, et al. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9. J Immunol. 2015;195:4396-405 pubmed publisher
  913. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  914. Murayama M, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6:8483 pubmed publisher
  915. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  916. Bai H, Liu Y, Xie Y, Hoyle D, Brodsky R, Cheng L, et al. Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells. J Cell Physiol. 2016;231:1065-76 pubmed publisher
  917. Herranz D, Ambesi Impiombato A, Sudderth J, Sánchez Martín M, Belver L, Tosello V, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21:1182-9 pubmed publisher
  918. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  919. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed publisher
  920. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  921. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  922. Shirasuna K, Karasawa T, Usui F, Kobayashi M, Komada T, Kimura H, et al. NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy. Endocrinology. 2015;156:4281-92 pubmed publisher
  923. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  924. Catenacci D, Chapman C, Xu P, Koons A, Konda V, Siddiqui U, et al. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. Gastroenterology. 2015;149:1794-1803.e4 pubmed publisher
  925. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  926. Ramirez H, Liang L, Pastar I, Rosa A, Stojadinovic O, Zwick T, et al. Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin. PLoS ONE. 2015;10:e0137133 pubmed publisher
  927. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  928. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  929. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed publisher
  930. Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, et al. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Thromb Res. 2015;136:786-96 pubmed publisher
  931. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  932. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed publisher
  933. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  934. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed publisher
  935. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  936. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  937. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  938. Fujimura N, Xu B, Dalman J, Deng H, Aoyama K, Dalman R. CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci Rep. 2015;5:11664 pubmed publisher
  939. Ishikawa M, Ohnishi H, Skerleva D, Sakamoto T, Yamamoto N, Hotta A, et al. Transplantation of neurons derived from human iPS cells cultured on collagen matrix into guinea-pig cochleae. J Tissue Eng Regen Med. 2017;11:1766-1778 pubmed publisher
  940. Sternebring O, Alifrangis L, Christensen T, Ji H, Hegelund A, Högerkorp C. A weighted method for estimation of receptor occupancy for pharmacodynamic measurements in drug development. Cytometry B Clin Cytom. 2016;90:220-9 pubmed publisher
  941. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  942. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  943. Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Klaßen C, et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun. 2015;6:7796 pubmed publisher
  944. Croes M, Oner F, Kruyt M, Blokhuis T, Bastian O, Dhert W, et al. Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment. PLoS ONE. 2015;10:e0132781 pubmed publisher
  945. Deng B, Deng W, Xiao P, Zeng K, Zhang S, Zhang H, et al. Nonadherent culture method downregulates stem cell antigen-1 expression in mouse bone marrow mesenchymal stem cells. Exp Ther Med. 2015;10:31-36 pubmed
  946. Boag S, Das R, Shmeleva E, Bagnall A, Egred M, Howard N, et al. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. J Clin Invest. 2015;125:3063-76 pubmed publisher
  947. Jobin C, Cloutier M, Simard C, Néron S. Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral blood. Cytotherapy. 2015;17:1472-84 pubmed publisher
  948. Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39:338-44 pubmed publisher
  949. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  950. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed publisher
  951. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  952. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  953. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  954. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  955. Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J, et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450 pubmed publisher
  956. Zhang J, Li L, Baldwin A, Friedman A, Paz Priel I. Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells. PLoS ONE. 2015;10:e0130441 pubmed publisher
  957. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed publisher
  958. Tacke R, Hilgendorf I, Garner H, Waterborg C, Park K, Nowyhed H, et al. The transcription factor NR4A1 is essential for the development of a novel macrophage subset in the thymus. Sci Rep. 2015;5:10055 pubmed publisher
  959. Elong Ngono A, Lepetit M, Reindl M, Garcia A, Guillot F, Genty A, et al. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis. J Immunol Res. 2015;2015:673503 pubmed publisher
  960. Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2015;87:15-25 pubmed publisher
  961. Cimini E, Agrati C, D Offizi G, Vlassi C, Casetti R, Sacchi A, et al. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 2015;10:e0129771 pubmed publisher
  962. Charmsaz S, Beckett K, Smith F, Bruedigam C, Moore A, Al Ejeh F, et al. EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia. PLoS ONE. 2015;10:e0130692 pubmed publisher
  963. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  964. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed publisher
  965. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  966. Rasmussen T, Andersen T, Bak R, Yiu G, Sørensen C, Stengaard Pedersen K, et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:154 pubmed publisher
  967. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  968. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  969. Wielgosz M, Kim Y, Carney G, Zhan J, Reddivari M, Coop T, et al. Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev. 2015;2:14063 pubmed publisher
  970. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  971. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  972. Huo C, Chew G, Hill P, Huang D, Ingman W, Hodson L, et al. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res. 2015;17:79 pubmed publisher
  973. Louveau A, Smirnov I, Keyes T, Eccles J, Rouhani S, Peske J, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337-41 pubmed publisher
  974. Cioffi M, D Alterio C, Camerlingo R, Tirino V, Consales C, Riccio A, et al. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep. 2015;5:10357 pubmed publisher
  975. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed publisher
  976. Jacque E, Schweighoffer E, Tybulewicz V, Ley S. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival. J Exp Med. 2015;212:883-92 pubmed publisher
  977. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  978. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed publisher
  979. Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, et al. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer. 2015;15:399 pubmed publisher
  980. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher
  981. Tsuneki M, Hardee S, Michaud M, Morotti R, Lavik E, Madri J. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway. Lab Invest. 2015;95:765-80 pubmed publisher
  982. Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92 pubmed publisher
  983. Zhou H, Martínez H, Sun B, Li A, Zimmer M, Katsanis N, et al. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. Stem Cell Rev. 2015;11:652-65 pubmed publisher
  984. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  985. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  986. Zeng S, Wang L, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep. 2015;12:2511-20 pubmed publisher
  987. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  988. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  989. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed publisher
  990. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  991. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  992. Opata M, Carpio V, Ibitokou S, Dillon B, Obiero J, Stephens R. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells. J Immunol. 2015;194:5346-54 pubmed publisher
  993. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  994. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  995. Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dörner T, Tony H. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61 pubmed publisher
  996. Siegemund S, Shepherd J, Xiao C, Sauer K. hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells. PLoS ONE. 2015;10:e0124661 pubmed publisher
  997. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  998. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  999. Sharei A, Trifonova R, Jhunjhunwala S, Hartoularos G, Eyerman A, Lytton Jean A, et al. Ex vivo cytosolic delivery of functional macromolecules to immune cells. PLoS ONE. 2015;10:e0118803 pubmed publisher
  1000. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  1001. Hensley M, de Andrade J, Keene B, MEURS K, Tang J, Wang Z, et al. Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts. J Cell Mol Med. 2015;19:1805-13 pubmed publisher
  1002. Rao T, Marks Bluth J, Sullivan J, Gupta M, Chandrakanthan V, Fitch S, et al. High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice. Stem Cell Res. 2015;14:307-22 pubmed publisher
  1003. Rozanski C, Utley A, Carlson L, Farren M, Murray M, Russell L, et al. CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif. J Immunol. 2015;194:4717-28 pubmed publisher
  1004. Sutherland D, Illingworth A, Keeney M, Richards S. High-Sensitivity Detection of PNH Red Blood Cells, Red Cell Precursors, and White Blood Cells. Curr Protoc Cytom. 2015;72:6.37.1-30 pubmed publisher
  1005. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  1006. Flores Nascimento M, Aléssio A, de Andrade Orsi F, Annichino Bizzacchi J. CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell. Rev Bras Hematol Hemoter. 2015;37:98-102 pubmed publisher
  1007. Luo Z, Jiang L, Xu Y, Li H, Xu W, Wu S, et al. Mechano growth factor (MGF) and transforming growth factor (TGF)-β3 functionalized silk scaffolds enhance articular hyaline cartilage regeneration in rabbit model. Biomaterials. 2015;52:463-75 pubmed publisher
  1008. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed publisher
  1009. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  1010. Kaifi J, Kunkel M, Das A, Harouaka R, Dicker D, Li G, et al. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques. Cancer Biol Ther. 2015;16:699-708 pubmed publisher
  1011. Wong E, Soni C, Chan A, Domeier P, Shwetank -, Abraham T, et al. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance. J Immunol. 2015;194:4130-43 pubmed publisher
  1012. Saland E, Boutzen H, Castellano R, Pouyet L, Griessinger E, Larrue C, et al. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer J. 2015;5:e297 pubmed publisher
  1013. Povinelli B, Kokolus K, Eng J, Dougher C, Curtin L, Capitano M, et al. Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cells. PLoS ONE. 2015;10:e0120078 pubmed publisher
  1014. Hänggi P, Telezhkin V, Kemp P, Schmugge M, Gassmann M, Goede J, et al. Functional plasticity of the N-methyl-d-aspartate receptor in differentiating human erythroid precursor cells. Am J Physiol Cell Physiol. 2015;308:C993-C1007 pubmed publisher
  1015. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  1016. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  1017. Liu B, Lee J, Chen C, Hershey G, Wang Y. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015;194:3583-93 pubmed publisher
  1018. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed publisher
  1019. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed publisher
  1020. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  1021. Kim Y, Lim H, Jung H, Wetsel R, Chung Y. Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cells. PLoS ONE. 2015;10:e0120294 pubmed publisher
  1022. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  1023. Mellott A, Devarajan K, Shinogle H, Moore D, Talata Z, Laurence J, et al. Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues. Tissue Eng Part A. 2015;21:1795-809 pubmed publisher
  1024. Tomasini D, Niccoli A, Crivelli F. Pagetoid reticulosis tumor cells with double expression of TCRγδ and TCRαβ: an off-target phenomenon or genuine expression?. J Cutan Pathol. 2015;42:427-34 pubmed publisher
  1025. Perna F, Vu L, Themeli M, Kriks S, Hoya Arias R, Khanin R, et al. The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. Stem Cell Reports. 2015;4:658-69 pubmed publisher
  1026. Li C, Cheng P, Liang M, Chen Y, Lu Q, Wang J, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125:1509-22 pubmed publisher
  1027. Steindor M, Nkwouano V, Mayatepek E, Mackenzie C, Schramm D, Jacobsen M. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. PLoS ONE. 2015;10:e0119737 pubmed publisher
  1028. Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, et al. Rhof promotes murine marginal zone B cell development. Nagoya J Med Sci. 2014;76:293-305 pubmed
  1029. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed publisher
  1030. Holmfeldt L, Mullighan C. Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. Curr Protoc Pharmacol. 2015;68:14.32.1-19 pubmed publisher
  1031. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  1032. Matsuda T, Yanase S, Takaoka A, Maruyama M. The immunosenescence-related gene Zizimin2 is associated with early bone marrow B cell development and marginal zone B cell formation. Immun Ageing. 2015;12:1 pubmed publisher
  1033. van der Waart A, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunol Immunother. 2015;64:645-54 pubmed publisher
  1034. Laurenti E, Frelin C, Xie S, Ferrari R, Dunant C, Zandi S, et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell. 2015;16:302-13 pubmed publisher
  1035. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  1036. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed publisher
  1037. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed publisher
  1038. Jobsri J, Allen A, Rajagopal D, Shipton M, Kanyuka K, Lomonossoff G, et al. Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody. PLoS ONE. 2015;10:e0118096 pubmed publisher
  1039. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  1040. Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, et al. Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015;6:6351 pubmed publisher
  1041. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  1042. Reddy S, Zeng N, Al Diery H, Jung D, Yeu C, Joret M, et al. Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia. 2015;58:1024-35 pubmed publisher
  1043. Rönn R, Guibentif C, Moraghebi R, Chaves P, Saxena S, Garcia B, et al. Retinoic acid regulates hematopoietic development from human pluripotent stem cells. Stem Cell Reports. 2015;4:269-81 pubmed publisher
  1044. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  1045. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  1046. Li Y, Wu Y, Abbatiello T, Wu W, Kim J, Sarkissyan M, et al. Slug contributes to cancer progression by direct regulation of ERα signaling pathway. Int J Oncol. 2015;46:1461-72 pubmed publisher
  1047. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  1048. Valle A, Barbagiovanni G, Jofra T, Stabilini A, Pérol L, Baeyens A, et al. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation. J Immunol. 2015;194:2117-27 pubmed publisher
  1049. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed publisher
  1050. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  1051. Hu W, Dooley J, Chung S, Chandramohan D, Cimmino L, Mukherjee S, et al. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 2015;125:2206-16 pubmed publisher
  1052. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  1053. Feldman S, Achour I, Wuerffel R, Kumar S, Gerasimova T, Sen R, et al. Constraints contributed by chromatin looping limit recombination targeting during Ig class switch recombination. J Immunol. 2015;194:2380-9 pubmed publisher
  1054. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  1055. Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195-207 pubmed publisher
  1056. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  1057. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  1058. Däster S, Eppenberger Castori S, Hirt C, Zlobec I, Delko T, Nebiker C, et al. High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer. Dis Markers. 2014;2014:792183 pubmed publisher
  1059. Du Z, Abedalthagafi M, Aizer A, McHenry A, Sun H, Bray M, et al. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015;6:4704-16 pubmed
  1060. Du J, Shen X, Hu X, Sun B, Guan W, Li S, et al. Wip1-deficient neutrophils significantly promote intestinal ischemia/reperfusion injury in mice. Curr Mol Med. 2015;15:100-8 pubmed
  1061. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  1062. Leon Rico D, Fernández García M, Aldea M, Sánchez R, Peces Barba M, Martínez Palacio J, et al. Comparison of haematopoietic stem cell engraftment through the retro-orbital venous sinus and the lateral vein: alternative routes for bone marrow transplantation in mice. Lab Anim. 2015;49:132-41 pubmed publisher
  1063. Cao A, Yao S, Gong B, Nurieva R, Elson C, Cong Y. Interleukin (IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol. 2015;8:1072-82 pubmed publisher
  1064. Sakuraba K, Fujimura K, Nakashima Y, Okazaki K, Fukushi J, Ohishi M, et al. Brief report: successful in vitro culture of rheumatoid arthritis synovial tissue explants at the air-liquid interface. Arthritis Rheumatol. 2015;67:887-92 pubmed publisher
  1065. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed publisher
  1066. Lee Y, Lim K, Oh J, Yoon A, Joo W, Kim H, et al. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs). J Control Release. 2015;205:128-33 pubmed publisher
  1067. Ruiz C, Li J, Luttgen M, Kolatkar A, Kendall J, Flores E, et al. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients. Phys Biol. 2015;12:016008 pubmed publisher
  1068. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher
  1069. Bettman N, Avivi I, Rosenbaum H, Bisharat L, Katz T. Impaired migration capacity in monocytes derived from patients with Gaucher disease. Blood Cells Mol Dis. 2015;55:180-6 pubmed publisher
  1070. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed publisher
  1071. Vettermann C, Timblin G, Lim V, Lai E, Schlissel M. The proximal J kappa germline-transcript promoter facilitates receptor editing through control of ordered recombination. PLoS ONE. 2015;10:e0113824 pubmed publisher
  1072. Watson M, Hedley D. Whole blood measurement of histone modifications linked to the epigenetic regulation of gene expression. Curr Protoc Cytom. 2015;71:6.36.1-9 pubmed publisher
  1073. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed publisher
  1074. Tusi B, Deng C, Salz T, Zeumer L, Li Y, So C, et al. Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement. FASEB J. 2015;29:1505-15 pubmed publisher
  1075. Krysiak K, Tibbitts J, Shao J, Liu T, Ndonwi M, Walter M. Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells. Exp Hematol. 2015;43:319-30.e10 pubmed publisher
  1076. Bacchetta J, Chun R, Gales B, Zaritsky J, Leroy S, Wesseling Perry K, et al. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS ONE. 2014;9:e116530 pubmed publisher
  1077. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed publisher
  1078. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  1079. Karamitros D, Patmanidi A, Kotantaki P, Potocnik A, Bähr Ivacevic T, Benes V, et al. Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors. Development. 2015;142:70-81 pubmed publisher
  1080. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  1081. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  1082. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  1083. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  1084. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  1085. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed publisher
  1086. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  1087. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  1088. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  1089. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  1090. Guo X, Tanaka Y, Kondo M. Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103. Immunol Lett. 2015;163:40-8 pubmed publisher
  1091. Yuan K, Orcholski M, Panaroni C, Shuffle E, Huang N, Jiang X, et al. Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis. Am J Pathol. 2015;185:69-84 pubmed publisher
  1092. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  1093. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed publisher
  1094. Dabydeen S, Kang K, Díaz Cruz E, Alamri A, Axelrod M, Bouker K, et al. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis. 2015;36:122-32 pubmed publisher
  1095. Schliehe C, Flynn E, Vilagos B, Richson U, Swaminanthan S, Bosnjak B, et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol. 2015;16:67-74 pubmed publisher
  1096. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  1097. Radecke C, Warrick A, Singh G, Rogers J, Simon S, Armstrong E. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction. Thromb Haemost. 2015;113:605-16 pubmed publisher
  1098. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  1099. Zanotti K, Maul R, Castiblanco D, Yang W, Choi Y, Fox J, et al. ATAD5 deficiency decreases B cell division and Igh recombination. J Immunol. 2015;194:35-42 pubmed publisher
  1100. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  1101. Marques Howarth M, Simpson D, Ngok S, Nieves B, Chen R, Siprashvili Z, et al. Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J Clin Invest. 2014;124:5275-90 pubmed publisher
  1102. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  1103. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  1104. Peschke K, Dudeck A, Rabenhorst A, Hartmann K, Roers A. Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation. Methods Mol Biol. 2015;1220:403-21 pubmed publisher
  1105. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  1106. Jurkin J, Henkel T, Nielsen A, Minnich M, Popow J, Kaufmann T, et al. The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cells. EMBO J. 2014;33:2922-36 pubmed publisher
  1107. Su Y, Cheng T, Chen C, Chang W, Tsai N, Kung C, et al. Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic Lupus erythematosus. J Transl Med. 2014;12:303 pubmed publisher
  1108. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  1109. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  1110. Santoro S, Kim S, Motz G, Alatzoglou D, Li C, Irving M, et al. T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer Immunol Res. 2015;3:68-84 pubmed publisher
  1111. Llosa N, Cruise M, Tam A, Wicks E, Hechenbleikner E, Taube J, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5:43-51 pubmed publisher
  1112. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  1113. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  1114. Tiendrebeogo R, Adu B, Singh S, Dodoo D, Dziegiel M, Mordmüller B, et al. High-throughput tri-colour flow cytometry technique to assess Plasmodium falciparum parasitaemia in bioassays. Malar J. 2014;13:412 pubmed publisher
  1115. Martin R, Brooks K, Henningsson F, Heyman B, Conrad D. Antigen transfer from exosomes to dendritic cells as an explanation for the immune enhancement seen by IgE immune complexes. PLoS ONE. 2014;9:e110609 pubmed publisher
  1116. Trinité B, Chan C, Lee C, Mahajan S, Luo Y, Muesing M, et al. Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells. PLoS ONE. 2014;9:e110719 pubmed publisher
  1117. Sakamoto H, Takeda N, Arai F, Hosokawa K, García P, Suda T, et al. Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes. Stem Cells. 2015;33:479-90 pubmed publisher
  1118. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  1119. Morales D, Monte K, Sun L, Struckhoff J, Agapov E, Holtzman M, et al. Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice. J Virol. 2015;89:337-49 pubmed publisher
  1120. Wheeler S, Clark A, Taylor D, Young C, Pillai V, Stolz D, et al. Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system. Br J Cancer. 2014;111:2342-50 pubmed publisher
  1121. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
  1122. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed publisher
  1123. Becker A, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Exp Hematol. 2015;43:44-52.e1-3 pubmed publisher
  1124. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  1125. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  1126. Nagano T, Edamatsu H, Kobayashi K, Takenaka N, Yamamoto M, Sasaki N, et al. Phospholipase cε, an effector of ras and rap small GTPases, is required for airway inflammatory response in a mouse model of bronchial asthma. PLoS ONE. 2014;9:e108373 pubmed publisher
  1127. Donaldson D, Bradford B, Artis D, Mabbott N. Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23. Mucosal Immunol. 2015;8:582-95 pubmed publisher
  1128. Willis E, Eberle R, Wolf R, White G, McFarlane D. The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS ONE. 2014;9:e107167 pubmed publisher
  1129. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  1130. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed publisher
  1131. Baccelli I, Stenzinger A, Vogel V, Pfitzner B, Klein C, Wallwiener M, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014;5:8147-60 pubmed
  1132. Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington G, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol. 2014;155:91-107 pubmed publisher
  1133. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed publisher
  1134. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  1135. Jacque E, Schweighoffer E, Visekruna A, Papoutsopoulou S, Janzen J, Zillwood R, et al. IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen. J Exp Med. 2014;211:2085-101 pubmed publisher
  1136. Renand A, Newbrough S, Wambre E, Delong J, Robinson D, Kwok W. Arginine kinase Pen m 2 as an important shrimp allergen recognized by TH2 cells. J Allergy Clin Immunol. 2014;134:1456-1459.e7 pubmed publisher
  1137. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  1138. Chen W, Saparov A, Corselli M, Crisan M, Zheng B, Péault B, et al. Isolation of blood-vessel-derived multipotent precursors from human skeletal muscle. J Vis Exp. 2014;:e51195 pubmed publisher
  1139. Bacher P, Kniemeyer O, Teutschbein J, Thön M, Vödisch M, Wartenberg D, et al. Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells. J Immunol. 2014;193:3332-43 pubmed publisher
  1140. Zorin V, Komlev V, Zorina A, Khromova N, Solovieva E, Fedotov A, et al. Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomed Mater. 2014;9:055005 pubmed publisher
  1141. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  1142. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  1143. Cremasco V, Woodruff M, Onder L, Cupovic J, Nieves Bonilla J, Schildberg F, et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol. 2014;15:973-81 pubmed publisher
  1144. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed publisher
  1145. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  1146. Al Barwani F, Young S, Baird M, Larsen D, Ward V. Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS ONE. 2014;9:e104523 pubmed publisher
  1147. Menon M, Sawada A, Chaturvedi A, Mishra P, Schuster Gossler K, Galla M, et al. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis. PLoS Genet. 2014;10:e1004558 pubmed publisher
  1148. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  1149. Chuang H, Sheu W, Lin Y, Tsai C, Yang C, Cheng Y, et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun. 2014;5:4602 pubmed publisher
  1150. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  1151. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  1152. Flach J, Bakker S, Mohrin M, Conroy P, Pietras E, Reynaud D, et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014;512:198-202 pubmed publisher
  1153. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  1154. Pisano F, Heine W, Rosenheinrich M, Schweer J, Nuss A, Dersch P. Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route. PLoS ONE. 2014;9:e103541 pubmed publisher
  1155. Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor ?t (ROR?t) in Th17 cells. J Biol Chem. 2014;289:25546-55 pubmed publisher
  1156. Ochiai S, Roediger B, Abtin A, Shklovskaya E, Fazekas de St Groth B, Yamane H, et al. CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells are activated by thymic stromal lymphopoietin during contact sensitization in mice. J Immunol. 2014;193:2504-11 pubmed publisher
  1157. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  1158. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  1159. Wu D, Allen C, Fromm J. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry B Clin Cytom. 2015;88:58-63 pubmed publisher
  1160. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  1161. Minonzio G, Corazza M, Mariotta L, Gola M, Zanzi M, Gandolfi E, et al. Frozen adipose-derived mesenchymal stem cells maintain high capability to grow and differentiate. Cryobiology. 2014;69:211-6 pubmed publisher
  1162. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  1163. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed publisher
  1164. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  1165. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  1166. Hagel C, Krasemann S, Löffler J, Puschel K, Magnus T, Glatzel M. Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1? expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms. Brain Pathol. 2015;25:146-56 pubmed publisher
  1167. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed publisher
  1168. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed publisher
  1169. Kläsener K, Maity P, Hobeika E, Yang J, Reth M. B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk. elife. 2014;3:e02069 pubmed publisher
  1170. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  1171. Oksvold M, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, et al. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther. 2014;36:847-862.e1 pubmed publisher
  1172. Kubach J, Hubo M, Amendt C, Stroh C, Jonuleit H. IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity. Int J Cancer. 2015;136:821-30 pubmed publisher
  1173. Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, et al. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ?ureC::hly vaccine's superior protection against tuberculosis. J Infect Dis. 2014;210:1928-37 pubmed publisher
  1174. Arif S, Leete P, Nguyen V, Marks K, Nor N, Estorninho M, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes. 2014;63:3835-45 pubmed publisher
  1175. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed publisher
  1176. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed publisher
  1177. Mise Omata S, Alles N, Fukazawa T, Aoki K, Ohya K, Jimi E, et al. NF-?B RELA-deficient bone marrow macrophages fail to support bone formation and to maintain the hematopoietic niche after lethal irradiation and stem cell transplantation. Int Immunol. 2014;26:607-18 pubmed publisher
  1178. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  1179. Rito M, Schmitt F, Pinto A, André S. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. Virchows Arch. 2014;465:185-91 pubmed publisher
  1180. Alsadeq A, Hobeika E, Medgyesi D, Kläsener K, Reth M. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol. 2014;193:268-76 pubmed publisher
  1181. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  1182. Jovanovic D, Djurdjevic P, Andjelkovic N, Zivić L. Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia. Contemp Oncol (Pozn). 2014;18:29-33 pubmed publisher
  1183. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  1184. Cichocki F, Schlums H, Li H, Stache V, Holmes T, Lenvik T, et al. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency. J Exp Med. 2014;211:1079-91 pubmed publisher
  1185. Gautron A, Dominguez Villar M, de Marcken M, Hafler D. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703-2711 pubmed publisher
  1186. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  1187. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed publisher
  1188. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  1189. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher
  1190. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  1191. Yang Y, Li Y, Liu Y, Yang M, Liu K. CD30+ extranodal natural killer/T-cell lymphoma mimicking phlegmonous myositis: A case report. Oncol Lett. 2014;7:1419-1421 pubmed
  1192. Chen M, Hong M, Sun H, Wang L, Shi X, Gilbert B, et al. Essential role for autophagy in the maintenance of immunological memory against influenza infection. Nat Med. 2014;20:503-10 pubmed publisher
  1193. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  1194. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  1195. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed publisher
  1196. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  1197. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  1198. Grosso A, De Oliveira S, Higuchi M, Favarato D, Dallan L, da Luz P. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. Diabetol Metab Syndr. 2014;6:47 pubmed publisher
  1199. Grassinger J, Khomenko A, Hart C, Baldaranov D, Johannesen S, Mueller G, et al. Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. Cytokine. 2014;67:21-8 pubmed publisher
  1200. Sipol A, Babenko E, Borisov V, Naumova E, Boyakova E, Yakunin D, et al. An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort. Hematology. 2015;20:31-8 pubmed publisher
  1201. Lee J, Hong W, Majeti R, Stearns T. Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms. PLoS ONE. 2014;9:e92641 pubmed publisher
  1202. Kasama Y, Mizukami T, Kusunoki H, Peveling Oberhag J, Nishito Y, Ozawa M, et al. B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-?B signalling. PLoS ONE. 2014;9:e91373 pubmed publisher
  1203. Loh L, Ivarsson M, Michaelsson J, Sandberg J, Nixon D. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol. 2014;7:1233-43 pubmed publisher
  1204. Hofner T, Macher Goeppinger S, Klein C, Schillert A, Eisen C, Wagner S, et al. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy. Urol Oncol. 2014;32:678-86 pubmed publisher
  1205. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  1206. Suzuki O, Abe M. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans. Int J Oncol. 2014;44:1433-42 pubmed publisher
  1207. Vanoaica L, Richman L, Jaworski M, Darshan D, Luther S, Kühn L. Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations. PLoS ONE. 2014;9:e89270 pubmed publisher
  1208. Oh B, Huang N, Chen W, Seo J, Chen P, Cornell T, et al. Integrated nanoplasmonic sensing for cellular functional immunoanalysis using human blood. ACS Nano. 2014;8:2667-76 pubmed publisher
  1209. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  1210. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  1211. Ye J, Vives Pi M, Gillespie K. Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells. PLoS ONE. 2014;9:e86985 pubmed publisher
  1212. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  1213. Schneppenheim J, Hüttl S, Mentrup T, Lüllmann Rauch R, Rothaug M, Engelke M, et al. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo. Mol Cell Biol. 2014;34:1398-411 pubmed publisher
  1214. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  1215. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed publisher
  1216. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  1217. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  1218. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed publisher
  1219. Bodi I, Curran O, Selway R, Elwes R, Burrone J, Laxton R, et al. Two cases of multinodular and vacuolating neuronal tumour. Acta Neuropathol Commun. 2014;2:7 pubmed publisher
  1220. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  1221. Lauer M, Aytekin M, Comhair S, Loftis J, Tian L, Farver C, et al. Modification of hyaluronan by heavy chains of inter-?-inhibitor in idiopathic pulmonary arterial hypertension. J Biol Chem. 2014;289:6791-8 pubmed publisher
  1222. Heuts F, Rottenberg M, Salamon D, Rasul E, Adori M, Klein G, et al. T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. J Virol. 2014;88:3235-45 pubmed publisher
  1223. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed publisher
  1224. Poggi A, Miniscalco B, Morello E, Comazzi S, Gelain M, Aresu L, et al. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma. Vet Comp Oncol. 2015;13:475-80 pubmed publisher
  1225. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  1226. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  1227. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed publisher
  1228. Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu L, et al. Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression. Int J Hematol. 2014;99:79-86 pubmed publisher
  1229. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  1230. Adams R, Cheung C, Banh R, Saal R, Cross D, Gill D, et al. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry B Clin Cytom. 2014;86:80-90 pubmed
  1231. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed publisher
  1232. Bittner Eddy P, Fischer L, Costalonga M. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice. Mol Oral Microbiol. 2013;28:452-66 pubmed publisher
  1233. Povinelli B, Nemeth M. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells. 2014;32:105-15 pubmed publisher
  1234. Satpathy A, Briseño C, Lee J, Ng D, Manieri N, Kc W, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol. 2013;14:937-48 pubmed publisher
  1235. Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, et al. Transcription factor early growth response 3 is associated with the TGF-?1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol. 2013;191:2351-9 pubmed publisher
  1236. Pioli P, Dahlem T, Weis J, Weis J. Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency. PLoS ONE. 2013;8:e69216 pubmed publisher
  1237. van Leeuwen M, Du Pré M, van Wanrooij R, de Ruiter L, Raatgeep H, Lindenbergh Kortleve D, et al. Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients. PLoS ONE. 2013;8:e68432 pubmed publisher
  1238. Ruparel S, Hargreaves K, Eskander M, Rowan S, de Almeida J, Roman L, et al. Oxidized linoleic acid metabolite-cytochrome P450 system (OLAM-CYP) is active in biopsy samples from patients with inflammatory dental pain. Pain. 2013;154:2363-71 pubmed publisher
  1239. Trichler S, Bulla S, Thomason J, Lunsford K, Bulla C. Ultra-pure platelet isolation from canine whole blood. BMC Vet Res. 2013;9:144 pubmed publisher
  1240. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  1241. Ye L, Muench M, Fusaki N, Beyer A, Wang J, Qi Z, et al. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med. 2013;2:558-66 pubmed publisher
  1242. Billerbeck E, Horwitz J, Labitt R, Donovan B, Vega K, Budell W, et al. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol. 2013;191:1753-64 pubmed publisher
  1243. Stoilova B, Kowenz Leutz E, Scheller M, Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBP? structure and post-translational modifications. PLoS ONE. 2013;8:e65169 pubmed publisher
  1244. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed publisher
  1245. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  1246. Zhou D, Tan R, Lin L, Zhou L, Liu Y. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int. 2013;84:509-20 pubmed publisher
  1247. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  1248. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed publisher
  1249. Chaimowitz N, Falanga Y, Ryan J, Conrad D. Fyn kinase is required for optimal humoral responses. PLoS ONE. 2013;8:e60640 pubmed publisher
  1250. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed publisher
  1251. Billich A, Baumruker T, Beerli C, Bigaud M, Bruns C, Calzascia T, et al. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. PLoS ONE. 2013;8:e59630 pubmed publisher
  1252. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  1253. Smith A, Gibbons H, Oldfield R, Bergin P, Mee E, Faull R, et al. The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia. 2013;61:929-42 pubmed publisher
  1254. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  1255. Roubelakis M, Tsaknakis G, Pappa K, Anagnou N, Watt S. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS ONE. 2013;8:e54747 pubmed publisher
  1256. Raynaud C, Halabi N, Elliott D, Pasquier J, Elefanty A, Stanley E, et al. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS ONE. 2013;8:e54524 pubmed publisher
  1257. McArthur M, Sztein M. Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol. 2013;146:140-52 pubmed publisher
  1258. Kipari T, Hadoke P, Iqbal J, Man T, Miller E, Coutinho A, et al. 11?-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB J. 2013;27:1519-31 pubmed publisher
  1259. Bergmann H, Yabas M, Short A, Miosge L, Barthel N, Teh C, et al. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A. J Exp Med. 2013;210:31-40 pubmed publisher
  1260. Zimmerlin L, Donnenberg V, Rubin J, Donnenberg A. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A. 2013;83:134-40 pubmed publisher
  1261. Nakajima Takagi Y, Osawa M, Oshima M, Takagi H, Miyagi S, Endoh M, et al. Role of SOX17 in hematopoietic development from human embryonic stem cells. Blood. 2013;121:447-58 pubmed publisher
  1262. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  1263. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed publisher
  1264. Behnke M, Fentress S, Mashayekhi M, Li L, Taylor G, Sibley L. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog. 2012;8:e1002992 pubmed publisher
  1265. Zschemisch N, Glage S, Wedekind D, Weinstein E, Cui X, Dorsch M, et al. Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol. 2012;13:60 pubmed publisher
  1266. Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi A, De Metrio M, et al. Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. J Am Heart Assoc. 2012;1:27-41 pubmed publisher
  1267. Gillespie E, Raychaudhuri N, Papageorgiou K, Atkins S, Lu Y, Charara L, et al. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-?B. Invest Ophthalmol Vis Sci. 2012;53:7746-53 pubmed publisher
  1268. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  1269. Yang Y, Li J, Pan X, Zhou P, Yu X, Cao H, et al. Co-culture with mesenchymal stem cells enhances metabolic functions of liver cells in bioartificial liver system. Biotechnol Bioeng. 2013;110:958-68 pubmed publisher
  1270. Weiss J, Bilate A, Gobert M, Ding Y, Curotto de Lafaille M, Parkhurst C, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med. 2012;209:1723-42, S1 pubmed
  1271. Sharma S, Pichichero M. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281-91 pubmed publisher
  1272. Venigalla R, Guttikonda P, Eckstein V, Ho A, Sertel S, Lorenz H, et al. Identification of a human Th1-like IFN?-secreting Treg subtype deriving from effector T cells. J Autoimmun. 2012;39:377-87 pubmed publisher
  1273. Elkins K, Zheng B, Go M, Slaga D, Du C, Scales S, et al. FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther. 2012;11:2222-32 pubmed publisher
  1274. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  1275. Clarner T, Diederichs F, Berger K, Denecke B, Gan L, van der Valk P, et al. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia. 2012;60:1468-80 pubmed publisher
  1276. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  1277. Seung S, Curti B, Crittenden M, Walker E, Coffey T, Siebert J, et al. Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses. Sci Transl Med. 2012;4:137ra74 pubmed publisher
  1278. Jenkins C, Shevchuk O, Giambra V, Lam S, Carboni J, Gottardis M, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715-723.e6 pubmed publisher
  1279. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  1280. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  1281. Lemire B, Debigare R, Dubé A, Thériault M, Cote C, Maltais F. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012;113:159-66 pubmed publisher
  1282. Yang H, Xu C, Tang Y, Wan C, Liu W, Wang L. The significance of multiplex PCR/heteroduplex analysis-based TCR-? gene rearrangement combined with laser-capture microdissection in the diagnosis of early mycosis fungoides. J Cutan Pathol. 2012;39:337-46 pubmed publisher
  1283. Imataki O, Ansén S, Tanaka M, Butler M, Berezovskaya A, Milstein M, et al. IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells. J Immunol. 2012;188:1609-19 pubmed publisher
  1284. Purtha W, Tedder T, Johnson S, Bhattacharya D, Diamond M. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med. 2011;208:2599-606 pubmed publisher
  1285. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed publisher
  1286. Ruckwardt T, Malloy A, Gostick E, Price D, Dash P, McClaren J, et al. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 2011;7:e1002377 pubmed publisher
  1287. Su X, Huang J, Jiang Y, Tang Y, Li G, Liu W. Serous effusion cytology of extranodal natural killer/T-cell lymphoma. Cytopathology. 2012;23:96-102 pubmed publisher
  1288. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  1289. Neunkirchner A, Leb Reichl V, Schmetterer K, Mutschlechner S, Kueng H, Haiderer D, et al. Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells. J Immunol. 2011;187:4077-87 pubmed publisher
  1290. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  1291. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  1292. Hemmers S, Teijaro J, Arandjelovic S, Mowen K. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE. 2011;6:e22043 pubmed publisher
  1293. Belisle S, Yin J, Shedlock D, Dai A, Yan J, Hirao L, et al. Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine. PLoS ONE. 2011;6:e19681 pubmed publisher
  1294. Alvares C, Schenk T, Hulkki S, Min T, Vijayaraghavan G, Yeung J, et al. Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations. Br J Haematol. 2011;154:457-65 pubmed publisher
  1295. Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13:R29 pubmed publisher
  1296. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, Park J, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol. 2011;186:2106-16 pubmed publisher
  1297. Libri V, Azevedo R, Jackson S, Di Mitri D, Lachmann R, Fuhrmann S, et al. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology. 2011;132:326-39 pubmed publisher
  1298. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  1299. Farias V, Linares Fernández J, Peñalver J, Payá Colmenero J, Ferrón G, Duran E, et al. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta. 2011;32:86-95 pubmed publisher
  1300. Res P, Piskin G, de Boer O, van der Loos C, Teeling P, Bos J, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE. 2010;5:e14108 pubmed publisher
  1301. Chui K, Trivedi A, Cheng C, Cherbavaz D, Dazin P, Huynh A, et al. Characterization and functionality of proliferative human Sertoli cells. Cell Transplant. 2011;20:619-35 pubmed publisher
  1302. Mokry J, Soukup T, Micuda S, Karbanova J, Visek B, Brcakova E, et al. Telomere attrition occurs during ex vivo expansion of human dental pulp stem cells. J Biomed Biotechnol. 2010;2010:673513 pubmed publisher
  1303. Hoffmann P, Eder R, Edinger M. Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells. Methods Mol Biol. 2011;677:15-30 pubmed publisher
  1304. Estes M, Mund J, Mead L, Prater D, Cai S, Wang H, et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry A. 2010;77:831-9 pubmed publisher
  1305. Hodson D, Janas M, Galloway A, Bell S, Andrews S, Li C, et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol. 2010;11:717-24 pubmed publisher
  1306. Ksiazkiewicz M, Gottfried E, Kreutz M, Mack M, Hofstaedter F, Kunz Schughart L. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts. Immunobiology. 2010;215:737-47 pubmed publisher
  1307. Mehling M, Lindberg R, Raulf F, Kuhle J, Hess C, Kappos L, et al. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology. 2010;75:403-10 pubmed publisher
  1308. Bittner S, Bobak N, Herrmann A, Göbel K, Meuth P, Höhn K, et al. Upregulation of K2P5.1 potassium channels in multiple sclerosis. Ann Neurol. 2010;68:58-69 pubmed publisher
  1309. Giltiay N, Lu Y, Allman D, Jørgensen T, Li X. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol. 2010;185:99-109 pubmed publisher
  1310. DiMeglio L, Tosh A, Saha C, Estes M, Mund J, Mead L, et al. Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae?. J Pediatr. 2010;157:540-6 pubmed publisher
  1311. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  1312. Guikema J, Schrader C, Brodsky M, Linehan E, Richards A, El Falaky N, et al. p53 represses class switch recombination to IgG2a through its antioxidant function. J Immunol. 2010;184:6177-87 pubmed publisher
  1313. Cicin Sain L, Smyk Pearson S, Smyk Paerson S, Currier N, Byrd L, Koudelka C, et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J Immunol. 2010;184:6739-45 pubmed publisher
  1314. Estes M, Mund J, Ingram D, Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr Protoc Cytom. 2010;Chapter 9:Unit 9.33.1-11 pubmed publisher
  1315. Coffey F, Manser T. Expression of cellular FLIP by B cells is required for their participation in an immune response. J Immunol. 2010;184:4871-9 pubmed publisher
  1316. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  1317. Shedlock D, Talbott K, Morrow M, Ferraro B, Hokey D, Muthumani K, et al. Ki-67 staining for determination of rhesus macaque T cell proliferative responses ex vivo. Cytometry A. 2010;77:275-84 pubmed publisher
  1318. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  1319. Sadri N, Lu J, Badura M, Schneider R. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010;11:1 pubmed publisher
  1320. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  1321. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE. 2009;4:e7067 pubmed publisher
  1322. Göbel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood. 2009;114:3813-21 pubmed publisher
  1323. Serikov V, Hounshell C, Larkin S, Green W, Ikeda H, Walters M, et al. Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood). 2009;234:813-23 pubmed publisher
  1324. Schaeffer M, Han S, Chtanova T, van Dooren G, Herzmark P, Chen Y, et al. Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. J Immunol. 2009;182:6379-93 pubmed publisher
  1325. Hoffmann P, Boeld T, Eder R, Huehn J, Floess S, Wieczorek G, et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol. 2009;39:1088-97 pubmed publisher
  1326. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  1327. Fujimaki W, Takahashi N, Ohnuma K, Nagatsu M, Kurosawa H, Yoshida S, et al. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol. 2008;2008:305859 pubmed publisher
  1328. Lages C, Suffia I, Velilla P, Huang B, Warshaw G, Hildeman D, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol. 2008;181:1835-48 pubmed
  1329. Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008;105:9041-6 pubmed publisher
  1330. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed publisher
  1331. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  1332. Waskow C, Liu K, Darrasse Jèze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9:676-83 pubmed publisher
  1333. Dunham R, Cervasi B, Brenchley J, Albrecht H, Weintrob A, Sumpter B, et al. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol. 2008;180:5582-92 pubmed
  1334. Streeck H, Cohen K, Jolin J, Brockman M, Meier A, Power K, et al. Rapid ex vivo isolation and long-term culture of human Th17 cells. J Immunol Methods. 2008;333:115-25 pubmed publisher
  1335. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299-304 pubmed
  1336. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood. 2008;111:142-9 pubmed
  1337. Laurie K, Blundell M, Baxendale H, Howe S, Sinclair J, Qasim W, et al. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector. Gene Ther. 2007;14:1623-31 pubmed
  1338. Wei C, Anolik J, Cappione A, Zheng B, Pugh Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178:6624-33 pubmed
  1339. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  1340. Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood. 2007;110:877-85 pubmed
  1341. Andersen H, Barsov E, Trivett M, Trubey C, Giavedoni L, Lifson J, et al. Transduction with human telomerase reverse transcriptase immortalizes a rhesus macaque CD8+ T cell clone with maintenance of surface marker phenotype and function. AIDS Res Hum Retroviruses. 2007;23:456-65 pubmed
  1342. Gottfried E, Kreutz M, Haffner S, Holler E, Iacobelli M, Andreesen R, et al. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand J Immunol. 2007;65:329-35 pubmed
  1343. Saada J, Pinchuk I, Barrera C, Adegboyega P, Suarez G, Mifflin R, et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J Immunol. 2006;177:5968-79 pubmed
  1344. Gebe J, Unrath K, Falk B, Ito K, Wen L, Daniels T, et al. Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice. Clin Immunol. 2006;121:294-304 pubmed
  1345. Hoves S, Krause S, Schutz C, Halbritter D, Scholmerich J, Herfarth H, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol. 2006;177:2691-8 pubmed
  1346. Lim H, Broxmeyer H, Kim C. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol. 2006;177:840-51 pubmed
  1347. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  1348. Paiardini M, Cervasi B, Sumpter B, McClure H, Sodora D, Magnani M, et al. Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys. J Virol. 2006;80:634-42 pubmed
  1349. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed
  1350. Schwendemann J, Choi C, Schirrmacher V, Beckhove P. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells. J Immunol. 2005;175:1433-9 pubmed
  1351. Nakae S, Suto H, Kakurai M, Sedgwick J, Tsai M, Galli S. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 2005;102:6467-72 pubmed
  1352. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  1353. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  1354. Craig M, Waitumbi J, Taylor R. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J Immunol. 2005;174:3059-66 pubmed
  1355. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  1356. Suarez L, Vidriales M, Moreno M, Lopez A, García Laraña J, Perez Lopez C, et al. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Haematologica. 2005;90:54-9 pubmed
  1357. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  1358. Suarez L, Vidriales M, García Laraña J, Sanz G, Moreno M, Lopez A, et al. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Clin Cancer Res. 2004;10:7599-606 pubmed
  1359. Bouma Ter Steege J, Baeten C, Thijssen V, Satijn S, Verhoeven I, Hillen H, et al. Angiogenic profile of breast carcinoma determines leukocyte infiltration. Clin Cancer Res. 2004;10:7171-8 pubmed
  1360. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  1361. Eriksson M, Meadows S, Wira C, Sentman C. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol. 2004;76:667-75 pubmed
  1362. Dayyani F, Joeinig A, Ziegler Heitbrock L, Schmidmaier R, Straka C, Emmerich B, et al. Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma. J Leukoc Biol. 2004;75:207-13 pubmed
  1363. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T, et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol. 2003;33:2773-82 pubmed
  1364. Jasionowski T, Hartung L, Greenwood J, Perkins S, Bahler D. Analysis of CD10+ hairy cell leukemia. Am J Clin Pathol. 2003;120:228-35 pubmed
  1365. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  1366. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  1367. Luo H, Yu G, Wu Y, Wu J. EphB6 crosslinking results in costimulation of T cells. J Clin Invest. 2002;110:1141-50 pubmed
  1368. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  1369. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  1370. Janossy G, Jani I, Kahan M, Barnett D, Mandy F, Shapiro H. Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer. Cytometry. 2002;50:78-85 pubmed
  1371. Jacobsen M, Hoffmann S, Cepok S, Stei S, Ziegler A, Sommer N, et al. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics. 2002;54:158-63 pubmed
  1372. Yu Y, Rabinowitz R, Polliack A, Ben Bassat H, Schlesinger M. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells. Eur J Haematol. 2002;68:22-30 pubmed
  1373. Thompson S, Luyrink L, Graham T, Tsoras M, Ryan M, Passo M, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001;166:6899-906 pubmed
  1374. Berckmans R, Nieuwland R, Böing A, Romijn F, Hack C, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85:639-46 pubmed
  1375. Blom B, Ho S, Antonenko S, Liu Y. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med. 2000;192:1785-96 pubmed
  1376. McRae B, Nagai T, Semnani R, van Seventer J, van Seventer G. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood. 2000;96:210-7 pubmed
  1377. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  1378. Chakrabarti L, Lewin S, Zhang L, Gettie A, Luckay A, Martin L, et al. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol. 2000;74:1209-23 pubmed
  1379. Capmany G, Querol S, Cancelas J, Garcia J. Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells. Haematologica. 1999;84:675-82 pubmed
  1380. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  1381. Holada K, Mondoro T, Muller J, Vostal J. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets. Br J Haematol. 1998;103:276-82 pubmed
  1382. Waterfall M, Black A, Riley E. Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun. 1998;66:2393-8 pubmed
  1383. Kim C, Pelus L, White J, Applebaum E, Johanson K, Broxmeyer H. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-24 pubmed
  1384. Negrier C, Vinciguerra C, Attali O, Grenier C, Larcher M, Dechavanne M. Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia. Br J Haematol. 1998;100:33-9 pubmed
  1385. Basch R, Quito F, Beh J, Hirst J. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. Stem Cells. 1997;15:314-23 pubmed
  1386. Bleul C, Wu L, Hoxie J, Springer T, Mackay C. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A. 1997;94:1925-30 pubmed
  1387. Smith S, Brown M, Rowe D, Callard R, Beverley P. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology. 1986;58:63-70 pubmed